Home Cart Sign in  
Chemical Structure| 137281-23-3 Chemical Structure| 137281-23-3

Structure of Pemetrexed
CAS No.: 137281-23-3

Chemical Structure| 137281-23-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Pemetrexed (LY231514) is an antifolate with Ki values of 1.3, 7.2, and 65 nM for inhibiting thymidylate synthase (TS), dihydrofolate reductase (DHFR), and glycinamide ribonucleotide formyltransferase (GARFT), respectively.

Synonyms: LY231514

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Pemetrexed

CAS No. :137281-23-3
Formula : C20H21N5O6
M.W : 427.41
SMILES Code : O=C([C@H](CCC(O)=O)NC(C1=CC=C(C=C1)CCC2=CNC(NC(N)=N3)=C2C3=O)=O)O
Synonyms :
LY231514
MDL No. :MFCD19105065
InChI Key :WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
Pubchem ID :135410875

Safety of Pemetrexed

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • DHFR

    DHFR , Ki:7.2 nM

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03655834 Non Small Cell Lung Cancer|Mes... More >>othelioma Less << PHASE4 COMPLETED 2021-08-01 Jeroen Bosch Hospital, 's-Hert... More >>ogenbosch, Netherlands|Antoni van Leeuwenhoek, Amsterdam, Netherlands|Maastricht University Medical centre, Maastricht, Netherlands|Radboud university medical centre, Nijmegen, Netherlands|Erasmus University Medical Centre, Rotterdam, Netherlands Less <<
NCT02211833 Carcinoma, Non-Small-Cell Lung Phase 1 Completed - -
NCT02049060 Malignant Pleural Mesothelioma... More >> Nonsquamous Nonsmall Cell Neoplasm of Lung Less << Phase 1 Phase 2 Active, not recruiting December 2017 Italy ... More >> Istituto Clinico Humanitas Rozzano, Milan, Italy, 20089 Less <<
NCT02426658 Stage IV Non-Small Cell Lung C... More >>ancer Less << Phase 2 Recruiting November 2019 United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Stefan C. Grant    336-713-5172    scgrant@wakehealth.edu    Principal Investigator: Stefan C. Grant Less <<
NCT00916630 Central Nervous System Lymphom... More >>a Less << Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00497315 Non-Small Cell Lung Cancer Phase 2 Completed - Belgium ... More >> ZNA Middelheim Antwerpen, Antwerp, Belgium, 2020 University Hospital Antwerp Edegem, Antwerp, Belgium, 2650 St Augustinus Ziekenhuis Wilrijk, Antwerp, Belgium, 2610 Less <<
NCT00107419 Sarcoma Phase 2 Completed - -
NCT01450384 Unspecified Adult Solid Tumor Phase 1 Completed - United States, Virginia ... More >> Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT03671538 Non-squamous Non-small Cell Lu... More >>ng Cancer Less << Not Applicable Not yet recruiting August 31, 2020 -
NCT02787473 Squamous Cell Lung Cancer Phase 2 Recruiting September 2020 China, Zhejiang ... More >> Hangzhou First People's Hospital Recruiting Hangzhou, Zhejiang, China, 310006 Contact: Shirong Zhang, Dr.    086057156007650    shirley4444@gmail.com Less <<
NCT01000480 Non Small Cell Lung Cancer Phase 2 Completed - France ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Le Mans, France, 72000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lyon, France, 69373 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montpellier, France, 34070 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris, France, 75015 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toulouse, France, 31300 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 14165 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hemer, Germany, 58675 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Köln, Germany, 51109 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lübeck, Germany, 23538 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nürnberg, Germany, 90419 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Avellino, Italy, 50019 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Firenze, Italy, 50139 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy, 20132 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Monza, Italy, 20900 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orbassano, Italy, 10043 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Perugia, Italy, 06156 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sabadell, Spain, 08208 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sevilla, Spain, 41013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46010 Less <<
NCT03366064 Non-small Cell Lung Cancer Phase 1 Recruiting October 2020 Korea, Republic of ... More >> Asan Medical Center - University of Ulsan College of Medicine Recruiting Seoul, Korea, Republic of, 138-736 Contact: Kyoo H. Lee, MD    82-2-2224-3210    khlee2@amc.seoul.kr Less <<
NCT01000480 - Completed - -
NCT00491075 Renal Cell Carcinoma Phase 2 Terminated(Closed early for po... More >>or accrual.) Less << - United States, Texas ... More >> UT MD . Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00604461 Mesothelioma Phase 1 Phase 2 Terminated(Slow Accrual) - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02497053 Malignant Pleural Mesothelioma Phase 2 Unknown - Egypt ... More >> Ain Shams University Hospitals Recruiting Cairo, Egypt Contact: Omar Abdel-Rahman, MD    26858397    omar.abdelrhman@med.asu.edu.eg    Contact: Ahmed Nagi, MD       ahmedalynagy@yahoo.com    Principal Investigator: Omar Abdel-Rahman, MD          Sub-Investigator: Ahmed Nagi, MD Less <<
NCT00491075 - Terminated(Closed early for po... More >>or accrual.) Less << - -
NCT00321308 Carcinoma, Non-Small Cell Lung Phase 2 Terminated(See Termination Rea... More >>son in Detailed Description.) Less << - United States, Arizona ... More >> Pfizer Investigational Site Litchfield Park, Arizona, United States, 85340 Pfizer Investigational Site Sun City, Arizona, United States, 85351 United States, Arkansas Pfizer Investigational Site Bentonville, Arkansas, United States, 72712 Pfizer Investigational Site Fayetteville, Arkansas, United States, 72703 United States, Florida Pfizer Investigational Site Hudson, Florida, United States, 34667 Pfizer Investigational Site New Port Richey, Florida, United States, 34655 United States, New Jersey Pfizer Investigational Site Mahwah, New Jersey, United States, 07430 Pfizer Investigational Site Midland Park, New Jersey, United States, 07432 Pfizer Investigational Site Paramus, New Jersey, United States, 07652 Pfizer Investigational Site Westwood, New Jersey, United States, 07675 United States, New York Pfizer Investigational Site Oneida, New York, United States, 13421 Pfizer Investigational Site Oswego, New York, United States, 13126 Pfizer Investigational Site Syracuse, New York, United States, 13210-2306 Pfizer Investigational Site Syracuse, New York, United States, 13210 United States, Ohio Pfizer Investigational Site Sylvania, Ohio, United States, 43560 United States, Washington Pfizer Investigational Site Seattle, Washington, United States, 89109 Pfizer Investigational Site Seattle, Washington, United States, 98195 Germany Pfizer Investigational Site Grosshansdorf, Germany, 22927 Pfizer Investigational Site Mannheim, Germany, 68167 Italy Pfizer Investigational Site Torino, Italy, 10126 Less <<
NCT01646125 Advanced Non Small Cell Lung C... More >>ancer (NSCLC) Less << Phase 2 Terminated(An interim analysis... More >> was conducted in May-2014. Upon review of the data, the committee recommended study termination due to futility.) Less << - -
NCT01646125 - Terminated(An interim analysis... More >> was conducted in May-2014. Upon review of the data, the committee recommended study termination due to futility.) Less << - -
NCT02182102 Carcinoma, Non-Small-Cell Lung Phase 1 Completed - -
NCT00732303 Non-Small Cell Lung Cancer Phase 2 Terminated(Study terminated du... More >>e to withdrawal of pharmaceutical funding) Less << - United States, Illinois ... More >> Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 NorthShore University Health System - Kellogg Cancer Center Evanston, Illinois, United States, 60201 Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Cancer Care Center of Southern Indiana Bloomington, Indiana, United States, 47403 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 IN Onc/Hem Associates Indianapolis, Indiana, United States, 46202 Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 Community Regional Cancer Center Indianapolis, Indiana, United States, 46256 Horizon Oncology Center Lafayette, Indiana, United States, 47905 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Monroe Medical Associates Munster, Indiana, United States, 46321 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 Providence Medical Group Terre Haute, Indiana, United States, 47802 United States, Missouri Siteman Cancer Center St. Louis, Missouri, United States, 63110 United States, New Jersey Hematology Oncology Associates S.J., P.A. Mt. Holly, New Jersey, United States, 08060 United States, Oregon Providence Portland Medical Center Portland, Oregon, United States, 97213 United States, Pennsylvania Pennsylvania Oncology-Hematology Associates Philadelphia, Pennsylvania, United States, 19106 Fox Chase Cancer Center Extramural Research Program Rockledge, Pennsylvania, United States, 19046 Less <<
NCT00614822 Non Small Cell Lung Cancer Phase 2 Completed - -
NCT00604461 - Terminated(Slow Accrual) - -
NCT03101579 Leptomeningeal Metastases Phase 1 Completed - China, Jilin ... More >> The First Hospital of Jilin University Changchun, Jilin, China, 130021 Less <<
NCT02725918 Non-small Cell Lung Cancer Phase 2 Recruiting June 2020 China, Guangdong ... More >> Guangdong Lung cancer institute Recruiting Guangzhou, Guangdong, China, 510080 Contact: Qing Zhou, MD    86 13544561166    gzzhouqing@126.com Less <<
NCT02200354 Advanced Non-small Cell Lung C... More >>ancer Less << Phase 2 Recruiting March 2019 Japan ... More >> Kobe City Medical Center General Hospital Recruiting Kobe, Hyogo, Japan, 650-0046 Contact: Daichi Fujimoto, MD    +81-78-302-4321 ext 773    daichianzen@yahoo.co.jp Less <<
NCT00732303 - Terminated(Study terminated du... More >>e to withdrawal of pharmaceutical funding) Less << - -
NCT01565538 Lung Cancer Phase 2 Completed - China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT00950365 Non-small Cell Lung Cancer Phase 2 Unknown - United States, Massachusetts ... More >> University of Massachusetts Recruiting Worcester, Massachusetts, United States, 01655 Contact: Bilal Piperdi, MD    508-856-3702    piperdib@ummhc.org    Principal Investigator: Bilal Piperdi, MD          Sub-Investigator: William V Walsh, MD          United States, New York Albert Einstein Cancer Center Recruiting Bronx, New York, United States, 10461 Contact: Tianhong Li, MD, PhD    718-904-2900    tli@montefiore.org    Contact: Cheryl Baker, APRN    718-405-8508    cbaker@montefiore.org    Principal Investigator: Tianhong Li, MD, PhD          Montefiore Medical Center Recruiting Bronx, New York, United States, 10467 Contact: Rasim Gucalp, MD    718-920-4826    rgucalp@montefiore.org    Contact: Yoko Eng, RN    718-920-2090    yeng@montefiore.org    Sub-Investigator: Rasim Gucalp, MD Less <<
NCT00868192 - Completed - -
NCT00807573 Lung Cancer Phase 2 Completed - United States, New Jersey ... More >> Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital Sleepy Hollow, New York, United States Less <<
NCT00744900 Lung Cancer Phase 2 Completed - France ... More >> Centre Hôspitalier du Pays d'Aix, Service des Maladies Respiratoires Aix En Provence, France, 13616 CHU d'Angers, Service de Pneumologie Angers, France, 49033 Médecine 4, C.H.G. de la Fontonne Antibes Antibes, France, 06606 CHU brest, institut de cancérologie et d'hématologie Brest, France, 29200 Centre François Baclesse Caen, France, 14000 Centre Hospitalier René Dubos - Pontoise, Service d'Oncologie - Hématologie Clinique Cergy Pontoise, France, 95303 Centre Hospitalier, Service de Pneumologie Charleville, France, 08 000 CHI, Service de Pneumologie Creteil, France, 94010 Pneumologie, Centre hôspitalier, DRAGUIGNAN Draguignan, France, 83300 CH GAP GAP, France, 05000 Centre Hospitalier Départemental, Service de Pneumologie, La Roche Sur Yon, France, 85000 Hôpital A. Mignot, Service de Pneumologie Le Chesnay, France, 78157 Hopital de la Croix Rousse Lyon, France, 69317 Centre Hôspitalier, Service de Pneumo-Neuro Mantes La Jolie, France, 78200 Hôpital Sainte Margueritte Marseilles, France, 13274 Serv. de Pneumo-Allergo, CH de Martigues Martigues, France, 13695 Serv. de Pneumo - Hôpital St Antoine Paris, France, 75571 Service Pneumologie, Pavillon 1A, CH de Lyon-Sud Pierre-benite, France, 69495 Hôpital Pontchailloux, Service de Pneumologie. Rennes, France, 35033 CHG, Service de Pneumologie Roanne, France, 42300 Luc THIBERVILLE Rouen, France, 76031 CHU de ROUEN, Hôpital Bois Guillaume, Serv. de Pneumo. Rouen, France, 76233 Institut de Cancérologie de la Loire Saint-Priest en Jarez Cedex, France, 42271 CHU, Service du Pr. Carles Toulouse, France, 31059 Pneumologie, Centre Hospitalier VILLEFRANCHE sur SAONE, France, 69655 Less <<
NCT01565538 - Completed - -
NCT00864513 Pancreas Cancer Phase 2 Terminated(At interim analysis... More >> the study did not meet the response criteria to continue) Less << - United States, District of Col... More >>umbia Georgetown University Hospital/Lombardi Cancer Center Washington, District of Columbia, United States, 20007 Less <<
NCT00868192 Ovarian Carcinoma ... More >> Primary Peritoneal Carcinoma Less << Phase 2 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00864513 - Terminated(At interim analysis... More >> the study did not meet the response criteria to continue) Less << - -
NCT00529100 Non-Small Cell Lung Cancer Phase 1 Phase 2 Completed - Canada, Alberta ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Edmonton, Alberta, Canada, T6G 1Z2 Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamilton, Ontario, Canada, L8V 5C2 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ottawa, Ontario, Canada, K1H 8L6 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00807573 - Completed - -
NCT00684099 Non Small Cell Lung Cancer Phase 1 Phase 2 Completed - Greece ... More >> University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupolis, Greece "IASO" General Hospital of Athnes, Dep of Medical Oncology Athens, Greece "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece Sismanogleio General Hospital, 1st, 2nd Dep of Pulmonary Diseases Athens, Greece Sotiria" General Hospital, 1st Dep of Pulmonary Diseases Athens, Greece "Diabalkaniko" Hospital of Thessaloniki Thessaloniki, Greece "Theagenion" Anticancer Hospital of Thessaloniki Thessaloniki, Greece Less <<
NCT00540241 Non Small Cell Lung Cancer COMPLETED 2025-03-10 For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bad Homburg, 61352, Germany Less <<
NCT00529100 - Completed - -
NCT01313663 Lung Cancer, Small Cell Phase 2 Terminated - -
NCT01313663 - Terminated - -
NCT00692159 Neoplasm Phase 1 Completed - United States, Arizona ... More >> Scottsdale, Arizona, United States, 85260 United States, California Santa Monica, California, United States, 90404 United States, Ohio Cleveland, Ohio, United States, 44106 Less <<
NCT03507244 Leptomeningeal Metastasis Phase 1 Phase 2 Recruiting December 31, 2019 China, Jilin ... More >> The First Hospital of Jilin University Recruiting Changchun, Jilin, China, 130021 Contact: Zhenyu Pan, Professor    +8615804302753    dr-zypan@163.com    Contact: Guozi Yang, Professor    +8615804302755    guoziyang_1982@163.com Less <<
NCT01593293 Non-small Cell Lung Cancer Phase 3 Unknown November 2015 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Sang-We Kim, M.D.    82-2-3010-3215    swkim@amc.seoul.kr Less <<
NCT00434174 Non Small Cell Lung Cancer Phase 1 Completed - Australia, New South Wales ... More >> Novartis Investigative Site Camperdown, New South Wales, Australia, 2050 Australia, Victoria Novartis Investigative Site Melbourne, Victoria, Australia, 3002 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Germany Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Koeln, Germany, 50924 Less <<
NCT00310050 Pancreatic Cancer Phase 1 Terminated(slow accrual) - United States, North Carolina ... More >> Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT01567384 Cancer Neopla... More >>sms Tumors Less << Phase 1 Withdrawn(The sponsor withdrew... More >> support for the study before any patients were enrolled.) Less << October 2013 United States, Georgia ... More >> Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT00316225 Non-small Cell Lung Cancer ... More >> Mesothelioma Lung Neoplasms Less << Phase 2 Completed - Denmark ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kobenhavn, Denmark, 2100 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30625 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28041 Less <<
NCT02134912 Adenocarcinoma of the Lung ... More >> Large Cell Lung Cancer Recurrent Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 2 Terminated(science has moved f... More >>orward and there is no intent to complete the study) Less << - -
NCT00310050 - Terminated(slow accrual) - -
NCT00424723 Neuroendocrine Tumors PHASE2 COMPLETED 2025-03-10 Dana-Farber Cancer Center, Bos... More >>ton, Massachusetts, 02115, United States Less <<
NCT00489359 Ovarian Cancer ... More >> Primary Peritoneal Cancer Less << Phase 1 Phase 2 Completed - Argentina ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bahia Blanca, Argentina, B8000HXM For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Buenos Aires, Argentina, C1199ACK For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ramos Mejia, Argentina, B1704ESN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salta, Argentina, 4400 Canada, Alberta For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toronto, Ontario, Canada, M5G 2M9 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 13353 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bonn, Germany, 53127 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chemnitz, Germany, D-09116 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Duesseldorf, Germany, 40489 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Erlangen, Germany, D-91054 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Essen, Germany, DE-45145 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 22081 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jena, Germany, D-07743 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kiel, Germany, D-24105 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, 55131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tübingen, Germany, 72076 Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gdansk, Poland, 80-402 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Olsztyn, Poland, 10-228 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland, 00909 Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Göteborg, Sweden, 416 85 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lund, Sweden, 22241 Less <<
NCT00316225 - Completed - -
NCT02639091 Medical Oncology Phase 1 Active, not recruiting June 28, 2019 United States, Illinois ... More >> Chicago, Illinois, United States, 60637 United States, Maryland Bethesda, Maryland, United States, 20892 United States, Michigan Detroit, Michigan, United States, 48202 United States, South Carolina Charleston, South Carolina, United States, 29425 Italy Milano, Lombardia, Italy, 20089 Milano, Lombardia, Italy, 20133 Less <<
NCT03713944 NSCLC Stage IV ... More >> NSCLC, Recurrent Less << Phase 2 Not yet recruiting November 2021 United States, Indiana ... More >> Indiana Univeristy Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00923637 Non Small Cell Lung Cancer Phase 2 Unknown June 2015 China, Guangdong ... More >> The First Affiliated Hospital of Guangzhou Medical College Recruiting Guangzhou, Guangdong, China, 510120 Contact: Daoyuan Wang, MD    +86-20-83337792    ghealth2008@gmail.com    Contact: Wenlong Shao, MD    +86-20-83337792    myfriends2003@126.com    Principal Investigator: Jianxing He, MD, FACS Less <<
NCT00507858 Head and Neck Cancer Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00489359 - Completed - -
NCT00528619 Neoplasms Phase 1 Completed - United States, Colorado ... More >> Pfizer Investigational Site Aurora, Colorado, United States, 80045 Canada, Ontario Pfizer Investigational Site Ottawa, Ontario, Canada, K1H 8L6 Canada, Quebec Pfizer Investigational Site Montreal, Quebec, Canada, H2L 4M1 Less <<
NCT00906282 Non Small Cell Lung Cancer Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Medical Oncology Associates of Augusta Augusta, Georgia, United States, 30901 Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, Nebraska Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT00906282 - Completed - -
NCT01836575 Non Small Cell Lung Carcinoma Phase 3 Completed - United States, Florida ... More >> The Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States, 33140 Brazil Instituto do Câncer do Ceará - ICC Fortaleza, Ceará, Brazil Hospital Lifecenter Belo Horizonte, Minas Gerais, Brazil Hospital Caridade de Ijuí - CACON Ijuí, RS, Brazil Hospital São Lucas Porto Alegre, RS, Brazil Centro de Pesquisas Oncológicas - CEPON Florianópolis, Santa Catarina, Brazil Hospital Amaral Carvalho Jaú, São Paulo, Brazil INCA Rio de Janeiro, Brazil Instituto do Câncer Arnaldo Vieira de Carvalho São Paulo, Brazil Less <<
NCT01951482 Non Squamous Non-small Cell Lu... More >>ng Cancer Brain Metastases Bevacizumab Less << Phase 2 Recruiting June 2020 China, Guangdong ... More >> Sun Yat-sen University of Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: li-kun Chen, doctor    13798019964    chenlk@sysucc.org.cn Less <<
NCT01172028 Breast Cancer ... More >> Esophageal Cancer Gastric Cancer Head and Neck Cancer Lung Cancer Ovarian Cancer Prostate Cancer Less << Phase 1 Completed - United States, Arizona ... More >> Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724-5024 Less <<
NCT00216216 Small Cell Lung Cancer PHASE2 TERMINATED 2025-10-05 Helen F. Graham Cancer Center,... More >> Newark, Delaware, 19713, United States|Medical & Surgical Specialists, LLC, Galesburg, Illinois, 61401, United States|Elkhart Clinic, Elkhart, Indiana, 46515, United States|Oncology Hematology Associates of SW Indiana, Evansville, Indiana, 47714, United States|Fort Wayne Oncology & Hematology, Inc, Fort Wayne, Indiana, 46815, United States|Center for Cancer Care at Goshen Health System, Goshen, Indiana, 46527, United States|Indiana University Cancer Center, Indianapolis, Indiana, 46202, United States|Community Regional Cancer Center, Indianapolis, Indiana, 46256, United States|Arnett Cancer Care, Lafayette, Indiana, 47904, United States|Medical Consultants, P.C., Muncie, Indiana, 47303, United States|Center for Cancer Care, Inc., P.C., New Albany, Indiana, 47150, United States|Northern Indiana Cancer Research Consortium, South Bend, Indiana, 46601, United States|Northern Indiana Oncology Associates, South Bend, Indiana, 46617, United States|AP&S Clinic, Terre Haute, Indiana, 47804, United States|Siteman Cancer Center, St. Louis, Missouri, 63110, United States|Methodist Cancer Center, Omaha, Nebraska, 68114, United States Less <<
NCT00976456 - Completed - -
NCT00786331 Advanced Non-Small Cell Lung C... More >>ancer Less << Phase 2 Unknown December 2009 Italy ... More >> Azienda Ospedaliero-Universitaria Umberto I, Clinica di Oncologia Medica Active, not recruiting Ancona, Italy, 60020 Azienda Ospedaliera Ospedali Riuniti di Bergamo, UO di Oncologia Medica Recruiting Bergamo, Italy, 24128 Principal Investigator: Roberto Labianca, MD          Azienda Istituti Ospitalieri di Cremona, UO di Oncologia Medica Recruiting Cremona, Italy, 26100 Principal Investigator: Rodolfo Passalacqua, MD          Azienda Sanitaria Ospedaliera S. Croce e Carle, UO di Oncologia Medica Recruiting Cuneo, Italy, 12100 Principal Investigator: Marco Merlano, MD          Ospedale S. Croce, U.O. di Oncologia Medica Recruiting Fano, PU, Italy, 61032 Principal Investigator: Rodolfo Mattioli, MD          Azienda Ospedaliera Careggi, UO di Oncologia Medica Recruiting Firenze, Italy, 50139 Principal Investigator: Francesco Di Costanzo, MD          EO Ospedali Galliera, SC Oncologia Medica Recruiting Genova, Italy, 16128 Principal Investigator: Andrea Decensi, MD          Ospedale Versilia, UO di Oncologia Medica Recruiting Lido di Camaiore, LU, Italy, 55043 Principal Investigator: Domenico Amoroso, MD          USL 6, Presidio Ospedaliero di Livorno, U.O. di Oncologia MedicaAzienda Recruiting Livorno, Italy, 57122 Principal Investigator: Alfredo Falcone, MD          Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-IRST, Oncologia Medica Recruiting Meldola, FC, Italy, 47014 Principal Investigator: Dino Amadori, MD          Istituto Nazionale Tumori, SC di Oncologia 2 Recruiting Milano, Italy, 20133 Principal Investigator: Emilio Baietta, MD          Azienda Ospedaliero-Universitaria di Modena-Policlinico, U.O. di Oncologia Medica ed Ematologia Recruiting Modena, Italy, 41100 Principal Investigator: Fausto Barbieri, MD          AO S. Gerardo, Nuovo Ospedale S. Gerardo-settore A, Oncologia Medica Not yet recruiting Monza, MI, Italy, 20052 Principal Investigator: Paolo Bidoli, MD          Azienda Ospedaliero-Universitaria di Parma, UOC di Oncologia Medica Recruiting Parma, Italy, 43100 Principal Investigator: Andrea Ardizzoni, MD          Ospedale Silvestrini, S.C. di Oncologia Medica Recruiting Perugia, Italy, 06156 Principal Investigator: Lucio Crinò, MD          Arcispedale Santa Maria Nuova, UO di Oncologia Medica Recruiting Reggio Emilia, Italy, 42100 Principal Investigator: Corrado Boni, MD          Azienda Ospedaliera S. Camillo-Forlanini, U.O. di Oncologia Medica Recruiting Roma, Italy, 00151 Principal Investigator: Filippo De Marinis, MD          Ospedale SS. Annunziata, UO di Oncologia Medica Recruiting Sassari, Italy, 07100 Principal Investigator: Antonio Contu, MD          Azienda Sanitaria Ospedaliera Molinette, U.O. di Oncologia Medica Recruiting Torino, Italy, 10126 Principal Investigator: Libero Ciuffreda, MD          P.O. Treviglio-Caravaggio, U.O. di Oncologia Medica Not yet recruiting Treviglio, BG, Italy, 24047 Principal Investigator: Barni Sandro, MD          Policlinico "G. B. Rossi"-Borgo Roma, U.O. di Oncologia Medica Clinicizzata Recruiting Verona, Italy, 37126 Principal Investigator: Antonio Santo, MD Less <<
NCT01088906 Carcinoma, Non Small Cell Lung Phase 2 Terminated(No safety reasons. ... More >>Low recruitment.) Less << - Spain ... More >> H. Clínica Benidorm Benidorm, Alicante, Spain, 03501 H. General de Elche Elche, Alicante, Spain, 03202 H. Germans Trias i Pujol Badalona, Barcelona, Spain, 088916 H. Insular de Gran Canarias Las Palmas de Gran Canarias, Gran Canarias, Spain, 35016 H. Universitario de Canarias La Laguna, Tenerife, Spain, 38320 MD Anderson Madrid, Spain, 28033 Hospital 12 de Octubre Madrid, Spain, 28041 H. Morales Messeguer Murcia, Spain, 30008 Less <<
NCT00265785 Lung Cancer Phase 2 Terminated(Closed due to poor ... More >>accrual) Less << - -
NCT00976456 Non-squamous Non-small Cell Lu... More >>ng Cancer Less << Phase 3 Completed - Germany ... More >> Krankenhaus Martha-Maria Halle-Doelau Halle, Germany, 06120 Less <<
NCT00487669 Advanced Non-small Cell Lung C... More >>ancer Less << Phase 2 Completed - United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT00487669 - Completed - -
NCT00701857 Esophageal Cancer Phase 1 Completed - United States, Arizona ... More >> University of Arizona Cancer Center Tucson, Arizona, United States, 85724 Less <<
NCT00424242 Brain and Central Nervous Syst... More >>em Tumors|Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Lymphoproliferative Disorder|Metastatic Cancer|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Precancerous Condition|Secondary Myelofibrosis|Unspecified Adult Solid Tumor, Protocol Specific Less << EARLY_PHASE1 COMPLETED 2025-09-11 Robert H. Lurie Comprehensive ... More >>Cancer Center at Northwestern University, Chicago, Illinois, 60611-3013, United States Less <<
NCT00528281 Lung Cancer, Non-Small Cell Phase 1 Completed - Germany ... More >> GSK Investigational Site Heidelberg, Baden-Wuerttemberg, Germany, 69126 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 Italy GSK Investigational Site Orbassano (TO), Piemonte, Italy, 10043 Poland GSK Investigational Site Poznan, Poland, 60-569 United Kingdom GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE7 7DN Less <<
NCT01336842 Solid Tumors ... More >>Non-Small Cell Lung Cancer (NSCLC) Less << Phase 1 Completed - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 Less <<
NCT00265785 - Terminated(Closed due to poor ... More >>accrual) Less << - -
NCT03655821 Non Small Cell Lung Cancer|Mes... More >>othelioma Less << PHASE4 TERMINATED 2021-05-11 Jeroen Bosch Hospital, 's-Hert... More >>ogenbosch, Netherlands|Antoni van Leeuwenhoek, Amsterdam, Netherlands|Maastricht University Medical centre, Maastricht, Netherlands|Radboud university medical centre, Nijmegen, Netherlands|Erasmus University Medical Centre, Rotterdam, Netherlands Less <<
NCT00293579 Head and Neck Cancer PHASE2 COMPLETED 2025-11-08 Ohio State University, Columbu... More >>s, Ohio, 43210, United States Less <<
NCT00293579 Head and Neck Cancer PHASE2 COMPLETED 2025-11-08 Ohio State University, Columbu... More >>s, Ohio, 43210, United States Less <<
NCT01953419 Gastric Cancer Phase 2 Completed - China, Guangdong ... More >> Sun Yat-sen UniversityCancer center Guangzhou, Guangdong, China, 510060 Less <<
NCT00589667 Head and Neck Cancer Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01783834 Previous Treated Metastatic No... More >>n-small Cell Lung Cancer Less << Phase 2 Completed - Korea, Republic of ... More >> Gachon university Gil Medical Center Incheon, Korea, Republic of Less <<
NCT03086538 Colo-rectal Cancer Phase 2 Recruiting December 2018 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 06351 Contact: seungtae kim, MD,PhD Less <<
NCT02974933 Nonsmall Cell Lung Cancer Phase 2 Recruiting November 2018 China, Hubei ... More >> Ou wuling Recruiting Wuhan, Hubei, China, 430079 Contact: Ou Wu ling, 40    13469989766 ext 86    609700817@qq.com Less <<
NCT00700336 Malignant Pleural Mesothelioma... More >> Solid Tumors Less << Phase 1 Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale, Arizona, United States Arizona Cancer Center Tucson, Arizona, United States United States, California City of Hope Duarte, California, United States United States, Illinois University of Chicago Chicago, Illinois, United States United States, Michigan Karmanos Cancer Institute/Wayne State University Detroit, Michigan, United States United States, Nevada Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 United States, New Mexico University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87131 United States, New York Memorial-Sloan Kettering Cancer Center New York, New York, United States, 10022 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States United States, Pennsylvania Penn State Milton S. Hershey Medical Ctr. Hershey, Pennsylvania, United States, 17033 United States, Texas Cancer Therapy & Research Center San Antonio, Texas, United States, 78229 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States Less <<
NCT00589667 - Completed - -
NCT03374280 Non Small Cell Lung Cancer Phase 2 Recruiting December 30, 2021 China, Guangdong ... More >> The first affiliated hospital of Guangzhou MC Recruiting Guangzhou, Guangdong, China, 510120 Contact: Haihong Yang, MD    0862083062825    bjrf2009@yahoo.com    Principal Investigator: Haihong Yang, Dr. Less <<
NCT01442909 Non-small-cell Lung Cancer Phase 4 Completed - Taiwan ... More >> Taipei VGH Taipei City, Taiwan, 112 Less <<
NCT03656549 Non Small Cell Lung Cancer ... More >> Mesothelioma Less << Phase 2 Not yet recruiting October 1, 2021 Netherlands ... More >> Jeroen Bosch Hospital Not yet recruiting 's-Hertogenbosch, Netherlands Contact: Bonne Biesma       b.biesma@jbz.nl    Principal Investigator: Bonne Biesma          Sub-Investigator: Jeroen Derijks          Antoni van Leeuwenhoek Not yet recruiting Amsterdam, Netherlands Contact: Sjaak Burgers       s.burgers@nki.nl    Principal Investigator: Sjaak Burgers          Sub-Investigator: Alwin Huitema          Maastricht University Medical centre Not yet recruiting Maastricht, Netherlands Contact: Anne-Marie Dingemans       a.dingemans@mumc.nl    Principal Investigator: Anne-Marie Dingemans          Radboud university medical centre Not yet recruiting Nijmegen, Netherlands Contact: Rob ter Heine       R.terHeine@radboudumc.nl    Principal Investigator: Rob ter Heine          Sub-Investigator: Nikki de Rouw          Sub-Investigator: Michel van den Heuvel          Erasmus University Medical Centre Not yet recruiting Rotterdam, Netherlands Contact: Joachim Aerts       j.aerts@erasmusmc.nl    Principal Investigator: Joachim Aerts          Sub-Investigator: Ron Mathijsen Less <<
NCT02723578 Metastatic Colorectal Cancer Phase 2 Active, not recruiting November 2018 Korea, Republic of ... More >> Yonsei University Health System, Severance Hospital Seoul, Korea, Republic of, 03722 Less <<
NCT02693717 Bladder Cancer ... More >> Urothelial Cancer Less << Phase 2 Recruiting May 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       jgao1@mdanderson.org    MD Anderson Katy Regional Care Center Recruiting Houston, Texas, United States, 77094 Contact: Jennifer Wang, MD          MD Anderson Sugarland Regional Care Center Recruiting Sugar Land, Texas, United States, 77478 Contact: Jennifer Wang, MD Less <<
NCT00921310 Carcinoma, Non-Small-Cell Lung Phase 1 Phase 2 Terminated(Withdrawal of fundi... More >>ng from sponsor) Less << - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00921310 - Terminated(Withdrawal of fundi... More >>ng from sponsor) Less << - -
NCT01909830 Colorectal Cancer Metastatic Phase 2 Completed - Italy ... More >> UO Oncologia Medica IRCCS IRST Meldola (FC), FC, Italy, 47014 Less <<
NCT03744793 Infiltrating Bladder Urothelia... More >>l Carcinoma Sarcomatoid Variant Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant Metastatic Urothelial Carcinoma MTAP Negative Less << Phase 2 Not yet recruiting January 1, 2020 United States, Texas ... More >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Amishi Y. Shah    713-792-2830       Principal Investigator: Amishi Y. Shah Less <<
NCT02838745 Mesothelioma Phase 1 Recruiting August 2018 United States, Texas ... More >> Baylor St Lukes Recruiting Houston, Texas, United States, 77030 Contact: Michelle G Almarez, BBA    713-798-3680    Michelle.Almarez@bcm.edu    Contact: Bryan Burt, MD    713-798-8266    Bryan.Burt@bcm.edu    Principal Investigator: Bryan Burt, MD Less <<
NCT03700333 Carcinoma, Non-Small-Cell Lung Phase 3 Not yet recruiting October 20, 2019 -
NCT00907179 Non-Small Cell Lung Cancer Phase 1 Terminated(Widespread use firs... More >>tline Pemetrexed; slow recruitment; funding withdrawn..) Less << - United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT02624700 Breast Cancer ... More >> Metastatic Breast Cancer Recurrent Breast Cancer Less << Phase 2 Recruiting April 1, 2025 United States, Virginia ... More >> Virginia Commonwealth University/Massey Cancer Center Recruiting Richmond, Virginia, United States, 23298 Contact: Alison Ryan, NP    804-628-1936    masseysiit@vcu.edu    Contact: Andrew S Poklepovic, MD    804-628-2321    andrew.poklepovic@vcuhealth.org    Principal Investigator: Andrew S Poklepovic, MD Less <<
NCT01397305 Rectal Cancer Phase 1 Phase 2 Completed - Sweden ... More >> Sahlgrenska University Hospital Göteborg, Sweden, 416 85 Less <<
NCT02093962 Non-small Cell Lung Cancer Phase 2 Terminated(At the interim anal... More >>ysis, the futility boundary was not met and the study was stopped due to insufficient efficacy.) Less << - -
NCT01473563 Nonsquamous Non-Small Cell Neo... More >>plasm of Lung|Non-Small Cell Lung Cancer Metastatic|Non-Small Cell Lung Cancer Stage IIIB Less << PHASE2 COMPLETED 2025-09-13 For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Linkoping, 58185, Sweden|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Solna, 17176, Sweden|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., London, Greater London, SE1 9RT, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Maidstone, Kent, ME16 9QQ, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Nottingham, Nottinghamshire, NG5 1PD, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Aberdeen, Scotland, AB25 2ZN, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Huddersfield, West Yorkshire, HD3 3EA, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Birmingham, B95SS, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Manchester, M20 4BX, United Kingdom Less <<
NCT02093962 - Terminated(At the interim anal... More >>ysis, the futility boundary was not met and the study was stopped due to insufficient efficacy.) Less << - -
NCT02829008 Metastatic Breast Cancer Phase 2 Active, not recruiting April 2020 China, Beijing ... More >> Cancer Hospital, ChineseAMS Beijing, Beijing, China, 100021 Less <<
NCT03537833 - Recruiting September 1, 2020 France ... More >> Chu Reims Recruiting Reims, France, 51092 Contact: Damien JOLLY    326788472 ext 33    djolly@chu-reims.fr Less <<
NCT01473563 Nonsquamous Non-Small Cell Neo... More >>plasm of Lung|Non-Small Cell Lung Cancer Metastatic|Non-Small Cell Lung Cancer Stage IIIB Less << PHASE2 COMPLETED 2025-09-13 For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Linkoping, 58185, Sweden|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Solna, 17176, Sweden|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., London, Greater London, SE1 9RT, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Maidstone, Kent, ME16 9QQ, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Nottingham, Nottinghamshire, NG5 1PD, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Aberdeen, Scotland, AB25 2ZN, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Huddersfield, West Yorkshire, HD3 3EA, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Birmingham, B95SS, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Manchester, M20 4BX, United Kingdom Less <<
NCT03768037 Advanced Non-squamous NSCLC Phase 4 Recruiting November 26, 2020 China, Beijing ... More >> Beijing Chest Hospital Recruiting Beijing, Beijing, China, 101149 Contact: Shucai Zhang    86-010-89509324    sczhang6304@163.com    Contact: Zhe Liu    86-010-89509323    liuzhe1968@aliyun.com Less <<
NCT00230542 Ovarian Cancer ... More >> Peritoneal Cancer Fallopian Tube Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02518802 Lung Neoplasms Phase 3 Recruiting January 2020 China, Shaanxi ... More >> Tangdu Hospital of the Fourth Millitary Medical University Recruiting Xi'an, Shaanxi, China, 710038 Contact: Li Xiaofei, MD    +8629,84777436    lxfchest@fmmu.edu.cn    Contact: Yan Xiaolong, MD    +862984717558    yanxiaolong@fmmu.edu.cn Less <<
NCT03607149 Non-small Cell Lung Cancer PHASE4 COMPLETED 2020-02-20 CH William Morey, Chalon-sur-S... More >>a?ne, 71100, France|Centre Georges Francois Leclerc, Dijon, 21079, France|Centre Universitaire Hospitalier de Dijon, Dijon, 21079, France Less <<
NCT00712062 Primary Central Nervous System... More >> Lymphoma Less << PHASE2 WITHDRAWN 2025-02-10 -
NCT03023319 Carcinoma, Non-Small-Cell Lung... More >> Mesothelioma Bladder Cancer Ovarian Cancer Peritoneal Cancer Thymoma Thymus Cancer Uterine Cervical Cancer Less << Phase 1 Recruiting July 2020 United States, Ohio ... More >> UC Health Recruiting Cincinnati, Ohio, United States, 45219 Contact: UCCI Clinical Trials Office    513-584-7698    kastla@ucmail.uc.edu Less <<
NCT02284490 Brain Metastases Phase 2 Unknown November 2017 China, Shandong ... More >> Neurosurgery, Shandong Cancer Hospital and Institute Jinan, Shandong, China, 250117 Less <<
NCT02004184 Carcinoma, Non-small-cell Lung Phase 3 Terminated(Poor enrollment due... More >> to the introduction of immunotherapy) Less << - Norway ... More >> St Olavs Hospital Trondheim, Norway Less <<
NCT01918761 Non Small Cell Lung Cancer Phase 1 Suspended(poor accrual) September 15, 2018 Austria ... More >> Medizinische Universität Graz Klinische Abteilung für Onkologie Graz, Austria Universitätsklinik für Innere Medizin I Innsbruck, Austria Less <<
NCT03460678 Carcinoma, Non-Small-Cell Lung Phase 4 Recruiting December 2019 Jordan ... More >> King Hussein Cancer Center (KHCC) Recruiting Amman, Jordan, 11118 Principal Investigator: Taher Abu Hijleh, MD          Sub-Investigator: Samir Yaser, MD          Sub-Investigator: Kamal Al Rabi, MD          Lebanon American University of Beirut Medical Center Not yet recruiting Beirut, Lebanon, 1107 2020 Principal Investigator: Arafat Tfayli, MD Less <<
NCT02868892 Adenocarcinoma of the Cervix|A... More >>denosquamous Cell Carcinoma of the Cervix Less << PHASE2 TERMINATED 2025-07-17 Western Regional Medical Cente... More >>r, Inc., Goodyear, Arizona, 85338, United States Less <<
NCT02868892 Adenocarcinoma of the Cervix|A... More >>denosquamous Cell Carcinoma of the Cervix Less << PHASE2 TERMINATED 2025-07-17 Western Regional Medical Cente... More >>r, Inc., Goodyear, Arizona, 85338, United States Less <<
NCT02588781 Colorectal Cancer PHASE2 UNKNOWN 2025-12-23 Samsung Medical Center, Seoul,... More >> Seoul, Korea, Republic Of, 135-710, Korea, Republic of Less <<
NCT01333696 Squamous Cell Carcinoma of Hea... More >>d and Neck Less << PHASE2 UNKNOWN 2025-06-13 Fudan University Shanghai Canc... More >>er Center, Shanghai, 200032, China Less <<
NCT01287520 Advanced Cancer Phase 1 Completed - United States, Florida ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampa, Florida, United States United States, Tennessee For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nashville, Tennessee, United States Less <<
NCT00061464 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - United States, Florida ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Miami, Florida, United States United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Chicago, Illinois, United States United States, Louisiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Shreveport, Louisiana, United States United States, South Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Columbia, South Carolina, United States Less <<
NCT00061451 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palo Alto, California, United States United States, Missouri For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Columbia, Missouri, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kansas City, Missouri, United States United States, Montana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Great Falls, Montana, United States United States, Washington For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seattle, Washington, United States Less <<
NCT01017874 Non Small Cell Lung Cancer Phase 3 Completed - Hong Kong ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kowloon, Hong Kong Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Incheon, Korea, Republic of, 405-760 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 110-744 Singapore For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore, 258499 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kuei Shan Hsiang, Taiwan, 33305 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Liouying/Tainan, Taiwan, 736 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Puzih City, Taiwan, 613 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 407 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 100 Thailand For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bangkok, Thailand, 10700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiang Mai, Thailand, 50200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hat Yai, Thailand, 90110 Less <<
NCT01017874 - Completed - -
NCT00190983 Cervical Intraepithelial Neopl... More >>asia|Uterine Neoplasms|Genital Neoplasms, Female Less << PHASE2 COMPLETED 2025-10-07 Gynecologic Oncology Group 215... More >>-854-0770, Philadelphia, Pennsylvania, United States Less <<
NCT00606021 Non Small Cell Lung Cancer Phase 2 Completed - Egypt ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Assiut, Egypt, 0000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cairo, Egypt, 11372 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mounofia, Egypt, 32514 Lebanon For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beirut, Lebanon Saudi Arabia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Riyadh, Saudi Arabia, 11211 Less <<
NCT00606021 - Completed - -
NCT00117962 Lung Cancer Phase 2 Completed - -
NCT00190983 Cervical Intraepithelial Neopl... More >>asia|Uterine Neoplasms|Genital Neoplasms, Female Less << PHASE2 COMPLETED 2025-10-07 Gynecologic Oncology Group 215... More >>-854-0770, Philadelphia, Pennsylvania, United States Less <<
NCT00668499 Mesothelioma Phase 1 Phase 2 Withdrawn(Sponsor withdrew sup... More >>port) Less << April 2011 United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT00117962 - Completed - -
NCT01172470 Head and Neck Cancer Phase 2 Completed - United States, Illinois ... More >> The University of Chicago Medical Center Chicago, Illinois, United States, 60653 Less <<
NCT00988858 Non Small Cell Lung Cancer Phase 2 Completed - United States, Arizona ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tucson, Arizona, United States, 85704 United States, Colorado For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Denver, Colorado, United States, 80218 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampa, Florida, United States, 33612 United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kettering, Ohio, United States, 45409 United States, Oregon For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Portland, Oregon, United States, 97213 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75201 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. The Woodlands, Texas, United States, 77380 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tyler, Texas, United States, 75702 United States, Washington For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yakima, Washington, United States, 98902 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orbassano, Italy, 10043 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 138-736 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 407 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tainan, Taiwan, 70403 Less <<
NCT02743923 Carcinoma, Non-Small Cell Lung Phase 3 Recruiting April 2020 Netherlands ... More >> VUmc Medical Center Recruiting Amsterdam, Noord-Holland, Netherlands, 1081HV Contact: Idris Bahce, MD       i.bahce@vumc.nl    Principal Investigator: Idris Bahce, MD          Medical spectrum Twente Recruiting Enschede, Overijssel, Netherlands, 7500 KA Contact: Hugo Schouwink, MD       J.Schouwink@mst.nl    Principal Investigator: Hugo Schouwink, MD          Meander Medical Center Recruiting Amersfoort, Utrecht, Netherlands, 3818 ES Contact: Joop van den Brand, MD       JJG.vanden.Brand@meandermc.nl    Principal Investigator: Joop van den Brand, MD          ZGT Recruiting Almelo, Netherlands, 7609 PP Contact: Jeske Staal, MD       j.staal@zgt.nl    Principal Investigator: Jeske Staal, MD          Antoni van Leeuwenhoek Recruiting Amsterdam, Netherlands, 1066CX Contact: Egbert Smit       e.smit@nki.nl    Principal Investigator: Egbert Smit, MD          OLVG Not yet recruiting Amsterdam, Netherlands, 1090 HM Contact: A Moons, MD       A.Moons-Pasic@olvg.nl    Principal Investigator: A Moons, MD          Gelre Ziekenhuis Recruiting Apeldoorn, Netherlands Contact: Niels Pronk, MD       n.pronk@gelre.nl    Principal Investigator: Niels Pronk, MD          Amphia Hospital Recruiting Breda, Netherlands Contact: Nicolaas van Walree, MD       nwalree@amphia.nl    Principal Investigator: Nicolaas van Walree, MD          Jeroen Bosch Hospital Recruiting Den Bosch, Netherlands Contact: Bonne Biesma, MD       b.biesma@jbz.nl    Principal Investigator: Bonne Biesma, MD          Haga Recruiting Den Haag, Netherlands, 2545 CH Contact: Pepijn Brocken, MD       p.brocken@hagaziekenhuis.nl    Principal Investigator: Pepijn Brocken, MD          Deventer Ziekenhuis Recruiting Deventer, Netherlands Contact: Suzy Samii, MD       s.samii@dz.nl    Principal Investigator: Suzy Samii, MD          Albert Schweitzer ziekenhuis Recruiting Dordrecht, Netherlands Contact: Eric van Thiel, MD       EricvanThiel@asz.nl    Principal Investigator: Eric van Thiel, MD          Ziekenhuis Gelderse Vallei Recruiting Ede, Netherlands Contact: Wouter de Jong, MD       jongw@zgv.nl    Principal Investigator: Wouter de Jong, MD          Maxima Medisch Centrum Recruiting Eindhoven, Netherlands, 5631 BM Contact: Arjen van Henten, MD       a.vanhenten@mmc.nl    Principal Investigator: Arjen van Henten, MD          Groene Hart Recruiting Gouda, Netherlands Contact: ten Heuvel, MD       alexandra.ten.heuvel@ghz.nl    Principal Investigator: ten Heuvel, MD          UMCG Recruiting Groningen, Netherlands, 9713 GZ Contact: Harry Groen, MD       h.j.m.groen@umcg.nl    Principal Investigator: Harry Groen, MD          Martini Ziekenhuis Recruiting Groningen, Netherlands Contact: John van Putten, MD       jwg.van.putten@mzh.nl    Principal Investigator: John van Putten, MD          Tergooi ziekenhuizen Recruiting Hilversum, Netherlands Contact: Jan Maarten van Haarst, MD       jvanhaarst@tergooi.nl    Principal Investigator: Jan Maarten van Haarst, MD          Spaarne Gasthuis Recruiting Hoofddorp, Netherlands, 2130 AT Contact: Frans Krouwels, MD       fkrouwels@spaarnegasthuis.nl    Principal Investigator: Frans Krouwels, MD          Medisch Centrum Leeuwarden Recruiting Leeuwarden, Netherlands Contact: Venmans, MD          Principal Investigator: Venmans, MD          Maastricht University Medical Center Recruiting Maastricht, Netherlands Contact: Anne-Marie Dingemans, MD       a.dingemans@mumc.nl    Principal Investigator: Anne-Marie Dingemans, MD          Maasstad ziekenhuis Recruiting Rotterdam, Netherlands, 3007 AC Contact: Susan van 't Westeinde, MD       westeindes@maasstadziekenhuis.nl    Contact: , MD          Principal Investigator: Susan van 't Westeinde, MD          St. Fransicus Gasthuis Recruiting Rotterdam, Netherlands, 3045 PM Contact: Wessel Hanselaar, MD       w.hanselaar@franciscus.nl    Principal Investigator: Wessel Hanselaar, MD          Medical Center Haaglanden Recruiting the Hague, Netherlands Contact: Klaar Maas, MD       k.maas@mchaaglanden.nl    Principal Investigator: Klaar Maas, MD          Diakonessenhuis Utrecht Recruiting Utrecht, Netherlands, 3582 KE Contact: Leontine van Elden, MD       lvelden@diakhuis.nl    Principal Investigator: Leontine van Elden, MD          St. Antonius ziekenhuis Recruiting Utrecht, Netherlands Contact: Franz Schramel, MD       f.schramel@antoniusziekenhuis.nl    Principal Investigator: Franz Schramel, MD          VieCuri Medisch Centrum voor Noord-Limburg Recruiting Venlo, Netherlands Contact: Vivian van Kampen, MD       vvankampen@viecuri.nl    Principal Investigator: Vivian van Kampen, MD          Isala Klinieken Recruiting Zwolle, Netherlands, 8000 GK Contact: Jos Stigt       j.a.stigt@isala.nl    Principal Investigator: Jos Stigt, MD Less <<
NCT00988858 - Completed - -
NCT00427466 Sarcoma PHASE2 COMPLETED 2025-12-08 Medical Center II, University ... More >>of Tuebingen, Tuebingen, 72076, Germany Less <<
NCT01004601 Non Small Cell Lung Cancer Not Applicable Completed - Taiwan ... More >> Chang Gung Memorial Hospital Taipei, Taiwan, 10507 Less <<
NCT01169675 Neoplasms Phase 1 Completed - Canada, Alberta ... More >> 1200.92.1001 Boehringer Ingelheim Investigational Site Edmonton, Alberta, Canada Canada, Ontario 1200.92.1002 Boehringer Ingelheim Investigational Site Hamilton, Ontario, Canada Less <<
NCT01656551 Non-small Cell Lung Cancer Met... More >>astatic Non-small Cell Lung Cancer Stage IIIB Less << Phase 3 Active, not recruiting September 2018 -
NCT00490373 Pancreatic Cancer Phase 2 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany Less <<
NCT00190918 Trophoblastic Neoplasms|Uterin... More >>e Neoplasms|Hydatidiform Mole|Choriocarcinoma Less << PHASE2 COMPLETED 2025-07-07 Gynecologic Oncology Group 215... More >>-854-0770, Philadelphia, Pennsylvania, United States Less <<
NCT01169675 - Completed - -
NCT01860508 Non-small Cell Lung Cancer Not Applicable Unknown - China, Shanghai ... More >> Cancer hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Jia lei Wang, Master    02164175590 ext 8907    luwangjialei@hotmail.com Less <<
NCT00573989 - Terminated(Drug Supply Issue) - -
NCT00343720 Non-Small Cell Lung Cancer Phase 2 Completed - Belgium ... More >> Hopital de Jolimont Haine-Saint-Paul, Belgium, 7100 Less <<
NCT02488694 Non-small-cell Lung Cancer Wit... More >>h Somatic EGFR Mutations Less << Phase 2 Terminated(unsufficient recrui... More >>tment) Less << - Germany ... More >> Universitätsklinikum Essen Essen, Germany Less <<
NCT00867009 Non-Small-Cell Lung Cancer Phase 2 Completed - Austria ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Graz, Austria, 8036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salzburg, Austria, 5020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wels, Austria, 4600 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 13125 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Halle, Germany, D-06120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Homburg, Germany, 66421 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mannheim, Germany, 68167 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tuebingen, Germany, 72076 Greece For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Athens, Greece, 11527 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Patras, Greece, 26500 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bari, Italy, 70126 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bergamo, Italy, 24128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palermo, Italy, 90146 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Potenza, Italy, 85028 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Torino, Italy, 10100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Treviso, Italy, 31100 Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Amsterdam, Netherlands, 1081 HV For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Groningen, Netherlands, 9713 GZ For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Maastricht, Netherlands, 6229 HX For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. S-Hertogenbosch, Netherlands, 5211 NL Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lleida, Spain, 25198 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Reus, Spain, 43201 Less <<
NCT00573989 Head and Neck Cancer Phase 1 Phase 2 Terminated(Drug Supply Issue) - United States, North Carolina ... More >> UNC Linberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT01481259 Non-small Cell Lung Cancer Phase 2 Phase 3 Unknown July 2013 China, Guangxi ... More >> Clinical Cancer Center, People's Hospital of Guangxi Zhuang Autonomous Region Recruiting Nanning, Guangxi, China, 530021 Less <<
NCT01705184 Non-small Cell Lung Cancer Met... More >>astatic Nonsquamous Nonsmall Cell Neoplasm of Lung Less << Phase 2 Completed - France ... More >> Avignon - Institut Sainte-Catherine Avignon, France, 84918 Caen - Centre François Baclesse Caen, France, 14000 Caen - CHU Côte de Nacre Caen, France, 14000 Centre Hospitalier Chauny, France CH du Mans Le Mans, France Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques Marseille, France Mulhouse - CH Mulhouse, France, 68000 Nantes - Centre René Gauducheau Nantes, France, 44805 Hopital Tenon - Pneumologie Paris, France, 75020 HCL - Lyon Sud (Pneumologie) Pierre Bénite, France, 69495 Rennes - CHU Rennes, France, 35033 Strasbourg - NHC Strasbourg, France, 63000 Less <<
NCT00961415 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 3 Completed - -
NCT00867009 - Completed - -
NCT00961415 - Completed - -
NCT03380468 Lung Neoplasms Phase 2 Phase 3 Recruiting December 31, 2025 China, Shanghai ... More >> Fudan University Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Chen Haiquan, MD    +86-21 64175590 ext 1707    hqchen1@yahoo.com Less <<
NCT01192243 Toxicity Non-... More >>small Cell Lung Cancer Less << Phase 2 Unknown - China, Shanghai ... More >> Cancer hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Jianhua Chang, MD,PhD    13916619284    changjianhua@hotmail.com Less <<
NCT00072865 Breast Cancer ... More >> Neoplasm Metastasis Less << Phase 2 Completed - Russian Federation ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Moscow, Russia, Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Saint Petersburg, Russia, Russian Federation Less <<
NCT00533429 Non-small Cell Lung Cancer Phase 2 Completed - United States, Arkansas ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bentonville, Arkansas, United States, 72712 United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States, 60611 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Galesburg, Illinois, United States, 61401 United States, Indiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bloomington, Indiana, United States, 47403 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Evansville, Indiana, United States, 47714 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fort Wayne, Indiana, United States, 46815 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States, 46202 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lafayette, Indiana, United States, 47904 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Muncie, Indiana, United States, 47303 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. South Bend, Indiana, United States, 46601 United States, Michigan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jackson, Michigan, United States, 49201 United States, Nebraska For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Omaha, Nebraska, United States, 68114 Less <<
NCT00087711 Non Small Cell Lung Carcinoma Phase 3 Completed - -
NCT01829113 Non Squamous Non Small Cell Lu... More >>ng Cancer Less << Phase 2 Completed - United States, Colorado ... More >> Rocky Mountain Cancer Center Denver, Colorado, United States, 80218 United States, Florida Florida Cancer Specialists-South Fort Myers, Florida, United States, 33916 Florida Hospital Cancer Insitute Orlando, Florida, United States, 32804 Florida Cancer Specialists-North Saint Petersburg, Florida, United States, 33705 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Missouri Research Medical Center Kansas City, Missouri, United States, 64132 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, New Jersey Hematology-Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07932 United States, Ohio Oncology Hematology Care, Inc. Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates Columbia, South Carolina, United States, 29210 United States, Tennessee Tennessee Oncology - Chattanooga Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas The Center for Cancer and Blood Disorders Fort Worth, Texas, United States, 76104 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Virginia Cancer Institute Richmond, Virginia, United States, 23230 Less <<
NCT01373463 Nonsquamous Nonsmall Cell Neop... More >>lasm of Lung Nonsmall Cell Lung Cancer Stage III Less << Phase 1 Terminated(Investigator left s... More >>ite) Less << - United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT01303926 Non-squamous Nonsmall Cell Neo... More >>plasm of Lung Less << Phase 3 Unknown June 2012 Italy ... More >> "Giovanni Paolo II" Oncology Institute Bari, BA, Italy, 70124 "San Paolo Hospital" Oncology Service Bari, BA, Italy Division of Medical Oncology, "Fatebenefratelli" Hospital Benevento, BN, Italy Division of Medical Oncology, "Sen. Perrino" Hospital, Brindisi, Italy Brindisi, BR, Italy, 72100 7 Division of Medical Oncology, "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, FG, Italy Medical Oncology Division "Vito Fazzi" Hospital Lecce, Le, Italy Division of Medical Oncology, "Buccheri-La Ferla" Hospital Palermo, PA, Italy Division of Medical Oncology, "La Maddalena" Hospital Palermo, PA, Italy Division of Medical Oncology, Castellaneta Hospital Castellaneta, TA, Italy Division of Medical Oncology "San Giuseppe Moscati Hospital" Taranto, TA, Italy Clinical Trials Office, Department of Medical Sciences, Azienda ULSS 13 Mirano, VE, Italy National Cancer Institute "G. Pascale" Thoracic Dept. Napoli, Italy Less <<
NCT02029690 Pleural Mesothelioma Malignant... More >> Advanced Peritoneal Mesothelioma Malignant Advanced Non-squamous Non-small Cell Lung Carcinoma Stage IIIB/IV (NSCLC) Metastatic Uveal Melanoma Hepatocellular Carcinoma (HCC) Glioma Sarcomatoid Cancers Less << Phase 1 Active, not recruiting February 2019 United States, Minnesota ... More >> Mayo Clinic Rochester Rochester, Minnesota, United States, 55902 United Kingdom Centre for Experimental Cancer Medicine (CECM) London, England, United Kingdom, EC1M 6BQ Cambridge Hospital Cambridge, United Kingdom, CB2 0QQ Guys Hospital London, United Kingdom, SE1 7EH Less <<
NCT01829113 - Completed - -
NCT00974584 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 1 Completed - United States, New York ... More >> Buffalo, New York, United States, 14263 France Villejuif, France, 94805 Netherlands Groningen, Netherlands, 9700 RB Less <<
NCT00932893 Carcinoma, Non-Small-Cell Lung Phase 3 Completed - -
NCT00190801 Gastrointestinal Neoplasms Phase 2 Completed - Korea, Republic of ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goyang-Si, Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. In Cheon, Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of Less <<
NCT03513666 NSCLC Phase 2 Recruiting June 2019 China, Shanghai ... More >> Shanghai Pulmonary Hospita Recruiting Shanghai, Shanghai, China Contact: Caicun Zhou Less <<
NCT00165503 - Terminated(lack of acurral) - -
NCT00762034 - Completed - -
NCT00932893 - Completed - -
NCT00762034 Non-small Cell Lung Cancer Phase 3 Completed - -
NCT00063570 Breast Cancer ... More >> Breast Neoplasms Less << Phase 2 Completed - United States, Colorado ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Aurora, Colorado, United States United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Plantation, Florida, United States United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Morrisville, North Carolina, United States United States, Pennsylvania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Philadelphia, Pennsylvania, United States United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Dallas, Texas, United States United States, Washington For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Seattle, Washington, United States Puerto Rico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. San Juan, Puerto Rico Less <<
NCT00165503 Pleural Mesothelioma ... More >> Malignant Pleural Mesothelioma Less << Phase 2 Terminated(lack of acurral) - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00806819 - Completed - -
NCT00494026 Small Cell Lung Cancer Phase 2 Terminated(Study stopped early... More >> based on interim results of another trial, showing inferior activity of pemetrexed/carboplatin compared to etoposide/carboplatin in SCLC.) Less << - Italy ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orbassano, Italy, 10043 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Parma, Italy, 43100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Sisto, Italy, 06156 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Terni, Italy, 05100 Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland, 60-569 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland, 02-781 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palma de Mallorca, Spain, 07014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46010 United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Southampton, Hants, United Kingdom, SO16 6YD For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guilford, Surrey, United Kingdom, GU2 7XX For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wolverhampton, West Midlands, United Kingdom, WV10 0QP Less <<
NCT00806819 Carcinoma, Non-Small-Cell Lung Phase 3 Completed - -
NCT00063570 - Completed - -
NCT00494026 - Terminated(Study stopped early... More >> based on interim results of another trial, showing inferior activity of pemetrexed/carboplatin compared to etoposide/carboplatin in SCLC.) Less << - -
NCT00651456 Mesothelioma Phase 2 Phase 3 Completed - -
NCT00948675 Advanced Non-Small Cell Lung C... More >>ancer Less << Phase 3 Active, not recruiting December 2018 -
NCT00948675 - Active, not recruiting - -
NCT02899299 Mesothelioma Phase 3 Active, not recruiting September 28, 2021 -
NCT02578680 - Active, not recruiting - -
NCT00520845 Lung Cancer Phase 2 Terminated(slow accrual) - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00538681 Lung Cancer Phase 2 Completed - Belgium ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leuven, Belgium, 3000 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gauting, Germany, 82131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. GroBhansdorf, Germany, D-22927 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, D 21075 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Germany, 69126 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bergamo, Italy, 24128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Catania, Italy, 95100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Padova, Italy, 35128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trento, Italy, 38100 Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Otwock, Poland, 05-400 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland, 60-569 Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bucharest, Romania, 022328 Less <<
NCT00349089 Non-small Cell Lung Cancer Phase 2 Unknown December 2013 Belgium ... More >> Ziekenhuis Oost Limburg Genk, Belgium, 3600 Department of Pulmonology (Respiratory Tumor Unit), University Hospital Gasthuisberg, Catholic University Leuven, Belgium. Leuven, Belgium, 3000 Germany Helios-Klinikum Emil von Behring Berlin, Germany, 14109 Klinikum Bremen-Ost Bremen, Germany, 28325 Westdeutsches Tumorzentrum Essen, Germany, 45122 Department of Hematology and Oncology, University of Goettingen Goettingen, Germany, 37075 Lungenzentrum Großhansdorf Großhansdorf, Germany, 22927 Clinic for thoracic diseases at the University of Heidelberg Heidelberg, Germany, 69120 Lungenklinik Hemer Hemer, Germany, 58675 Klinik Löwenstein Loewenstein, Germany, 74245 University of München Muenchen, Germany Oldenburg Hospital Oldenburg, Germany Dr. Horst Schmidt Klinik Wiesbaden, Germany, 65199 Luxembourg Centre Hospitalier du Luxembourg Luxembourg, Luxembourg, L-1210 Less <<
NCT00520676 Non-Small Cell Lung Cancer Phase 3 Completed - Australia, Victoria ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ballarat, Victoria, Australia, 3350 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankston, Victoria, Australia, 3199 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wendouree, Victoria, Australia, 3355 Australia, Western Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bunbury, Western Australia, Australia, 6230 Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barretos, Brazil, 14784700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goiania, Brazil, 74075040 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santo André, Brazil, 09060-020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. São Paulo, Brazil, 01224 010 China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200032 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 120-752 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Suwon-City, Korea, Republic of, 442-723 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ulsan, Korea, Republic of, 682-714 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ciudad Obregon, Mexico, 85100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Durango, Mexico, 34208 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mexicali, Mexico, 21000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mexico City, Mexico, 11640 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 404 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 Less <<
NCT02578680 Non-Small-Cell Lung Carcinoma Phase 3 Active, not recruiting April 15, 2019 -
NCT00290017 Carcinoma, Non-Small-Cell Lung... More >> Lung Cancer Neoplasms, Lung Neoplasms, Pulmonary Less << Phase 3 Terminated(FDA Hold May 2007) - -
NCT00520845 - Terminated(slow accrual) - -
NCT00520676 - Completed - -
NCT00391274 Non-Small Cell Lung Cancer Phase 3 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 101149 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510080 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hang Zhou, China, 310022 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nan Jing, China, 210002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200433 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tianjin, China, 300060 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wu Han, China, 430030 Less <<
NCT03228537 Biphasic Mesothelioma ... More >> Epithelioid Mesothelioma Stage I Pleural Malignant Mesothelioma AJCC v7 Stage IA Pleural Malignant Mesothelioma AJCC v7 Stage IB Pleural Malignant Mesothelioma AJCC v7 Stage II Pleural Malignant Mesothelioma AJCC v7 Stage III Pleural Malignant Mesothelioma AJCC v7 Less << Phase 1 Recruiting June 1, 2020 -
NCT02709512 Mesothelioma Phase 2 Phase 3 Recruiting June 2021 -
NCT02679443 Lung Adenocarcinoma ... More >> Neutropenia Anemia Thrombocytopenia Nonsquamous Nonsmall Cell Neoplasm of Lung Less << Not Applicable Completed - India ... More >> PGIMER Chandigarh, India, 160012 Less <<
NCT00898820 - Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00390000 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Active, not recruiting December 2018 United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00078260 Non-Small Cell Lung Cancer Phase 3 Completed - Turkey ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ankara, Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gaziantep, Turkey Less <<
NCT00301808 Lung Cancer Phase 2 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Veterans Affairs Medical Center - Detroit Detroit, Michigan, United States, 48201 Less <<
NCT00391274 - Completed - -
NCT00259285 - Terminated(Trial was stopped e... More >>arly due to low enrollment.) Less << - -
NCT00301808 - Completed - -
NCT00259285 Non-Small-Cell Lung Cancer Phase 2 Terminated(Trial was stopped e... More >>arly due to low enrollment.) Less << - Spain ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barakaldo, Spain, 48903 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Coruña, Spain, 15006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pamplona, Spain, 31008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46014 Less <<
NCT00470405 Lymphoma Soli... More >>d Tumor Less << Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00745875 - Completed - -
NCT01323062 Non Small Cell Lung Cancer (NS... More >>CLC) Less << Phase 1 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center, UNC Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00745875 Non Small Cell Lung Cancer ... More >> Lung Cancer Less << Phase 2 Completed - Bulgaria ... More >> research Site Pleven, Bulgaria Research Site Sofia, Bulgaria Research Site Varna, Bulgaria Czech Republic Research Site Jicin, Czech Republic Research Site Prague, Czech Republic France Research Site Cedex, France Research Site Strasbourg, France Romania Research Site Bucharest, Romania Research Site Cluj-Napoca, Romania Ukraine Research Site Chernivtsi, Ukraine Research Site Kiev, Ukraine Research Site Sumy, Ukraine Research Site Uzngorod, Ukraine Less <<
NCT00415194 Head and Neck Neoplasms Phase 3 Completed - -
NCT03058094 NSCLC Phase 3 Not yet recruiting January 2020 China, Beijing ... More >> Beijing Cancer Hospital Not yet recruiting Beijing, Beijing, China, 100000 Contact: Jian Fang          Chinese General PLA Hospital Not yet recruiting Beijing, Beijing, China, 100000 Contact: Yi Hu          Peking Union Medical College Hospital Not yet recruiting Beijing, Beijing, China, 100000 Contact: Mengzhao Wang          China, Chongqing Xinqiao Hospital Army Medical University Not yet recruiting Chongqing, Chongqing, China, 400000 Contact: Dong Wang          China, Fujian Fujian Cancer Hospital Not yet recruiting Fuzhou, Fujian, China, 350000 Contact: Cheng Huang          Fuzhou General Hospital of Nanjing Military Command Not yet recruiting Fuzhou, Fujian, China, 350000 Contact: Xuenong Ouyang          China, Hebei Tumor Hospital of Hebei Province Not yet recruiting Shijiazhuang, Hebei, China, 050000 Contact: Cuimin Ding          China, Heilongjiang Harbin Medical University Cancer Hospital Not yet recruiting Harbin, Heilongjiang, China, 150000 Contact: Gongyan Chen          China, Henan Henan Cancer Hospital Not yet recruiting Zhengzhou, Henan, China, 450000 Contact: Zhiyong Ma          China, Jiangsu Jiangsu Province Hospital Not yet recruiting Nanjing, Jiangsu, China, 210000 Contact: Yongqian Shu          Nanjing General Hospital Not yet recruiting Nanjing, Jiangsu, China, 210000 Contact: Yong Song          China, Liaoning The First Affiliated Hospital of Dalian Medical University Not yet recruiting Dalian, Liaoning, China, 116000 Contact: Jiwei Liu          The second Hospital of Dalian Medical University Not yet recruiting Dalian, Liaoning, China, 116000 Contact: Yang Zhang          The First Affiliated Hospital of China Medical University Not yet recruiting Shenyang, Liaoning, China, 110000 Contact: Yunpeng Liu          China, Shanghai Fudan University Shanghai Cancer Center Not yet recruiting Shanghai, Shanghai, China, 200000 Contact: Jianhua Chang          China, Sichuan Sichuan Cancer Hospital & Institute Not yet recruiting Chengdu, Sichuan, China, 610000 Contact: Ping Yu          West China Hospital,Sichuan University Not yet recruiting Chengdu, Sichuan, China, 610000 Contact: You Lu          China, Tianjin Tianjin Medical University Cancer Institute & Hospital Not yet recruiting Tianjin, Tianjin, China, 300000 Contact: Kai Li          China, Zhejiang The First Affiliated Hospital,Zhejiang University Not yet recruiting Hangzhou, Zhejiang, China, 310000 Contact: Qiong Zhao          Zhejiang Cancer Hospital Not yet recruiting Hangzhou, Zhejiang, China, 310000 Contact: Yiping Zhang          China Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting Beijing, China, 100021 Principal Investigator: Yuankai Shi, Professor Less <<
NCT00191412 Liver Cancer PHASE2 COMPLETED 2025-03-06 For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Denver, Colorado, United States Less <<
NCT00415194 - Completed - -
NCT00789373 Non-Small Cell Lung Cancer Phase 3 Completed - -
NCT00754364 NSCLC Phase 2 Terminated(low enrollment rate... More >>) Less << December 2015 Italy ... More >> Istituto Clinco Humanitas Rozzano, Milan, Italy, 20089 Less <<
NCT00408226 Advanced Cancer ... More >> Non-Small Cell Lung Cancer Less << Phase 1 Phase 2 Completed - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Washington Swedish Cancer Institute Seattle, Washington, United States, 98122 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT02919462 Carcinoma, Non-Small-Cell Lung... More >> Secondary Advanced Stage IIIB High Thymidylate Synthase Expression Less << Phase 2 Terminated(low recruitement ra... More >>te) Less << - Italy ... More >> Ircc Irst Meldola, FC, Italy, 47014 U.O. Oncologia Medica Faenza, RA, Italy, 48018 Claudio Dazzi Ravenna, RA, Italy, 48121 Ospedale di Piacenza, ASL Piacenza Piacenza, Italy U.O. Oncologia Ospedale degli Infermi Rimini, Italy Less <<
NCT00129974 - Terminated(failure to accrue) - -
NCT00860015 Sarcoma, Soft Tissue Phase 2 Completed - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00129974 Carcinoma, Small Cell Phase 2 Terminated(failure to accrue) - United States, Massachusetts ... More >> Tufts-New England Medical Center Boston, Massachusetts, United States, 02111 Commonwealth Hematology/Oncology Quincy, Massachusetts, United States, 02169 Baystate Medical Center Springfield, Massachusetts, United States, 01199 Less <<
NCT03151161 Lung, Carcinoma Phase 2 Not yet recruiting May 2019 China, Guangdong ... More >> Recruiting Guanzhou, Guangdong, China, 510000 Contact: Long Hao, Prof    +86 2087343261    longhao@sysucc.org.cn    Contact: Ruping Xing    +86 2087343736    xingrp@sysucc.org.cn Less <<
NCT00660816 - Completed - -
NCT02087241 Previously Untreated Stage IV ... More >>Non-Squamous Non Small Cell Lung Cancer Less << Phase 2 Terminated(The sponsor decided... More >> to terminate the study.) Less << - United States, Colorado ... More >> Research Site Englewood, Colorado, United States United States, Florida Research Site Fort Myers, Florida, United States Research Site Orlando, Florida, United States United States, Illinois Research Site Peoria, Illinois, United States United States, Indiana Research Site Fort Wayne, Indiana, United States United States, Kansas Research Site Wichita, Kansas, United States United States, Ohio Research Site Cincinnati, Ohio, United States United States, Tennessee Research Site Nashville, Tennessee, United States Less <<
NCT00789373 - Completed - -
NCT00771953 Lung Cancer N... More >>on Small Cell Lung Cancer Less << Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Florida Mercy Research Institute Miami, Florida, United States, 33133 University of Miami Miami, Florida, United States, 33136 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Maryland University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New Mexico University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 United States, New York Weill Medical Cornell University New York, New York, United States, 10065 Stony Brook Cancer Center (SUNY) Stony Brook, New York, United States, 11794 United States, Oregon Providence Portland Medical Center Portland, Oregon, United States, 97213 United States, Pennsylvania Abramson Cancer Center of Uof Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, West Virginia West Virginia University Clinical Trials Research Unit Morgantown, West Virginia, United States, 26506 Less <<
NCT00660816 Lung Cancer Phase 2 Completed - United States, Michigan ... More >> Wayne State University Detroit, Michigan, United States, 48202 United States, New York Columbia Presbyterian New York City, New York, United States, 10032 United States, Ohio Lake/University Ireland Cancer Center Cleveland, Ohio, United States, 44060 Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 MetroHealth Medical Center Cleveland, Ohio, United States, 44109 UHHS Chagrin Highlands Medical Center Cleveland, Ohio, United States, 44122 Southwest General Health Center Cleveland, Ohio, United States, 44130 UHHS Westlake Medical Center Cleveland, Ohio, United States, 44145 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Riverside Methodist Hospital Columbus, Ohio, United States, 43124 Ohio State University Columbus, Ohio, United States, 43210 UH-Monarch Mayfield Heights, Ohio, United States, 44124 UH-Firelands Sandusky, Ohio, United States, 44870 Less <<
NCT02087241 - Terminated(The sponsor decided... More >> to terminate the study.) Less << - -
NCT00771953 - Completed - -
NCT01928160 Recurrent Non-small Cell Lung ... More >>Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 2 Withdrawn(study not accruing) - -
NCT01630174 - Unknown - China, Shandong ... More >> Shandong Cancer hospital and institute Recruiting Jinan, Shandong, China, 250017 Principal Investigator: Baosheng Li, Ph.D.          Sub-Investigator: Zhongtang Wang, M.D. Less <<
NCT00295503 Mesothelioma Phase 2 Completed - United States, Texas ... More >> University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390-8852 Less <<
NCT01139775 Non Small Cell Lung Cancer Phase 1 Phase 2 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mannheim, Baden-Wurttemberg, Germany, 68167 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munster, Nordhein-Westfalen, Germany, 48149 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Coswig, Sachsen, Germany, 01640 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 14165 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, 60596 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Germany, 69126 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Homburg, Germany, 66421 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Immenhausen, Germany, 34376 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lübeck, Germany, 23538 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, D-55131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rheine, Germany, 48431 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ulm, Germany, 89081 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oviedo, Asturias, Spain, 33006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mataro, Barcelona, Spain, 08304 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pozuelo de Alarcon, Madrid, Spain, 28223 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08908 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Girona, Spain, 17007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28046 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28050 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sevilla, Spain, 41013 Less <<
NCT00295503 - Completed - -
NCT01338792 - Completed - -
NCT00887549 - Completed - -
NCT01109615 Metastatic Colorectal Cancer Phase 2 Terminated(Lacking effect of t... More >>reatment) Less << - Denmark ... More >> Vejle Hospital Vejle, Denmark, DK-7100 Less <<
NCT00191308 Non-Small Cell Lung Cancer ... More >> Carcinoma Less << Phase 2 Completed - Poland ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bystra Slaska, Poland, 43-360 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland, 60-569 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland, 02-781 Less <<
NCT00191308 - Completed - -
NCT01139775 - Completed - -
NCT01338792 Hormone-resistant Prostate Can... More >>cer Recurrent Prostate Cancer Less << Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT00887549 Non-Small Cell Lung Cancer Phase 2 Completed - Ireland ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dublin, Ireland United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Derby, Derbyshire, United Kingdom, DE22 3NE For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Exeter, Devon, United Kingdom, EX2 5DW For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Maidstone, Kent, United Kingdom, ME16 9QQ For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Preston, Lancashire, United Kingdom, PR2 9HT For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Liverpool, Merseyside, United Kingdom, L14 3PE For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Northwood, Middlesex, United Kingdom, HA6 2RN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Scunthorpe, North Lincolnshire, United Kingdom, DN15 7BH For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Belfast, Northern Ireland, United Kingdom, BT9 7BL For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nottingham, Nottinghamshire, United Kingdom, NG5 1PD For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aberdeen, Scotland, United Kingdom, AB25 2ZN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wolverhampton, West Midlands, United Kingdom, WV10 0QP For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Grimsby, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Manchester, United Kingdom, M23 9LT Less <<
NCT00407550 Lung Cancer Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT00407550 - Completed - -
NCT00190840 Carcinoma, Non-Small Cell Lung Phase 2 Completed - Australia, New South Wales ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wollongong, New South Wales, Australia, 2500 Australia, Queensland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chermside, Queensland, Australia, 4032 Australia, South Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ashford, South Australia, Australia, 5035 Australia, Victoria For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fitzroy, Victoria, Australia, 3065 China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hong Kong, China Egypt For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alexandria, Egypt For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cairo, Egypt, 11796 India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyderabad, Andhra Pradesh, India, 500004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ludhiana, Punjab, India, 141001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chandigarh, India, 160012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chennai, India, 600035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Delhi, India, 110085 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goyang-Si, Gyeonggi-Do, Korea, Republic of, 411764 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oradea, Bihor, Romania, 3700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Craiova, Dolj, Romania, 1100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bucuresti, Romania, 72435 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Iasi, Romania, 6600 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Eskisehir, Turkey Less <<
NCT00071136 Lung Neoplasms Phase 1 Phase 2 Completed - United States, Florida ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC-GMT - 5 hours, EST), or speak with your personal physician. Ft. Myers, Florida, United States United States, Minnesota For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC-GMT - 5 hours, EST), or speak with your personal physician. Marshfield, Minnesota, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC-GMT - 5 hours, EST), or speak with your personal physician. Minneapolis, Minnesota, United States United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC-GMT - 5 hours, EST), or speak with your personal physician. Rochester, New York, United States United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC-GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States Less <<
NCT00363415 Small Cell Lung Cancer Phase 3 Completed - -
NCT00573690 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT00087087 Ovarian Cancer ... More >> Primary Peritoneal Cavity Cancer Less << Phase 2 Completed - -
NCT00363415 - Completed - -
NCT00096187 Gestational Trophoblastic Tumo... More >>r Less << Phase 2 Terminated - United States, Alabama ... More >> Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham Birmingham, Alabama, United States, 35294 United States, California Providence Saint Joseph Medical Center - Burbank Burbank, California, United States, 91505 Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange, California, United States, 92868 United States, Illinois Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Hinsdale Hematology Oncology Associates Hinsdale, Illinois, United States, 60521 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242 United States, Missouri St. John's Regional Health Center Springfield, Missouri, United States, 65804 Hulston Cancer Center at Cox Medical Center South Springfield, Missouri, United States, 65807 United States, New Jersey Cancer Institute of New Jersey at Cooper - Voorhees Voorhees, New Jersey, United States, 08043 United States, North Carolina Blumenthal Cancer Center at Carolinas Medical Center Charlotte, North Carolina, United States, 28232-2861 Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Wilson Medical Center Wilson, North Carolina, United States, 27893-3428 United States, Ohio Charles M. Barrett Cancer Center at University Hospital Cincinnati, Ohio, United States, 45267 Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus, Ohio, United States, 43210-1240 Riverside Methodist Hospital Cancer Care Columbus, Ohio, United States, 43214-3998 Hillcrest Cancer Center at Hillcrest Hospital Mayfield Heights, Ohio, United States, 44124 Lake/University Ireland Cancer Center Mentor, Ohio, United States, 44060 United States, Oklahoma Oklahoma University Cancer Institute Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania Rosenfeld Cancer Center at Abington Memorial Hospital Abington, Pennsylvania, United States, 19001 McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center Reading, Pennsylvania, United States, 19612-6052 United States, Texas Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 UMC Southwest Cancer and Research Center Lubbock, Texas, United States, 79415-3364 Less <<
NCT00386815 Malignant Pleural Mesothelioma Phase 2 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 464-8681 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 811-1395 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 060-8648 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 663-8501 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okayama, Japan, 702-8055 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 589-8511 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 104-0045 Less <<
NCT00102219 Breast Cancer Phase 2 Completed - Brazil ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Belo Horizonte, BH, Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Rio de Janeiro, Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Sao Paulo, Brazil Greece For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Athens, Greece Hungary For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Budapest, Hungary For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Szekesfehervar, Hungary Peru For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Lima, Peru Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Krakow, Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Lodz, Poland Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Madrid, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Valencia, Spain Venezuela For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Caracas, Venezuela Less <<
NCT01232452 Non-Small-Cell Lung Carcinoma Phase 2 Completed - -
NCT03647956 NSCLC Stage IIIB ... More >> NSCLC Stage IV EGFR Activating Mutation Less << Phase 2 Recruiting April 3, 2020 Hong Kong ... More >> Department of Clinical Oncology Recruiting Hong Kong, Hong Kong Principal Investigator: Tai-Chung Lam, FRCR          Sub-Investigator: Chi-Leung Chiang, FRCR          Sub-Investigator: Victor Ho-Fun Lee, MD          Sub-Investigator: Tsz-Him So, MBBS Less <<
NCT01232452 - Completed - -
NCT01004250 Non-Small Cell Lung Cancer Phase 2 Completed - Denmark ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Copenhagen, Denmark, 2200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Herlev, Denmark, 2730 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Coswig, Germany, 01640 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, 60431 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 22087 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamm, Germany, 59071 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Magdeburg, Germany, D-39120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mannheim, Germany, 68167 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lecce, Italy, 73100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Padova, Italy, 35128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rome, Italy, 00144 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rozzano, Italy, 20089 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trento, Italy, 38100 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jaen, Spain, 23007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28046 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pozuelo De Alarcon, Spain, 28223 Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Malmo, Sweden, 205 02 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Solna, Sweden, 17176 Less <<
NCT00022646 Lung Cancer Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Florida Mayo Clinic Jacksonville, Florida, United States, 32224 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Health Plaza Saint Cloud, Minnesota, United States, 56303 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68106 United States, North Dakota Medcenter One Health System Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Toledo Community Hospital Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinic and Medical Center Danville, Pennsylvania, United States, 17822-2001 Allegheny General Hospital Pittsburgh, Pennsylvania, United States, 15212-4772 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57104 Less <<
NCT01004250 - Completed - -
NCT02409342 Non-Squamous Non-Small Cell Lu... More >>ng Cancer, Squamous Non-Small Cell Lung Cancer Less << Phase 3 Active, not recruiting April 23, 2020 -
NCT00550173 Non-Small-Cell Lung Cancer Phase 2 Completed - Brazil ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barretos, Brazil, 14784700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ijui, Brazil, 98700 000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. São Paulo, Brazil, 01277-900 China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100730 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanning, China, 530000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200030 Hong Kong For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sha Tin, Hong Kong India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ahmedabad, India, 380016 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bhopal, India, 462001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyderabaad, India, 500082 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jaipur, India, 302013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kochin, India, 682304 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kolkata, India, 700 026 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madurai, India, 625020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mohali, India, 160062 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mumbai, India, 400 026 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Delhi, India, 110017 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vishakhapatnam, India, 530002 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jin-Ju-Si, Korea, Republic of, 660-702 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 138-736 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Suwon-City, Korea, Republic of, 442-723 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changhua, Taiwan, 500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 407 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poole, Dorset, United Kingdom, BH15 2JB For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chelmsford, Essex, United Kingdom, CM1 7ET For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aberdeen, Scotland, United Kingdom, AB25 2ZN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guildford, Surrey, United Kingdom, GU2 7XX For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Manchester, United Kingdom, M20 4BX Less <<
NCT01344824 Lung Cancer Phase 2 Completed - United States, North Carolina ... More >> Mission Hospital Asheville, North Carolina, United States, 28801 Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 CCHC New Bern Cancer Care New Bern, North Carolina, United States, 28562 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00087100 Endometrial Cancer Phase 2 Completed - -
NCT00315861 Ovarian Cancer ... More >> Endometrial Cancer Cervical Cancer Lung Cancer Less << Phase 1 Completed - United States, Tennessee ... More >> Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00550173 - Completed - -
NCT00070473 Unspecified Childhood Solid Tu... More >>mor, Protocol Specific Less << Phase 1 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 323669 Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States, 94305 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010-2970 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Maryland NCI - Pediatric Oncology Branch Bethesda, Maryland, United States, 301496 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Fairview University Medical Center - University Campus Minneapolis, Minnesota, United States, 55455 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Mississippi University of Mississippi Medical Center Jackson, Mississippi, United States, 39216-4505 United States, New York Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 SUNY Upstate Medical University Hospital Syracuse, New York, United States, 13210 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Oregon Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239-3098 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 215590 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Baylor University Medical Center - Houston Houston, Texas, United States, 832822 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 206987 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada Canada, Quebec Hopital Sainte Justine Montreal, Quebec, Canada Less <<
NCT01344824 - Completed - -
NCT00251524 Non-Small Cell Lung Cancer Phase 2 Completed - United States, Ohio ... More >> Veeda Oncology Columbus, Ohio, United States, 43215 Less <<
NCT03376737 Lung Adenocarcinoma Phase 2 Recruiting June 2019 China, Henan ... More >> Henan Cancer Hospital Recruiting Zhengzhou, Henan, China, 450008 Contact: Guowei Zhang       dugu4986@126.com Less <<
NCT00768755 Carcinoma, Non-Small Cell Lung Phase 1 Phase 2 Completed - -
NCT00447421 Small Cell Lung Cancer ... More >> Carcinoma, Small Cell SCLC Less << Phase 1 Phase 2 Terminated(Interim results of ... More >>another trial showed inferior activity of treatment) Less << - Belgium ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leuven, Belgium, 3000 Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Amsterdam, Netherlands, 1081 HV For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Den Bosch, Netherlands, 5211 NL For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rotterdam, Netherlands, 3075 EA Less <<
NCT00768755 - Completed - -
NCT00447421 - Terminated(Interim results of ... More >>another trial showed inferior activity of treatment) Less << - -
NCT03242616 Breast Neoplasms Phase 2 Recruiting December 31, 2019 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Seock-Ah Im    82-2-2072-0850    moisa@snu.ac.kr Less <<
NCT00087698 - Completed - -
NCT00087113 Cervical Cancer Phase 2 Completed - United States, Arkansas ... More >> Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 United States, California Doctors Medical Center Modesto, California, United States, 95350-4138 United States, Connecticut Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States, 06105 United States, Illinois Hinsdale Hematology Oncology Associates Hinsdale, Illinois, United States, 60521 United States, Missouri CCOP - Kansas City Kansas City, Missouri, United States, 64131 St. John's Regional Health Center Springfield, Missouri, United States, 65804 United States, Nevada Women's Cancer Center - Las Vegas Las Vegas, Nevada, United States, 89102 United States, New York SUNY Downstate Medical Center Brooklyn, New York, United States, 11203 SUNY Upstate Medical University Hospital Syracuse, New York, United States, 13210 United States, North Carolina Hope A Women's Cancer Center Asheville, North Carolina, United States, 28801 Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 United States, Ohio Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 MetroHealth's Cancer Care Center at MetroHealth Medical Center Cleveland, Ohio, United States, 44109 Hillcrest Cancer Center at Hillcrest Hospital Mayfield Heights, Ohio, United States, 44124 United States, Oklahoma Oklahoma University Medical Center Oklahoma City, Oklahoma, United States, 73104 Cancer Care Associates - Midtown Tulsa Tulsa, Oklahoma, United States, 74104 United States, Oregon Williamette Gynecologic Oncology P.C. Salem, Oregon, United States, 97301 United States, Pennsylvania Rosenfeld Cancer Center at Abington Memorial Hospital Abington, Pennsylvania, United States, 19001 Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest Allentown, Pennsylvania, United States, 18105 United States, Texas Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 United States, Virginia Massey Cancer Center at Virginia Commonwealth University Richmond, Virginia, United States, 23298-0037 Less <<
NCT00454194 Lung Cancer Phase 2 Completed - -
NCT01588704 Lung Cancer Phase 2 Completed - China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT00087698 Pleural Neoplasms Phase 2 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Francisco, California, United States United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States United States, Maryland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baltimore, Maryland, United States United States, Massachusetts For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Boston, Massachusetts, United States United States, Michigan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Detroit, Michigan, United States United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New York, New York, United States United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States Less <<
NCT00383331 Non-Small-Cell Lung Cancer Phase 2 Terminated(Trial was stopped e... More >>arly due to low enrollment) Less << - United States, Minnesota ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rochester, Minnesota, United States, 55905 Less <<
NCT03623776 Efficacy and Safety Phase 2 Active, not recruiting July 1, 2023 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT00516100 Non-small Cell Lung Cancer Phase 1 Phase 2 Unknown August 2012 United States, California ... More >> Cedars-Sinai Outpatient Cancer Center Los Angeles, California, United States, 90048 Comprehensive Cancer Center at Desert Regional Medical Center Palm Springs, California, United States, 92262 California Pacific Medical Center San Francisco, California, United States, 94115 United States, New Jersey Trinitas Comprehensive Cancer Center Elizabeth, New Jersey, United States, 07207 Less <<
NCT00454194 - Completed - -
NCT00846443 Local Advanced Non-Small Cell ... More >>Lung Cancer Less << Phase 1 Unknown - China, Shanghai ... More >> Department of Radiation Oncolory, Cancer Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Liang Xiahou, MB    862164175590 ext 1404    xiahouliang@hotmail.com    Principal Investigator: Xiaolong Fu, MD Less <<
NCT02535325 Non-Squamous Non-Small Cell Lu... More >>ng Carcinoma Stage III Large Cell Lung Carcinoma AJCC v7 Stage III Lung Adenocarcinoma AJCC v7 Stage III Non-Small Cell Lung Cancer AJCC v7 Stage IIIA Large Cell Lung Carcinoma AJCC v7 Stage IIIA Lung Adenocarcinoma AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIB Large Cell Lung Carcinoma AJCC v7 Stage IIIB Lung Adenocarcinoma AJCC v7 Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Stage IV Large Cell Lung Carcinoma AJCC v7 Stage IV Lung Adenocarcinoma AJCC v7 Stage IV Non-Small Cell Lung Cancer AJCC v7 Less << Phase 1 Recruiting - United States, Ohio ... More >> Case Western Reserve University Recruiting Cleveland, Ohio, United States, 44106 Contact: Tithi Biswas    800-641-2422       Principal Investigator: Tithi Biswas Less <<
NCT00377520 Neoplasms Neo... More >>plasms by Site Urogenital Neoplasms Genital Neoplasms, Female Uterine Neoplasms Endometrial Neoplasms Cancer of Endometrium Endometrial Cancer Cancer of the Endometrium Endometrium Cancer Neoplasms, Endometrial Less << Phase 2 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group 215-854-0770 Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00059865 Extrahepatic Bile Duct Cancer ... More >> Gallbladder Cancer Liver Cancer Less << Phase 1 Phase 2 Completed - -
NCT00383331 - Terminated(Trial was stopped e... More >>arly due to low enrollment) Less << - -
NCT02357147 Mesothelioma, Malignant Phase 2 Active, not recruiting November 30, 2018 -
NCT02604342 Non-small Cell Lung Cancer Phase 3 Completed - -
NCT01401192 Non-small Cell Lung Cancer Phase 2 Unknown - Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Myung-Ju Ahn, M.D., Ph.D.          Sub-Investigator: Jong-Mu Sun, M.D., Ph.D. Less <<
NCT02604342 - Completed - -
NCT00380718 Non-small Cell Lung Cancer Phase 4 Completed - Taiwan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 407 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 112 Less <<
NCT02964689 Advanced Non-small Cell Lung C... More >>ancer KRAS Gene Mutation Lung Cancer Less << Phase 1 Recruiting September 2020 Switzerland ... More >> Universitaetsspital Basel Recruiting Basel, Switzerland, 4031 Contact: Sacha Rothschild, MD    +41 (0)61 265 25 25    sacha.rothschild@usb.ch    Principal Investigator: Sacha Rothschild, MD          IOSI Ospedale Regionale di Bellinzona e Valli Recruiting Bellinzona, Switzerland, 6500 Contact: Patrizia Froesch, MD    +41 (0)91 811 48 40    patrizia.froesch@eoc.ch    Principal Investigator: Patrizia Froesch, MD          Kantonsspital Graubuenden Recruiting Chur, Switzerland, CH-7000 Contact: Michael Mark, MD    +41 (0)81 256 61 11    michael.mark@ksgr.ch    Principal Investigator: Michael Mark, MD          Kantonsspital St. Gallen Recruiting St. Gallen, Switzerland, 9007 Contact: Martin Früh, MD    +41 (0)71 494 11 11    martin.frueh@kssg.ch    Principal Investigator: Martin Früh, MD Less <<
NCT00380718 - Completed - -
NCT00614965 Non Small Cell Lung Cancer Phase 2 Completed - Greece ... More >> Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece Less <<
NCT00377520 - Completed - -
NCT02259582 Nonsquamous Nonsmall Cell Neop... More >>lasm of Lung Less << Phase 2 Completed - -
NCT00497770 Lung Neoplasms COMPLETED 2025-03-11 For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mobile, Alabama, 36608, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Glendale, Arizona, 85304, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Anaheim, California, 92801, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Campbell, California, 95008, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Daly City, California, 94015, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., La Jolla, California, 92093, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lancaster, California, 93534, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mission Hills, California, 91345, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Palo Alto, California, 94305, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Poway, California, 92064, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., San Diego, California, 92123, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., San Francisco, California, 94115, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., San Jose, California, 95116, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Santa Cruz, California, 95065, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Sunnyvale, California, 94088, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Denver, Colorado, 80209, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Greeley, Colorado, 80631, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Stamford, Connecticut, 06902, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Fort Lauderdale, Florida, 33308, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Miami, Florida, 33179, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Weston, Florida, 33331, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Decatur, Georgia, 30033, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Honolulu, Hawaii, 96813, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Kealakekua, Hawaii, 96750, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Morehead, Kentucky, 40351, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., New Orleans, Louisiana, 70121, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Omaha, Nebraska, 68131, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Las Vegas, Nevada, 89109, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Buffalo, New York, 14263, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Washington, North Carolina, 27889, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Memphis, Tennessee, 38138, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Nashville, Tennessee, 37203, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Corpus Christi, Texas, 78463, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Galveston, Texas, 77555, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Richardson, Texas, 75080, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Monroe, Washington, 98272, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Seattle, Washington, 98133, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., San Juan, 00918, Puerto Rico Less <<
NCT02259582 - Completed - -
NCT03515837 Non-small Cell Lung Cancer Phase 3 Recruiting June 15, 2023 -
NCT01531790 Non-Small Cell Lung Cancer Phase 1 Completed - China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China Less <<
NCT00191503 Adenocarcinoma Phase 2 Completed - Canada, Alberta ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Calgary, Alberta, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Edmonton, Alberta, Canada Less <<
NCT00226577 Lung Cancer Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00497770 Lung Neoplasms COMPLETED 2025-03-11 For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mobile, Alabama, 36608, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Glendale, Arizona, 85304, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Anaheim, California, 92801, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Campbell, California, 95008, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Daly City, California, 94015, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., La Jolla, California, 92093, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lancaster, California, 93534, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mission Hills, California, 91345, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Palo Alto, California, 94305, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Poway, California, 92064, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., San Diego, California, 92123, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., San Francisco, California, 94115, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., San Jose, California, 95116, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Santa Cruz, California, 95065, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Sunnyvale, California, 94088, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Denver, Colorado, 80209, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Greeley, Colorado, 80631, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Stamford, Connecticut, 06902, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Fort Lauderdale, Florida, 33308, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Miami, Florida, 33179, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Weston, Florida, 33331, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Decatur, Georgia, 30033, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Honolulu, Hawaii, 96813, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Kealakekua, Hawaii, 96750, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Morehead, Kentucky, 40351, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., New Orleans, Louisiana, 70121, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Omaha, Nebraska, 68131, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Las Vegas, Nevada, 89109, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Buffalo, New York, 14263, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Washington, North Carolina, 27889, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Memphis, Tennessee, 38138, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Nashville, Tennessee, 37203, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Corpus Christi, Texas, 78463, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Galveston, Texas, 77555, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Richardson, Texas, 75080, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Monroe, Washington, 98272, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Seattle, Washington, 98133, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., San Juan, 00918, Puerto Rico Less <<
NCT00743379 Non-Small Cell Lung Cancer ... More >> Prostate Cancer Pancreatic Cancer Less << Phase 1 Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Cancer Center Scottsdale, Arizona, United States, 85259 Premiere Oncology of Arizona Scottsdale, Arizona, United States, 85260 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Louisiana LSU Health Sciences Center Shreveport, Louisiana, United States, 71130 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas UT Health Science Center San Antonio, Texas, United States, 78229 United States, Washington Northwest Medical Specialties Tacoma, Washington, United States, 98405 United States, Wisconsin University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT00226577 - Completed - -
NCT01085630 Malignant Mesothelioma Phase 2 Active, not recruiting - -
NCT01107626 Lung Cancer Phase 3 Active, not recruiting May 8, 2020 -
NCT00227019 Non-small Cell Lung Cancer (NS... More >>CLC) Lung Cancer Neoplasm Metastasis Less << Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 United States, New Hampshire Norris Cotton Cancer Center Lebanon, New Hampshire, United States, 03756 United States, New Jersey Cooper Cancer Institute Voorhees, New Jersey, United States, 08043 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 Less <<
NCT01836341 Non-small Cell Lung Cancer Phase 1 Withdrawn April 2015 -
NCT00106002 Breast Cancer ... More >> Breast Neoplasms, Male Carcinoma, Ductal Less << Phase 2 Completed - United States, Texas ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75204 Less <<
NCT00325234 Breast Cancer Phase 2 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guetersloh, Germany, 33332 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 22081 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stuttgart, Germany, 70190 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bergamo, Italy, 24128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bologna, Italy, 40139 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Livorno, Italy, 57128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Meldola, Italy, 47014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rome, Italy, 00168 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Giovanni Rotondo, Italy, 71013 South Africa For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Durban, South Africa, 4067 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Morningside, South Africa, 2199 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pretoria, South Africa, 0001 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Girona, Spain, 17007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Coruña, Spain, 15006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lleida, Spain, 25198 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28040 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46010 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Zaragoza, Spain, 50009 Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Besevler/Ankara, Turkey, 06500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bornova, Turkey, 35100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kayseri, Turkey, 38039 Less <<
NCT00106002 - Completed - -
NCT00034619 Colorectal Cancer Phase 2 Completed - United States, Alabama ... More >> "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Huntsville, Alabama, United States United States, Massachusetts "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Pittsfield, Massachusetts, United States United States, Michigan "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Kalamazoo, Michigan, United States United States, New York "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Latham, New York, United States United States, North Carolina "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Asheville, North Carolina, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Goldsboro, North Carolina, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Hendersonville, North Carolina, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Winston-Salem, North Carolina, United States United States, Ohio "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Columbus, Ohio, United States United States, Oregon "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Bend, Oregon, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Portland, Oregon, United States United States, Pennsylvania "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Philadelphia, Pennsylvania, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Pittsburgh, Pennsylvania, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Reading, Pennsylvania, United States United States, South Carolina "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Charleston, South Carolina, United States United States, Utah "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Ivins, Utah, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Ogden, Utah, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Provo, Utah, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" St. George, Utah, United States United States, Washington "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Bellevue, Washington, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Seattle, Washington, United States "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)" Spokane, Washington, United States Less <<
NCT01296568 - Completed - -
NCT02707666 Pleural Mesothelioma Phase 1 Recruiting September 2018 United States, Illinois ... More >> University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Mehwish Ahmad    773-834-1472    mahmad3@medicine.bsd.uchicago.edu    Contact: Buerkley Rose, RN    773 834 4002    brose@medicine.bsd.uchicago.edu    Principal Investigator: Hedy Kindler, M.D. Less <<
NCT00227019 - Completed - -
NCT00103831 Non-small Cell Lung Cancer Phase 1 Phase 2 Completed - United States, Colorado ... More >> Local Institution Denver, Colorado, United States United States, Minnesota Local Institution Rochester, Minnesota, United States Canada, Ontario Local Institution Toronto, Ontario, Canada Less <<
NCT03706703 Lung Cancer Phase 2 Recruiting September 1, 2020 China, Guangdong ... More >> Affiliated Cancer Hospital & Institute of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510000 Contact: Chuan Jin, post-graduate    020-66673666    18302078099@163.com Less <<
NCT03298763 Adenocarcinoma of Lung Phase 1 Phase 2 Not yet recruiting March 1, 2024 United Kingdom ... More >> University College London Hospital Not yet recruiting London, United Kingdom Less <<
NCT02145078 Recurrent Non-small Cell Lung ... More >>Cancer Stage IV Non-small Cell Lung Cancer Less << Not Applicable Terminated(Slow accrual.) - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT00325234 - Completed - -
NCT01296113 Non-small Cell Lung Cancer ... More >> Hiv-positive Less << Phase 2 Completed - France ... More >> Centre Hospitalier du Pays d'Aix Aix-en-Provence, France Annemasse - CH Ambilly, France, 74100 Annecy - CH Annecy, France, 74374 Avignon - CH Avignon, France CH de la Côte Basque Bayonne, France CHU Besancon - Pneumologie Besancon, France, 25000 Caen - CHU Côte de Nacre Caen, France, 14000 CH Cahors Cahors, France CHU Clermont-Ferrand, France CH Colmar, France CH Compiègne - Pneumologie Compiègne, France Créteil - CHI Créteil, France, 94000 CHU Grenoble - pneumologie Grenoble, France, 38000 Le Mans - Centre Hospitalier Le Mans, France, 72000 CH Longjumeau, France Hôpital de la Croix Rousse Lyon, France Hôpital Louis Pradel Lyon, France APHM - Hôpital Nord Marseille, France, 13000 Montpellier - CHRU Montpellier, France, 34295 Nevers - CH Nevers, France, 58033 Centre Antoine Lacassagne Nice, France CHR d'Orléans La Source Orléans, France APHP - Hopital Tenon - Pneumologie Paris, France, 75020 GH Paris Saint-Joseph Paris, France Hôpital Saint Antoine Paris, France Paris - Pitié-salpêtrière Paris, France Pau - CH Pau, France, 64046 Centre François Magendie - hôpital du Haut-Lévèque Pessac, France HCL - Lyon Sud (Pneumologie) Pierre Bénite, France, 69495 Reims - CHU Reims, France, 51092 Rennes - CHU Rennes, France, 35033 Saint Brieuc - CHG Saint Brieuc, France, 22000 NHC - Pneumologie Strasbourg, France, 63000 Suresnes - Hopital Foch Suresnes, France, 92151 Thonon les bains - CH Thonon les bains, France, 74200 Toulon - CHI Toulon, France, 83000 CHU Toulouse - Pneumologie Toulouse, France Tourcoing - CH Tourcoing, France, 59208 Tours - CHU Tours, France, 37000 CH Valence Valence, France Less <<
NCT00055432 Ovarian Cancer ... More >> Peritoneal Cancer Less << Phase 2 Terminated - United States, Georgia ... More >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Atlanta, Georgia, United States Less <<
NCT00556322 Non-Small Cell Lung Cancer Phase 3 Completed - -
NCT01296568 Advanced Cancer Phase 1 Completed - Switzerland ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bruderholz, Switzerland, 4101 Less <<
NCT00034606 Carcinoma, Non-Small-Cell Lung... More >> Lung Neoplasms Neoplasms Less << Phase 2 Completed - United States, Minnesota ... More >> Rochester, Minnesota, United States Less <<
NCT00556322 - Completed - -
NCT03201146 Lung Cancer N... More >>on Small Cell Lung Cancer Combination Chemotherapy Apatinib Less << Phase 1 Phase 2 Recruiting August 1, 2020 China, Sichuan ... More >> West China Hospital, Sichuan University Recruiting Chengdu, Sichuan, China, 610041 Contact: You Lu, MD    86-028-85422114    radyoulu@hotmail.com    Contact: Meijuan Huang, MD    86-028-85422114    hmj107@163.com Less <<
NCT03381066 Completely Resected NSCLC With... More >> Common EGFR Mutations Less << Phase 3 Not yet recruiting December 2023 Korea, Republic of ... More >> Department of Oncology, Yonsei University College of Medicine Not yet recruiting Seoul, Korea, Republic of, 03722 Contact: Byoung Chul Cho, MD    82 2 2228 0880    cbc1971@yuhs.ac Less <<
NCT00034502 Colorectal Cancer Phase 1 Phase 2 Completed - United States, Kansas ... More >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Wichita, Kansas, United States United States, New York For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. New York, New York, United States United States, Pennsylvania For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Pittsburgh, Pennsylvania, United States Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Bielefeld, Nordrhein-Westfalen, Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Halle, Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Hamburg, Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Homburg/Saar, Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Magdeburg, Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Munchen, Germany Less <<
NCT00254319 Untreated Advanced Non-Small C... More >>ell Lung Cancer Less << Phase 2 Unknown - United States, New Jersey ... More >> The CINJ at Cooper University Hospital Recruiting Voorhees, New Jersey, United States, 08043 Principal Investigator: James Stevenson, MD          Sub-Investigator: Generosa Grana, MD Less <<
NCT00456261 - Completed - -
NCT01569919 Malignant Ple... More >>ural Mesothelioma Less << Phase 2 Unknown December 2014 United Kingdom ... More >> Velindre Cancer Centre Recruiting Cardiff, South Wales, United Kingdom, CF14 2TL Sub-Investigator: Mick Button Less <<
NCT00456261 Lung Cancer Phase 2 Completed - United States, Alabama ... More >> Northeast Alabama Regional Medical Center Anniston, Alabama, United States, 36207 United States, Arkansas NEA Baptist Clinic Jonesboro, Arkansas, United States, 72401 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States, 33805 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 United States, Kentucky Graves-Gilbert Clinic Bowling Green, Kentucky, United States, 42101 Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Maine Mercy Hospital Portland, Maine, United States, 04101 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, North Carolina Cancer Care of Western North Carolina Asheville, North Carolina, United States, 28801 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Associates in Hematology Oncology Chattanooga, Tennessee, United States, 37404 Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT01154140 Non Squamous Lung Cancer Phase 3 Completed - -
NCT00035061 Urologic Neoplasms ... More >> Metastases, Neoplasm Less << Phase 2 Completed - United States, California ... More >> Los Angeles, California, United States Palo Alto, California, United States United States, Florida Boca Raton, Florida, United States Tampa, Florida, United States United States, Illinois Decatur, Illinois, United States United States, Indiana Indianapolis, Indiana, United States Lafayette, Indiana, United States Muncie, Indiana, United States South Bend, Indiana, United States United States, Kansas Lenexa, Kansas, United States United States, Kentucky Saint Mathews, Kentucky, United States United States, Massachusetts Boston, Massachusetts, United States United States, Nebraska Omaha, Nebraska, United States United States, Ohio Cleveland, Ohio, United States United States, Pennsylvania Philadelphia, Pennsylvania, United States Pittsburgh, Pennsylvania, United States United States, Tennessee Nashville, Tennessee, United States United States, Texas Fort Worth, Texas, United States Houston, Texas, United States United States, Washington Seattle, Washington, United States Less <<
NCT00284778 Carcinoma, Non-Small-Cell Lung Phase 3 Completed - France ... More >> Service de Pneumologie, CHU Angers Angers, France, 49033 Service de pneumologie; Centre Hospitalier d'Annecy Annecy, France, 74011 Service de Pneumologie; Centre Hospitalier Beauvais, France, 60 021 Service de Pneumologie ; Centre hospitalier Charleville-Mezieres, France, 08 000 Service de Pneumologie; Centre Hospitalier Draguignan, France, 83300 Service de Pathologie Respiratoire; CHU de Limoges Limoges, France, 87000 Service de Pneumologie; Hôpital de la Croix Rousse Lyon, France, 69317 Service de Pneumologie-Neurologie ; Centre Hospitalier F. Quesnay Mantes La Jolie, France, 78200 Département des Maladies Respiratoires ; Hôpital Sainte Marguerite Marseille, France, 13274 Service de Pneumologie et Réanimation ; Hôpital Hôtel Dieu - Paris Paris, France, 75181 Service de Pneumologie - Hôpital St Antoine, Paris Paris, France, 75571 Service de Pneumologie ; Hôpital saint Antoine, Paris Paris, France Service de Pneumologie-Allergologie; Centre Hospitalier Général Perigueux, France, 24019 Service de Pneumologie; CHG de Roanne Roanne, France, 42300 Clinique Pneumologique; Hôpital Charles Nicolle Rouen, France, 76031 Service de Pneumologie; Hôpital Bois Guillaume Rouen, France, 76233 Service de Pathologie Respiratoire; Hôpital d'Instruction des Armées Sainte-Anne Toulon Naval, France, 83800 Service d'Oncologie Médicale; Clinique Sainte Marguerite Toulon, France, 83000 Less <<
NCT03242915 Non-small Cell Lung Cancer Phase 2 Recruiting August 2022 United States, Illinois ... More >> Rush Universtiy Medical Center Recruiting Chicago, Illinois, United States, 60612 Contact: Mary Jo Fidler, MD          Principal Investigator: Mary Jo Fidler, MD          United States, Michigan The University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Shirish M Gadgeel, M.D.    734-647-6883    sgadgeel@med.umich.edu    Principal Investigator: Shirish M Gadgeel, M.D.          Barbara Ann Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Misako Nagaska, MD          Principal Investigator: Misako Nagaska, MD          United States, New York Montefiore Cancer Center Recruiting Bronx, New York, United States, 10467 Contact: Balazs Halmos, MD          Principal Investigator: Balazs Halmos, MD          United States, Tennessee Sarah Cannon Recruiting Nashville, Tennessee, United States, 37203 Contact: Melissa Johnson, MD          Principal Investigator: Melissa Johnson, MD Less <<
NCT00149214 Breast Cancer Phase 2 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baden-Baden, Germany, 76532 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 10967 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 20357 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Germany, D-69115 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cremona, Italy, 26100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rozzano, Italy, 20089 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation, 129128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Petersburg, Russian Federation, 197022 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jaen, Spain, 23007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sabadell, Spain, 08208 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46010 Less <<
NCT00994097 Non-small Cell Lung Cancer Phase 2 Completed - Italy ... More >> Istituto Nazionale per la ricerca sul cancro Genoa, Italy, 16132 Fondazione San Raffaele del Monte Tabor Milan, Italy, 20132 Istituto Nazionale dei Tumori Milan, Italy, 20133 Istituto Europeo Oncologico Milan, Italy Less <<
NCT00149214 - Completed - -
NCT00686959 Non Small Cell Lung Cancer Phase 3 Completed - -
NCT02951637 Lung Adenocarcinoma Phase 2 Not yet recruiting December 2019 -
NCT01154140 - Completed - -
NCT00949650 Carcinoma, Non-Small-Cell Lung... More >> Adenocarcinoma Less << Phase 3 Completed - -
NCT00686959 - Completed - -
NCT01041781 Lung Cancer Phase 3 Terminated(DSMB recommendation... More >>) Less << - -
NCT00949650 - Completed - -
NCT00334594 Malignant Mesothelioma Phase 2 Completed - Germany ... More >> Universitaetsklinikum Freiburg Freiburg, Germany, D-79106 Switzerland Kantonsspital Aarau Aarau, Switzerland, CH-5001 Kantonsspital Baden Baden, Switzerland, CH-5404 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Spital Tiefenau Bern 4, Switzerland, 3004 Inselspital Bern Bern, Switzerland, CH-3010 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital Olten Olten, Switzerland, CH-4600 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 SpitalSTS AG Simmental-Thun-Saanenland Thun, Switzerland, 3600 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT01041781 - Terminated(DSMB recommendation... More >>) Less << - -
NCT00040625 - - - United States, New Jersey ... More >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Basking Ridge, New Jersey, United States Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician Porto Alegre, RS, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician Sao Paulo, Brazil Egypt "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Cairo, Egypt For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician Cairo, Egypt Saudi Arabia For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician Jeddah, Saudi Arabia Less <<
NCT00835471 Carcinoma, Non-Small-Cell Lung Phase 2 Unknown June 2014 Netherlands ... More >> VU medisch centrum Recruiting Amsterdam, Netherlands Contact: Smit       ef.smit@vumc.nl    Principal Investigator: Egbert F. Smit, MD PhD          Rode Kruis Ziekenhuis Recruiting Beverwijk, Netherlands Contact: Rikers       mscrk@rkz.nl    Principal Investigator: C. H. Rikers, MD          Amphia Ziekenhuis Recruiting Breda, Netherlands Contact: Aerts       jaerts@amphia.nl    Principal Investigator: Joachim G. Aerts, MD PhD          Reinier de Graaf Gasthuis Recruiting Delft, Netherlands Contact: Pannekoek       pkoek@rdgg.nl    Principal Investigator: B. J. Pannekoek, MD          Jeroen Bosch Ziekenhuis Recruiting Den Bosch, Netherlands Contact: Biesma       b.biesma@jbz.nl    Principal Investigator: Bonne Biesma, MD PhD          Catharina-Ziekenhuis Recruiting Eindhoven, Netherlands Contact: van den Borne       ben.vd.borne@cze.nl    Principal Investigator: Ben E. van den Borne, MD PhD          Martini Ziekenhuis Recruiting Groningen, Netherlands Contact: van Putten       jwg.van.putten@mzh.nl    Principal Investigator: John W. van Putten, MD PhD          Kennemer Gasthuis Recruiting Haarlem, Netherlands Contact: Weenink       weenink@kg.nl    Principal Investigator: C. Weenink, MD PhD          Academisch Ziekenhuis Maastricht Recruiting Maastricht, Netherlands Contact: Dingemans       a.c.dingemans@lung.azm.nl    Principal Investigator: A. C. Dingemans, MD PhD          Universitair Medisch Centrum Sint Radboud Recruiting Nijmegen, Netherlands Contact: van der Drift       m.vanderdrift@ulc.umcn.nl    Principal Investigator: M. A. van der Drift, MD          Maasstad Ziekenhuis Recruiting Rotterdam, Netherlands Contact: Slingerland       slingerlandr@mcrz.nl    Principal Investigator: Rob Slingerland, MD          Sint Franciscus Gasthuis Recruiting Rotterdam, Netherlands Contact: in 't Veen       h.intveen@sfg.nl    Principal Investigator: J. C. in 't Veen, MD PhD          HagaZiekenhuis Recruiting The Hague, Netherlands Contact: Codrington       h.codrington@hagaziekenhuis.nl    Principal Investigator: Henk E. Codrington, MD          Isala Klinieken Recruiting Zwolle, Netherlands Contact: Stigt       j.a.stigt@isala.nl    Principal Investigator: Jos A. Stigt, MD Less <<
NCT02397239 - Recruiting - Taiwan ... More >> National Cheng Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Szu-Chun Yang, M.D.    +886 972402279    yangszuchun@gmail.com Less <<
NCT02737774 Lung Adenocarcinoma Phase 2 Unknown April 2017 -
NCT03317496 Non-small Cell Lung Cancer ... More >> Urothelial Cancer Less << Phase 2 Recruiting October 2, 2021 -
NCT01675765 Malignant Pleural Mesothelioma Phase 1 Active, not recruiting December 2018 United States, California ... More >> University of California at San Francisco San Francisco, California, United States, 94115 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Maryland National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Pennsylvania University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00733031 Cancer, Solid... More >> Tumors Advanced Solid Malignancies Less << Phase 1 Terminated(PK results demonstr... More >>ate low and variable plasma concentrations so that achieving therapeutic concentrations is unlikely.) Less << - United States, Colorado ... More >> Research Site Aurora, Colorado, United States United States, Tennessee Research Site Nashville, Tennessee, United States Less <<
NCT02066038 Lung, Carcinoma Phase 2 Unknown March 2016 -
NCT00996567 Cancer Phase 2 Completed - Belgium ... More >> UZ Antwerpen Antwerpen, Belgium University Hospital Ghent Ghent, Belgium, 9000 AZ St. Maarten Mechelen, Belgium, 2800 Netherlands AMC Heerlen Heerlen, Netherlands Less <<
NCT00005636 Malignant Mesothelioma Phase 3 Completed - United States, New Jersey ... More >> Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00509366 Non Small Cell Lung Cancer Phase 2 Terminated(Study terminated du... More >>e to reproducibility issues with genomics prediction model.) Less << - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Maria Parham Hospital Henderson, North Carolina, United States, 27536 Scotland HealthCare System (Scotland Memorial Hospital) Laurinburg, North Carolina, United States, 28352 Southeastern Regional Medical Center, Gibson Cancer Center Lumberton, North Carolina, United States, 28358 Duke Raleigh Hospital Raleigh, North Carolina, United States, 27609 United States, South Carolina Beaufort Memorial Hospital Beaufort, South Carolina, United States, 29902 Coastal Cancer Center Myrtle Beach, South Carolina, United States, 29572 United States, Virginia Community Memorial Health Center South Hill, Virginia, United States, 23970 Less <<
NCT01631136 Advanced Non Small Cell Lung C... More >>ancer Less << Phase 3 Completed - -
NCT03559049 Stage IV Non-small Cell Lung C... More >>ancer Less << Phase 1 Phase 2 Not yet recruiting July 2027 United States, Michigan ... More >> The University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT01005680 Non Small Cell Lung Cancer Phase 3 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100730 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changchun, China, 130012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dalian, China, 116023 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510080 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanning, China, 530000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200433 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sichuan, China, 610041 Less <<
NCT03164694 Lung Cancer Phase 2 Recruiting May 20, 2020 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Si-Yu Wang, Doctor    +86 20 87343439    wsysums@163.net Less <<
NCT01907100 Mesothelioma Phase 3 Completed - -
NCT00051493 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - United States, Texas ... More >> Houston, Texas, United States Less <<
NCT00509366 - Terminated(Study terminated du... More >>e to reproducibility issues with genomics prediction model.) Less << - -
NCT01005680 - Completed - -
NCT01719536 NSCLC Phase 3 Unknown December 2016 -
NCT00308750 Non-small Cell Lung Cancer Phase 2 Completed - United States, North Carolina ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Burlington, North Carolina, United States, 27215 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chapel Hill, North Carolina, United States, 27599 United States, South Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Columbia, South Carolina, United States, 29210 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States, 77060 Less <<
NCT00166465 Locally Advanced Unresectable ... More >>or Stage IV Colorectal Cancer Less << Phase 1 Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03544814 Lung Adenocarcinoma ... More >> EGFR Activating Mutation Less << Phase 2 Completed - -
NCT03663205 Non-Small Cell Lung Cancer Phase 3 Recruiting September 23, 2020 China ... More >> Shanghai Chest Hospital Recruiting Shanghai, China Less <<
NCT02120807 Stage IV Lung Adenocarcinoma Phase 1 Active, not recruiting April 2019 United States, New Jersey ... More >> Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering West Harrison Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT01184287 Non-Small Cell Lung Cancer Phase 2 Withdrawn(Program discontinued... More >>) Less << - United States, California ... More >> Tower Cancer Research Foundation Beverly Hills, California, United States, 90211 United States, Michigan Van Andel Research Institute Grand Rapids, Michigan, United States, 49503 United States, Montana Sletten Cancer Specialists Great Falls, Montana, United States, 59405 United States, New York The Cancer Institute at NYU Langone Medical Center New York, New York, United States, 10016 United States, Ohio Tri-county Hematology-Oncology Associates, Inc Canton, Ohio, United States, 44718 United States, Utah Northern Utah Associates Ogden, Utah, United States, 84403 Less <<
NCT01664533 - Completed - Belgium ... More >> Aalst, Belgium, 9300 Antwerpen, Belgium, 2020 Boussu, Belgium, 7360 Bruxelles, Belgium, 1200 Charleroi, Belgium, 6000 Dendermonde, Belgium, 9200 Duffel, Belgium, 2570 Edegem, Belgium, 2650 Frameries, Belgium, 7080 Genk, Belgium, 3600 Gilly, Belgium, 6060 Gosselies, Belgium, 6041 Liege, Belgium, 4000 Mons, Belgium, 7000 Montegnée, Belgium, 4420 Namur, Belgium, 5000 Ottignies, Belgium, 1340 Roeselare, Belgium, 8800 Sint Niklaas, Belgium, 9100 Tournai, Belgium, 7500 Turnhout, Belgium, 2300 Less <<
NCT00097383 Breast Cancer Phase 1 Phase 2 Completed - Argentina ... More >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. La Plata, Buenos Aires, Argentina For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Rosario, Santa Fe, Argentina For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Buenos Aires, Argentina For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Ciudad De Buenos Aires, Argentina Belgium For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Brussels, Belgium For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Leuven, Belgium For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Wilrijk, Belgium Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Maceio, AL, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Belo Horizonte, BH, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Curitiba, PR, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Porto Alegre, RS, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Sao Paulo, Sao Paulo/SP, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Sao Paulo, SP, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Sorocaba, SP, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Sao Paulo, Brazil Mexico For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Guadalajara, Jalisco, Mexico For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Mexico, Mexico D.F., Mexico For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Col. Campestre Churubusco, Mexico For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Mexico City, Mexico Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Arquiparque-Miraflores, Alges, Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Coimbra, Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Lisboa, Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Porto, Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Proto, Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Santa Maria Da Feira, Portugal For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Santarem, Portugal Less <<
NCT01664533 - Completed - -
NCT01850303 Non Small Cell Lung Cancer (Sq... More >>uamous or Non Squamous) Less << Phase 3 Active, not recruiting December 2018 -
NCT01301716 Solid Cancers Phase 1 Completed - United States, California ... More >> Los Angeles, California, United States, 90025 United States, Florida Tampa, Florida, United States, 33612 United States, Massachusetts Boston, Massachusetts, United States, 02114 Boston, Massachusetts, United States, 02215 Spain Madrid, Spain, 28050 Less <<
NCT03607539 Lung Neoplasms Phase 3 Not yet recruiting September 2020 -
NCT01454102 Non-small Cell Lung Cancer Phase 1 Active, not recruiting December 29, 2018 United States, California ... More >> Ucla Santa Monica, California, United States, 90404 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Texas Ut Southwestern Medical Center At Dallas Dallas, Texas, United States, 75390-8852 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Canada, Ontario Local Institution Hamilton, Ontario, Canada, L8V 5C2 Local Institution Ottawa, Ontario, Canada, K1H 8L6 Local Institution Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00251550 Malignant Pleural Mesotherioma Phase 1 Phase 2 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Aichi, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Ehime, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Fukuoka, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Hokkaido, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Okayama, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Osaka, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Tokyo, Japan Less <<
NCT02303899 Mesothelioma, Malignant Phase 2 Active, not recruiting December 2017 Italy ... More >> Istituto Clinico Humanitas Rozzano, MI, Italy, 20089 Less <<
NCT01639001 NSCLC (Non-small Cell Lung Can... More >>cer) Less << Phase 3 Active, not recruiting January 2019 -
NCT02436733 Malignant Pleural Mesothelioma Phase 2 Recruiting April 2020 Belgium ... More >> UZ Antwerpen Recruiting Antwerpen, Belgium Contact: Jan Van Meerbeeck, Prof          UZ Gent Recruiting Gent, Belgium Contact: Veerle Surmont, Prof          France Assistance Publique - Hopitaux de Marseille - Hopital Nord Recruiting Marseille, France Contact: Pascal-Alexandre Thomas, Prof          Netherlands The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis Recruiting Amsterdam, Netherlands Contact: Paul Baas, Prof          Erasmus MC Hospital Recruiting Rotterdam, Netherlands Contact: Joachim Aerts, Prof Less <<
NCT00903292 Non-Small Cell Lung Cancer Not Applicable Unknown December 2010 Taiwan ... More >> National Cheng-Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Hui-Shu Yang, Bachelor    +886-6-2353535 ext 4289    huishuyang@gmail.com Less <<
NCT03319537 Mesothelioma Phase 1 Phase 2 Recruiting October 2020 United States, New Jersey ... More >> Memorial Sloan Kettering at Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Majorie Zauderer, MD    646-888-4656       Memoral Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Marjorie Zauderer, MD    646-888-4656       Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Marjorie Zauderer, MD    646-888-4656       United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Marjorie Zauderer, MD    646-888-4656       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Majorie Zauderer, MD    646-888-4656       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Marjorie Zauderer, MD    646-888-4656       Contact: Andrea Cercek, MD    646-888-4189       Principal Investigator: Marjorie Zauderer, MD          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Marjorie Zauderer, MD    646-888-4656 Less <<
NCT00541073 Malignant Mesothelioma Phase 2 Completed - France ... More >> Centre Oscar Lambret Lille, France, 59020 Less <<
NCT02407366 Non-small Cell Lung Cancer Phase 2 Unknown December 2017 China, Guangxi ... More >> The people's Hospital of the Guangxi Zhuang Autonomous Region Recruiting Nanning, Guangxi, China, 530021 Contact: GuoSheng Feng, professor    +86-771-218-6508    fengguosheng88988@163.com Less <<
NCT01063283 Advanced Non-squamous Non-Smal... More >>l Cell Lung Cancer Less << Not Applicable Completed - United States, Illinois ... More >> The University of Chicago Medical Center Chicago, Illinois, United States, 60637 North Shore University Health System Evanston, Illinois, United States, 60201 Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Less <<
NCT00867711 - Completed - Italy ... More >> Istituto Clinico Humanitas Rozzano, Milano, Italy, 20089 Less <<
NCT02595840 - - - -
NCT00106626 - Completed - -
NCT00101842 Carcinoma, Transitional Cell Phase 1 Phase 2 Completed - United States, Texas ... More >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Dallas, Texas, United States Less <<
NCT01639001 - Active, not recruiting - -
NCT03256136 Lung Cancer Phase 2 Recruiting October 31, 2024 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02115 Contact: Daniel B Costa, MD    617-667-9236       Principal Investigator: Daniel B Costa, MD          Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Amanda J Redig, MD, PhD    617-632-6036       Principal Investigator: Amanda J Redig, MD, PhD          Massachusetts general Hospital Recruiting Boston, Massachusetts, United States, 02214 Contact: Alice T Shaw, MD, PhD    617-643-0563       Principal Investigator: Alice T Shaw, MD, PhD Less <<
NCT01194453 Non-small Cell Lung Cancer ... More >> Efficacy Less << Phase 2 Completed - China, Guangdong ... More >> Cancer Center of Sun Yat-Sen University (CCSU) Guangzhou, Guangdong, China Less <<
NCT00106626 Advanced Cancer Phase 1 Completed - -
NCT01087970 Head and Neck Neoplasms Phase 2 Completed - -
NCT00034463 Metastases Ca... More >>ncer Less << Phase 1 Completed - United States, Texas ... More >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. San Antonio, Texas, United States Less <<
NCT01087970 - Completed - -
NCT01194453 - Completed - -
NCT01193959 - Unknown September 2011 Italy ... More >> Istituto Clinico Humanitas Rozzano, Milano, Italy, 20089 Less <<
NCT01192165 Cancer Phase 1 Completed - United States, Arizona ... More >> GSK Investigational Site Scottsdale, Arizona, United States, 85259 United States, California GSK Investigational Site Duarte, California, United States, 91010 GSK Investigational Site Sacramento, California, United States, 95817 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80218 United States, Nevada GSK Investigational Site Las Vegas, Nevada, United States, 89169 United States, New York GSK Investigational Site Albany, New York, United States, 12206 United States, South Carolina GSK Investigational Site Greenville, South Carolina, United States, 29605 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75246 GSK Investigational Site Houston, Texas, United States, 77030 GSK Investigational Site Tyler, Texas, United States, 75702 United States, Virginia GSK Investigational Site Norfolk, Virginia, United States, 23502 United States, Washington GSK Investigational Site Vancouver, Washington, United States, 98684 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M5G 2M9 France GSK Investigational Site Caen Cedex 9, France, 14033 GSK Investigational Site Marseille cedex 5, France, 13385 GSK Investigational Site Saint-Herblain cedex, France, 44805 GSK Investigational Site Toulouse cedex, France, 31052 Korea, Republic of GSK Investigational Site Seoul, Korea, Republic of, 120-752 GSK Investigational Site Seoul, Korea, Republic of, 135-710 Less <<
NCT00356525 - Terminated(Stopped early due t... More >>o low enrollment) Less << - -
NCT01666977 Non Small Cell Lung Cancer Phase 1 Phase 2 Completed - -
NCT01502202 Non Small Cell Lung Cancer ... More >> Adenocarcinoma Less << Phase 2 Unknown February 2015 Korea, Republic of ... More >> National Cancer Center Recruiting Goyang-si, Gyenggido, Korea, Republic of, 410-769 Contact: Sung Jin Yoon, RN    +82-31-920-0405    jinijiniya@ncc.re.kr    Contact: Jin Soo Lee, MD. Ph.D.    +82-31-920-1501    jslee@ncc.re.kr Less <<
NCT02669719 Non Small Cell Lung Cancer Phase 2 Recruiting January 2019 China, Shanghai ... More >> Shanghai Chest Hospital Recruiting Shanghai, Shanghai, China, 200030 Contact: Baohui Han, MD    86-21-62821990 ext 61201    xkyyhan@gmail.com    Principal Investigator: Baohui Han, MD Less <<
NCT02654587 Non Small Cell Lung Cancer Phase 3 Recruiting December 2021 -
NCT00389688 Lung Cancer Phase 2 Terminated(low accrual) - Belgium ... More >> Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 Less <<
NCT00330044 Inoperable Non Small Cell Lung... More >> Cancer Less << Phase 1 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00738582 Malignant Pleural Mesothelioma Phase 2 Completed - -
NCT00356525 Lung Neoplasms Phase 2 Terminated(Stopped early due t... More >>o low enrollment) Less << - United States, Florida ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States, 33179 United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Evanston, Illinois, United States, 60201 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wichita, Kansas, United States, 67214 United States, Minnesota For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Minneapolis, Minnesota, United States, 55455 United States, Missouri For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Louis, Missouri, United States, 63110 United States, Nebraska For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Omaha, Nebraska, United States, 68114 United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chapel Hill, North Carolina, United States, 27599 United States, Tennessee For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chattanooga, Tennessee, United States, 37404 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States, 38120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nashville, Tennessee, United States, 37203 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States, 77060 Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Caxias Do Sul, Brazil, 95070560 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Porto Alegre, Brazil, 90430-090 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santo Andre, Brazil, 09090780 India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bangalore, India, 560 029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mumbai, India, 400016 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trivandrum, India, 695011 Less <<
NCT01057589 - Completed - -
NCT00892710 - Completed - -
NCT01057589 Head and Neck Neoplasms Phase 2 Completed - Belgium ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Edegem, Belgium, 2650 France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Herblain, France, 44805 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dresden, Germany, 01307 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Essen, Germany, 45122 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leipzig, Germany, 04103 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy, 20133 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pamplona, Spain, 31008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46014 United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cardiff, South Glamorgan, United Kingdom, CF14 2TL For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, United Kingdom, SW3 6JJ Less <<
NCT00035035 Pancreatic Neoplasms ... More >> Metastases, Neoplasm Less << Phase 3 Completed - -
NCT00892710 Non Small Cell Lung Cancer Phase 2 Completed - -
NCT02468661 Non-Small Cell Lung Cancer Phase 1 Phase 2 Recruiting March 31, 2020 -
NCT00415636 Cancer Phase 1 Completed - United States, Arizona ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Scottsdale, Arizona, United States, 85258 Less <<
NCT00609518 Non Small Cell Lung Cancer Phase 2 Completed - Australia, New South Wales ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bankstown, New South Wales, Australia, 2200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Concord, New South Wales, Australia, 2139 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kingswood Penrith, New South Wales, Australia, 2747 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Liverpool, New South Wales, Australia, 2170 Australia, Queensland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Redcliffe, Queensland, Australia, 4020 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bologna, Italy, 40100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy, 20132 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Napoli, Italy, 80100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pisa, Italy, 56100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rome, Italy, 00149 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mexico City, Mexico, 14000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toluca, Mexico, CP50180 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pozuelo De Alarcon, Spain, 28223 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sevilla, Spain, 41014 Less <<
NCT01281800 Mesothelioma Phase 2 Unknown - Slovenia ... More >> Institute of Oncology Ljubljana Recruiting Ljubljana, Slovenia, 1000 Contact: Viljem Kovac, MD    +386 1 5879 504    vkovac@onko-i.si    Sub-Investigator: Matjaz Zwitter, MD, PhD          Principal Investigator: Viljem Kovac, MD Less <<
NCT01496742 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 2 Completed - -
NCT00609518 - Completed - -
NCT00248495 Lung Cancer Phase 2 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00248495 - Completed - -
NCT00415636 - Completed - -
NCT01445392 Mesothelioma Phase 1 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03256721 Nonsmall Cell Lung Cancer Phase 2 Recruiting May 26, 2019 China, Fujian ... More >> Fuzhou general hospital Recruiting Fuzhou, Fujian, China, 365000 Contact: Zongyang YU, PhD    13509327806    yuzy527@sina.com    Contact: Xiaoyan HUANG, Master    15860818302    170889977@qq.com Less <<
NCT00489983 Non-Small Cell Lung Cancer Phase 2 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, United Kingdom Less <<
NCT00389805 - Completed - -
NCT01160744 - Completed - -
NCT01160744 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - -
NCT00409006 Non-small Cell Lung Cancer Phase 2 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fujian, China, 350014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Qingdao, China, 266003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 201900 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 137-701 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changhua, Taiwan, 500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 Less <<
NCT00191347 Breast Cancer Phase 2 Completed - Canada, Ontario ... More >> For additional information regarding investigative sites for thsi trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ottawa, Ontario, Canada Less <<
NCT00389805 Lung Cancer U... More >>nspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Phase 2 Completed - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT01064648 Epithelioid Mesothelioma ... More >> Pleural Malignant Mesothelioma Recurrent Malignant Mesothelioma Sarcomatoid Mesothelioma Less << Phase 1 Phase 2 Active, not recruiting - -
NCT02309892 Non-Small Cell Lung Cancer Phase 1 Recruiting December 2018 United States, Ohio ... More >> University Hospitals Case Medical Center Recruiting Cleveland, Ohio, United States United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States Less <<
NCT00409006 - Completed - -
NCT00369629 Lymphoma Phase 1 Terminated(This was planned as... More >> a phase I/II study originally, but due to a lack of funding, the phase II portion was never conducted.) Less << - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT01165021 Non Small Cell Lung Cancer Phase 2 Completed - Italy ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy, 20133 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Novara, Italy, 28100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orbassano, Italy, 10043 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Padova, Italy, 35100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pisa, Italy, 56100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rome, Italy, 00144 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sondalo, Italy, 23039 Less <<
NCT01165021 - Completed - -
NCT01353482 Malignant Pleural Mesothelioma Phase 1 Phase 2 Withdrawn(UCL CTC were informe... More >>d by Merck Sharp & Dohme on 22.08.11 that support for the trial had been withdrawn in light of results from another trial with trial drug.) Less << - -
NCT00369629 - Terminated(This was planned as... More >> a phase I/II study originally, but due to a lack of funding, the phase II portion was never conducted.) Less << - -
NCT00517595 Non-Small Cell Lung Cancer Phase 2 Completed - United States, Connecticut ... More >> Medical Oncology & Hematology Waterbury, Connecticut, United States, 06708 United States, Georgia Augusta Oncology Associates Augusta, Georgia, United States, 30901 Central Georgia Cancer Care Macon, Georgia, United States, 31201 Northwest Georgia Oncology Center Marietta, Georgia, United States, 30060 United States, Montana Hematology Oncology Centers of the Northern Rockies Billings, Montana, United States, 59101 United States, Ohio Tri-County Oncology Hematology Associates Canton, Ohio, United States, 44718 United States, Oregon Pacific Oncology, PC Portland, Oregon, United States, 97225 United States, Pennsylvania Pennsylvania Oncology Hematology Associates Philadelphia, Pennsylvania, United States, 19106 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 United States, Virginia Cancer Specialists of Tidewater Chesapeake, Virginia, United States, 23320 Less <<
NCT00517595 - Completed - -
NCT00715611 Mesothelioma Phase 2 Recruiting July 2019 United States, Florida ... More >> Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Bradford Perez, MD    888-663-3488       Principal Investigator: Bradford Perez, MD          United States, Massachusetts Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Raymond Mak, MD    617-632-3591       United States, Minnesota Mayo Clinic Cancer Center Recruiting Rochester, Minnesota, United States, 55905 Contact: Nina Garces, MD    507-538-3270       United States, New Jersey Memorial Sloan Kettering at Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Andreas Rimner, MD    212-639-6025       United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering West Harrison Recruiting Harrison, New York, United States, 10604 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Andreas Rimner, MD    212-639-6025       Contact: Valerie Rusch, MD    212-639-5873       Principal Investigator: Andreas Rimner, MD          Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Recruiting Sleepy Hollow, New York, United States, 10591 Contact: Andreas Rimner, MD    212-639-6025       United States, Texas Md Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Daniel Gomez, MD          Principal Investigator: Daniel Gomez, MD Less <<
NCT01351415 - Completed - -
NCT01351415 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 3 Completed - -
NCT02886195 EGFR Gene Mutation Phase 3 Enrolling by invitation July 2019 -
NCT02079636 Carcinoma, Non-small Cell Lung Phase 1 Active, not recruiting July 2, 2020 United States, Arkansas ... More >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, California UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States, 90095 University of California, Davis - Health Systems Sacramento, California, United States, 95817 United States, Indiana Indiana Cancer Pavilion Indianapolis, Indiana, United States, 46202 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New Mexico University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87102 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28204 United States, Tennessee The West Clinic Germantown, Tennessee, United States, 38138 Spain Hospital Universitario Ramon y Cajal Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Majadahonda, Spain, 28222 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sevilla, Spain, 41013 Less <<
NCT01774578 Non-small Cell Lung Cancer ... More >> Progression of Non-small Cell Lung Cancer Non-small Cell Lung Cancer Recurrent Less << Phase 2 Phase 3 Active, not recruiting - -
NCT03177291 Lung Cancer N... More >>on Small Cell Lung Cancer Advanced Cancer Metastatic Lung Cancer Squamous Cell Lung Cancer Non-Squamous Non-Small Cell Neoplasm of Lung Less << Phase 1 Recruiting April 2022 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Germaine Gonzalez-Vazquez    813-745-6636    germain.gonzalezvazquez@moffitt.org    Contact: Jhanelle Gray, M.D.    813-745-7282    jhanelle.gray@moffitt.org    Principal Investigator: Jhanelle Gray, M.D.          Sub-Investigator: Scott Antonia, M.D., Ph.D.          Sub-Investigator: Alberto Chiappori, M.D.          Sub-Investigator: Benjamin Creelan, M.D.          Sub-Investigator: Eric Haura, M.D.          Sub-Investigator: Tawee Tanvetyanon, M.D.          Sub-Investigator: Charles Williams, Jr., M.D. Less <<
NCT02076477 Oligo-metastatic Stage IV Non-... More >>small Cell Lung Cancer Less << Phase 3 Unknown - China, Sichuan ... More >> Sichuan Cancer Hospital & Institute Recruiting Chengdu, Sichuan, China, 610041 Contact: TAO LI, MD, PhD    86-18908178818    litaoxmf@163.com    Principal Investigator: TAO LI, MD, PhD          Sub-Investigator: XIAOHU WANG, MD, PhD          Sub-Investigator: XIAOBO DU, MD, PhD          Sub-Investigator: BING LU, MD, PhD Less <<
NCT02977169 Non-small Cell Lung Cancer Sta... More >>ge IIIA Radiotherapy Less << Phase 2 Recruiting December 2019 China, Shanghai ... More >> Shanghai Chest Hospital Recruiting Shanghai, Shanghai, China Contact: Xiaolong Fu, PhD    +862122200000 ext 3602    xlfu1964@126.com Less <<
NCT02649829 Malignant Pleural Mesothelioma Phase 1 Phase 2 Recruiting November 2021 Belgium ... More >> Antwerp University Hospital Recruiting Edegem, Antwerp, Belgium, 2650 Contact: Zwi N Berneman, MD, PhD       zwi.berneman@uza.be    Contact: Sébastien Anguille, MD, PhD       sebastien.anguille@uza.be    Sub-Investigator: Paul Germonpré, MD          Sub-Investigator: Koen Deschepper, MD          AZ Middelares Recruiting Ghent, Belgium, 9000 Contact: Local investigator: Paul Germonpré, MD, PhD          AZ Nikolaas Recruiting Sint-Niklaas, Belgium, 9100 Contact: Local investigator: Koen Deschepper, MD Less <<
NCT03380871 Carcinoma, Non-Small-Cell Lung... More >> Lung Cancer Nonsquamous Nonsmall Cell Neoplasm of Lung Less << Phase 1 Recruiting February 2021 United States, California ... More >> University of California - Los Angeles Recruiting Santa Monica, California, United States, 90404 Contact: Virginia Del Casal, BSN       fdelcasal@mednet.ucla.edu    Principal Investigator: Edward Garon, MD          United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Alice Shaw, M.D., Ph.D.          Principal Investigator: Alice Shaw, M.D., Ph.D.          Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Jenna Scanlon    617-632-4764    jennae_scanlon@dfci.harvard.edu    Principal Investigator: Mark Awad, M.D., Ph.D          United States, Missouri Washington University in St. Louis Recruiting Saint Louis, Missouri, United States, 63130 Contact: Usha Rawat, MPH    314-286-2098    rawat@wustl.edu    Contact: Cindy Fogal, PhD, CCRP    314-362-1518    clfogal@wustl.edu    Principal Investigator: Ramaswamy Govindan, MD          United States, Tennessee Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact    615-339-4214    asksarah@sarahcannon.com    Principal Investigator: David Spigel, M.D. Less <<
NCT02710396 Carcinoma, Non-Small-Cell Lung... More >> Cancer of the Head and Neck Urinary Bladder Neoplasms Esophageal Squamous Cell Carcinoma Carcinoma, Transitional Cell Less << Phase 2 Recruiting March 31, 2023 United States, Connecticut ... More >> Yale Cancer Center Not yet recruiting New Haven, Connecticut, United States, 06510 Contact: Roy Herbst, MD    203-785-6879    roy.herbst@yale.edu    Principal Investigator: Roy Herbst, MD          United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Not yet recruiting Baltimore, Maryland, United States, 21231 Contact: Julie Brahmer, MD    410-502-7159    brahmju@jhmi.edu    Principal Investigator: Julie Brahmer, MD          United States, New York Laura & Isaac Perlmutter Cancer Center at NYU Langone Not yet recruiting New York, New York, United States, 10016 Contact: Leena Gandhi, MD, PhD       Leena.Gandhi@nyumc.org    Principal Investigator: Leena Gandhi, Md, PhD          Columbia University Recruiting New York, New York, United States, 10032 Contact: Anurita Sadhu, BA    212-342-3747    as5055@cumc.columbia.edu    Contact: Sara Marcus, MPH    (212) 304-5579    sm4100@columbia.edu    Sub-Investigator: Catherine Shu, MD          Sub-Investigator: Mark Stoopler, MD          Principal Investigator: Naiyer Rizvi, MD          United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Hossein Borghaei, DO    215-728-6900    Hossein.Borghaei@fccc.edu    Principal Investigator: Hossein Borghaei, DO Less <<
NCT01714037 Non-small Cell Lung Cancer Phase 1 Terminated - France ... More >> Centre GF Leclerc Dijon, France Centre Léon Bérard Lyon, France Institut de Cancérologie de l'Ouest- Institut René Gauduchau Nantes, France Institut Claudius Regaud Toulouse, France Spain Hospital Universitari Vall d'Hebron Barcelona, Spain Hospital Puerta de Hierro Majadahonda Madrid, Spain Hospital Universitario Virgen del Rocío Seville, Spain United Kingdom Freeman Hospital Newcastle, United Kingdom Less <<
NCT01783197 Non Small Cell Lung Cancer Phase 1 Active, not recruiting December 2018 Canada, British Columbia ... More >> BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada, K7L 5P9 Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Less <<
NCT03456063 Non-Small-Cell Lung Phase 3 Recruiting November 20, 2024 -
NCT03002844 Nonsmall Cell Lung Cancer ... More >> EGFR Gene Mutation Less << Phase 2 Unknown December 2018 -
NCT03628521 Lung Cancer A... More >>dvanced Stage Less << Phase 1 Recruiting December 31, 2020 China, Shanghai ... More >> Shanghai Chest Hospital Recruiting Shanghai, Shanghai, China, 200030 Contact: Baohui Han, MD,PhD    +8618930858216    18930858216@163.com Less <<
NCT03636685 NSCLC Adenoca... More >>rcinoma Squamous Cell Carcinoma Less << Phase 1 Phase 2 Not yet recruiting August 14, 2020 -
NCT02178397 NSCLC Patients With EGFR Activ... More >>ating Mutation Less << Phase 3 Terminated(lack of recruitment... More >>) Less << - France ... More >> CH Aix En Provence, France CH Amiens, France CHRU Angers, France, 49933 CH Annecy, France, 74374 CHU Brest, France, 29609 Centre François BACLESSE Caen, France, 14000 CHIC Creteil, France, 94000 CH Draguignan, France, 83007 CH Elbeuf, France CHIC GAP, France, 05007 Ch La Roche/Yon La Roche/yon, France Centre Hospitalier Le MANS, France, 72037 Centre Oscar Lambret Lille, France, 59020 CHU Limoges, France, 87042 CH Longjumeau, France, 91160 CH Lorient, France, 35632 CH Macon, France, 71018 CH Mantes La Jolie, France, 78201 Institut Paoli Calmettes Marseille, France, 13273 AP-HM - Hôpital Nord Marseille, France CH Meaux, France, 77104 Centre Hospitalier Intercommunal Meulan, France, 78250 CH PAU, France Centre Catalan Perpignan, France CHU Rennes, France, 35033 CH Roanne, France CHU Rouen, France CH Salon de Provence, France CH Sens, France, 89100 CH St BRIEUC, France Institut de Cancérologie de la Loire St ETIENNE, France, 42271 Centre Paul Strauss Strasbourg, France, 67065 CH Tarbes, France Hôpital d'instruction des Armées Sainte-Anne Toulon, France, 83041 CH Villefranche, France, 69655 Less <<
NCT00801736 Lung Cancer Phase 3 Terminated(The antibody used d... More >>id not appear prognostic/predictive based on interim results.) Less << - United Kingdom ... More >> University College London Hospitals London, United Kingdom Less <<
NCT02679963 Non Small Cell Lung Cancer Phase 2 Recruiting January 2021 France ... More >> Gustave Roussy Cancer Campus Recruiting Villejuif, Val de Marne, France, 94805 Contact: Valérie Mairot    0142113730 ext +33    Valerie.mairot@gustaveroussy.fr Less <<
NCT03489616 Carcinoma, Non-Small-Cell Lung Not Applicable Recruiting December 31, 2019 China, Shandong ... More >> Shandong Cancer Hospital and Institute Recruiting Jinan, Shandong, China, 250000 Contact: MINGHUAN LI, Doctor    13153035389 ext 0531-67626112    Sy_lmh2001@163.com    Contact: JIMING YU, Doctor    13806406293 ext 0531-87984729    jn7984729@public.jn.sd.cn    SHANDONG Cancer Hospital Recruiting Jinan, Shandong, China, 250000 Less <<
NCT01336192 Non Small Cell Lung Cancer Phase 4 Unknown April 2013 China, Shanghai ... More >> Shanghai Pulmonary Hospital Medical Oncology Department Recruiting Shanghai, Shanghai, China, 200433 Contact: Ying Xu, MD    86-21-65115006 ext 1053    xuying2186@hotmail.com    Principal Investigator: Di Zheng, MD Less <<
NCT01262859 Head and Neck Neoplasms Phase 2 Withdrawn(PI relocated to anot... More >>her institution. No subjects went on treatment.) Less << - United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT03063450 Mesothelioma Phase 3 Recruiting July 2021 United Kingdom ... More >> Aberdeen Royal Infirmary Recruiting Aberdeen, United Kingdom Contact: Gillian Price          Belfast City Hospital Not yet recruiting Belfast, United Kingdom Contact: Gerry Hanna          Royal Bournemouth Hospital Recruiting Bournemouth, United Kingdom Contact: Tom Geldart          Addenbrooke's Hospital Not yet recruiting Cambridge, United Kingdom Contact: David Gilligan          Velindre Cancer Centre Recruiting Cardiff, United Kingdom Contact: Jason Lester          Ninewells Hospital Not yet recruiting Dundee, United Kingdom Contact: Angela Scott          Beatson West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom Contact: Nicola Steele          Harrogate District Hospital Recruiting Harrogate, United Kingdom Contact: Samuel Chan          University Hospitals Morecambe Bay Recruiting Lancaster, United Kingdom Contact: Amy Ford          Leicester Royal Infirmary Recruiting Leicester, United Kingdom Contact: Dean Fennell          Barts Cancer Institute Not yet recruiting London, United Kingdom Contact: Peter Szlosarek          University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom Contact: Dionysis Papadatos-Pastos          Wythenshawe Hospital Recruiting Manchester, United Kingdom Contact: Raffaele Califano          Mount Vernon Cancer Centre Recruiting Northwood, United Kingdom Contact: Andreas Polychronis          Churchill Hospital Not yet recruiting Oxford, United Kingdom Contact: Denis Talbot          Southampton General Hospital Recruiting Southampton, United Kingdom Contact: Christian Ottensmeier          Southend Hospital Recruiting Southend-on-Sea, United Kingdom Contact: Gairin Dancey          Lister Hospital Recruiting Stevenage, United Kingdom Contact: Andreas Polychronis          Musgrove Park Hospital Recruiting Taunton, United Kingdom Contact: Petra Jankowska Less <<
NCT01802021 Carcinoma, Non-Small-Cell Lung Phase 2 Phase 3 Unknown February 2014 Taiwan ... More >> Center for traditional chinese medicine, Chang Gung Memorial Hospital Recruiting Gueishan Township, Taoyuan County, Taiwan, 33378 Contact: Tse-Hung Huang, M.D.    +886-3196200 ext 2613    tsehunghuang_1089@yahoo.com.tw    Principal Investigator: Tse-Hung Huang, M.D. Less <<
NCT02891733 - Recruiting December 31, 2018 France ... More >> Groupe Hospitalier Paris Saint Joseph Recruiting Paris, Ile-de-France, France, 75014 Contact: BEAUSSIER Helene, PhD, PharmD    +33 1 44 12 70 38    hbeaussier@hpsj.fr    Contact: Mohamed CHERIFI, PharmD    +33 1 44 12 70 84    mcherifi@hpsj.fr Less <<
NCT01869023 Advanced Malignant Pleural Mes... More >>othelioma Less << Phase 2 Active, not recruiting December 2017 Mexico ... More >> Instituto Nacional de Cancerología Mexico City, Mexico Less <<
NCT03304093 Non Small Cell Lung Cancer Met... More >>astatic Non Small Cell Lung Cancer Stage IIIB HIV/AIDS Less << Phase 2 Recruiting September 2020 France ... More >> CH d'Avignon Recruiting Avignon, France Contact: Nicolas CLOAREC, Dr       contact@ifct.fr    CH de la Côte Basque Recruiting Bayonne, France Contact: Sophie SCHNEIDER       contact@ifct.fr    CH Cahors Recruiting Cahors, France Contact: Patricia BARRE       contact@ifct.fr    CH Recruiting Colmar, France Contact: Lionel MOREAU          CHI Créteil Not yet recruiting Créteil, France Contact: Isabelle MONNET       contact@ifct.fr    Centre Hospitalier - Pneumologie Recruiting Le Mans, France, 72000 Contact: Olivier Molinier, Dr          Hôpital de la Croix Rousse Not yet recruiting Lyon, France Contact: Lize KIAKOUAMA-MALEKA, MD       contact@ifct.fr    AP-HM Hôpital Nord Not yet recruiting Marseille, France Contact: Laurent GREILLIER          Montpellier - CHRU Recruiting Montpellier, France, 34295 Contact: Benoit ROCH, Dr       contact@ifct.fr    Montpellier - ICM Not yet recruiting Montpellier, France Contact: Xavier QUANTIN, MD, PhD          APHP - Hopital Tenon - Pneumologie Recruiting Paris, France, 75020 Contact: Armelle LAVOLE, MD       contact@ifct.fr    Paris - APHP Bichat Not yet recruiting Paris, France Contact: Solenn Brosseau, Dr       contact@ifct.fr    Principal Investigator: Valérie Gounant, Dr          Paris - Pitié-salpêtrière Not yet recruiting Paris, France Contact: Jean-Philippe SPANO, MD-PhD       contact@ifct.fr    CH de Pau Recruiting Pau, France Contact: Aldo RENAULT, Dr       contact@ifct.fr    Saint Brieuc - CHG Not yet recruiting Saint Brieuc, France, 22000 Contact: Gwenaëlle Le Garff, Dr       contact@ifct.fr    NHC - Pneumologie Recruiting Strasbourg, France, 63000 Contact: Philippe Fraisse, Dr       contact@ifct.fr    Suresnes - Hopital Foch Not yet recruiting Suresnes, France, 92151 Contact: Hélène Doubre, Dr       contact@ifct.fr    CHU Toulouse - Pneumologie Recruiting Toulouse, France Contact: Julien Mazieres, Pr Less <<
NCT02353936 Squamous Cell Carcinoma of Eso... More >>phagus Less << Phase 2 Recruiting January 2019 Korea, Republic of ... More >> Severance hospital Recruiting Seoul, Korea, Republic of, 120-752 Contact: Hye Ryun Kim, MD    82-2-2228-8125    nobelg@yuhs.ac Less <<
NCT01416961 Lung Cancer Phase 1 Withdrawn(Neutron therapy has ... More >>become unavailable) Less << - -
NCT03158129 Non-Small Cell Lung Cancer Phase 2 Recruiting June 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       tcascone@mdanderson.org Less <<
NCT03337711 - Recruiting May 31, 2020 China, Guangdong ... More >> Sun Yat-Sen university cancer center Recruiting Guangzhou, Guangdong, China, 510000 Contact: Hao Long, Prof    +86 2087343261    longhao@sysucc.org.cn    Contact: Ruping Xing    +86 2087343736    xingrp@sysucc.org.cn Less <<
NCT03470350 Colorectal Cancer Metastatic Phase 1 Phase 2 Recruiting June 1, 2020 Netherlands ... More >> Antoni van Leeuwenhoek (NKI-AVL) Recruiting Amsterdam, Noord-Holland, Netherlands, 1066 CX Contact: S Huijberts, MD    +31 (0)20-5129111    s.huijberts@nki.nl    Contact: N Steeghs, MD    +31 (0)20-5129111    n.steeghs@nki.nl    Principal Investigator: N Steeghs, Dr.          Sub-Investigator: S Huijberts, MD Less <<
NCT01749072 Non-small Cell Lung Cancer ... More >> Effects of Chemotherapy Less << Phase 2 Unknown December 2017 China, Beijing ... More >> Department of Respiratory Medicine, Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Mengzhao Wang, MD    010-69155039 ext +86    mengzhaowang@sina.com    Contact: Jing Zhao, MD    010-69158206 ext +86    pumchzj@sina.com    Sub-Investigator: Wei Zhong, MD          Sub-Investigator: Jinmei Luo, MD Less <<
NCT03267654 Non-small-cell Lung Cancer Phase 2 Recruiting August 20, 2019 China, Shanghai ... More >> Shanghai Pulmonary Hospital; Recruiting Shanghai, Shanghai, China, 200000 Contact: Caicun Zhou, MD Less <<
NCT00828841 Non-Small Cell Lung Cancer Phase 2 Completed - -
NCT01870609 Malignant Pleural Mesothelioma Phase 2 Terminated(Interim analysis-DS... More >>MB stated good safety profile but lack of efficacy) Less << - -
NCT03178552 Non-Small Cell Lung Cancer Phase 2 Phase 3 Recruiting January 2, 2022 -
NCT00391586 Carcinoma, Non-Small-Cell Lung Phase 2 Terminated(PI left institution... More >>.) Less << - United States, New Mexico ... More >> Lovelace Medical Group Albuquerque, New Mexico, United States, 87102 Hematology Oncology Associates NM Albuquerque, New Mexico, United States, 87106 Presbyterian Medical Group Albuquerque, New Mexico, United States, 87110 University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87131 New Mexico Cancer Care Associates Santa Fe, New Mexico, United States, 87505 Less <<
NCT01803282 Tumors Pancre... More >>atic Cancer Non-small Cell Lung Cancer Esophagogastric Cancer Colorectal Cancer Breast Cancer Less << Phase 1 Active, not recruiting February 2019 United States, Alabama ... More >> Alabama Oncology Birmingham, Alabama, United States, 35213 United States, Arizona Pinnacle Oncology Hematology Scottsdale, Arizona, United States, 85258 United States, California Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309 San Diego Pacific Oncology and Hematology Associates, Inc. Encinitas, California, United States, 92024 University of Southern California (USC) Los Angeles, California, United States, 90033 California Pacific Medical Center San Francisco, California, United States, 94115 UCLA Medical Center Santa Monica, California, United States, 90404 United States, Florida Florida Cancer Specialists Sarasota, Florida, United States, 34232 United States, Indiana Parkview Research Center Fort Wayne, Indiana, United States, 46845 Indiana University Health Goshen Center for Cancer Care Goshen, Indiana, United States, 46526 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Cornell University New York, New York, United States, 10021 United States, South Carolina Greenville Health System, Institute for Translational Oncology Research Greenville, South Carolina, United States, 29605 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Vanderbilt Nashville, Tennessee, United States, 37212 United States, Texas UT Southwestern Dallas, Texas, United States, 75390 United States, Utah University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Northwest Medical Specialties Tacoma, Washington, United States, 98405 Less <<
NCT03631199 Non-small Cell Lung Cancer Phase 3 Not yet recruiting October 21, 2022 -
NCT02705820 Metastatic Non Small Cell Lung... More >> Cancer Less << Phase 2 Recruiting July 2020 Cyprus ... More >> Bank of Cyprus Oncology Centre Recruiting Nicosia, Strovolos, Cyprus, 2006 Contact: Haris Charalambous, BM MRCP FRCR    0035722847403    haris.charalambous@bococ.org.cy    Contact: Ioannis Stylianou, BSc RN    0035722847446    ioannis.stylianou@bococ.org.cy Less <<
NCT00391586 - Terminated(PI left institution... More >>.) Less << - -
NCT00828841 - Completed - -
NCT02661659 Malignant Pleural Mesothelioma... More >> (MPM) Less << Phase 1 Withdrawn(PI stopped study due... More >> to inability to accrue.) Less << - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT02876081 SMALL CELL LUNG CARCINOMA Phase 2 Withdrawn(medical decision) December 2018 France ... More >> Groupe Hospitalier Paris Saint Joseph Paris, Ile-de-France, France, 75014 Less <<
NCT03663166 Carcinoma, Non-Small-Cell Lung Phase 1 Phase 2 Recruiting March 1, 2027 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Austin Lannon    813-745-2169    Austin.Lannon@moffitt.org    Principal Investigator: Bradford Perez, MD          Sub-Investigator: Scott Antonia, MD, PhD          Sub-Investigator: Alberto Chiappori, MD          Sub-Investigator: Benjamin Creelan, MD          Sub-Investigator: Thomas Dilling, MD          Sub-Investigator: Jhanelle Gray, MD          Sub-Investigator: Eric Haura, MD          Sub-Investigator: Stephen Rosenberg, MD, MS          Sub-Investigator: Michael Shafique, MD          Sub-Investigator: Tawee Tanvetyanon, MD, MPH Less <<
NCT03337698 Carcinoma, Non-Small-Cell Lung Phase 1 Phase 2 Recruiting April 20, 2022 United States, Connecticut ... More >> Smilow Cancer Hospital at Yale New Haven Recruiting New Haven, Connecticut, United States, 06510 United States, Massachusetts Massachusetts General Hospital Not yet recruiting Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 United States, New York Columbia University Medical Center; Research Pharmacy, Irving Pavillion, Ip 7-749 Recruiting New York, New York, United States, 10032 United States, Tennessee Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Australia, Victoria Peter Mac Callum Cancer Center Recruiting East Melbourne, Victoria, Australia, 3002 France Centre Léon Bérard Recruiting Lyon, France, 69008 Hôpital Nord Not yet recruiting Marseille, France, 13915 Institut Universitaire du Cancer de Toulouse-Oncopole; PHARMACIE Recruiting Toulouse, France, 31100 Korea, Republic of Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Severance Hospital, Yonsei University Health System; Pharmacy Recruiting Seoul, Korea, Republic of, 03722 University of Ulsan College of Medicine - Asan Medical Center (AMC) - Asan Cancer Center (ACC) Recruiting Songpa-gu, Korea, Republic of, 05505 Spain Clínica Universidad de Navarra Recruiting Pamplona, Navarra, Spain, 31620 Hospital Universitari Vall d'Hebron Recruiting Barcelona, Spain, 08035 Fundación Jimenez Díaz Recruiting Madrid, Spain, 28040 South Texas Accelerated Research Therapeutics Madrid - CIOCC - Universitario Sanchinarro Recruiting Madrid, Spain, 28050 United Kingdom Barts Cancer Institute Recruiting London, United Kingdom, E1 2AT Royal Marsden Hospital; Institute of Cancer Research Recruiting Sutton, United Kingdom, SM2 5PT Less <<
NCT03769805 Nonsmall Cell Lung Cancer Not Applicable Not yet recruiting December 31, 2020 -
NCT01553942 Lung Cancer Phase 2 Recruiting December 2020 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Geoffrey Oxnard, MD    617-632-6049    goxnard@partners.org    Principal Investigator: Geoffrey Oxnard, MD          Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Lecia V Sequist, MD MPH    617-724-4000    lvsequist@partners.org    Principal Investigator: Lecia V Sequist, MD MPH Less <<
NCT03215706 Non-Small Cell Lung Cancer Phase 3 Recruiting May 20, 2020 -
NCT01878617 Medulloblastoma Phase 2 Recruiting December 2026 -
NCT03057106 Lung Cancer Metastatic Phase 2 Active, not recruiting December 2019 -
NCT03061058 Stomach Neoplasms ... More >> Chemotherapy Effect Chemotherapeutic Toxicity Less << Phase 3 Recruiting December 2019 China, Anhui ... More >> Ma'anshan People's Hospital Recruiting Ma'anshan, Anhui, China Contact: Fenglin Zhang, MD          Contact: Fangbo Cui, MD          China, Jiangsu Jiangyin People's Hospital Recruiting Jiangyin, Jiangsu, China Contact: Weisheng Shen, MD          Contact: Lei Xi, MD          Nanjing Gaochun People's Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Rongfu Wei, MD          Contact: Yajun Xin, MD          Nanjing Lishui People's Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Chunlan Nie, MD          Contact: Hui Xu, MD          The Comprehensive Cancer Center of Nanjing Drum Tower Hospital Recruiting Nanjing, Jiangsu, China, 210008 Contact: Yang Yang, MD,PhD,MSCR    0086-18602568379    wing_young7@hotmail.com    Contact: Baorui Liu, MD, PhD    0086-13770621908    baoruiliu07@163.com    Suqian People's Hospital Recruiting Suqian, Jiangsu, China Contact: Chuanwen You, MD          Contact: Qing Zhu, MD          Xuzhou Central Hospital Recruiting Xuzhou, Jiangsu, China Contact: Sanyuan Sun, MD          Contact: Yuan Yuan, MD          Affiliated Hospital of Jiangsu University Recruiting Zhenjiang, Jiangsu, China Contact: Xiaoqing Li, MD          Contact: Meilian Cheng, MD Less <<
NCT02716272 Mesothelioma Phase 2 Active, not recruiting December 2018 France ... More >> Angers - CHU Angers, France, 49000 Avignon - Institut Sainte-Catherine Avignon, France, 84918 CHU Clermont-Ferrand, France Dijon - CHU Dijon, France, 63000 Grenoble - CHU Grenoble, France, 38000 Centre Hospitalier - Pneumologie Le Havre, France, 76600 Centre Hospitalier - Pneumologie Le Mans, France, 72000 CHRU Lille - Hopital Calmette Lille, France AP-HM Hôpital Nord Marseille, France Mulhouse - CH Mulhouse, France, 68000 AP-HP Hopital Tenon - Pneumologie Paris, France, 75020 AP-HP Hôpital Bichat Paris, France HCL Lyon Sud Pierre Bénite, France, 69495 Pontoise - CH Pontoise, France Rennes - CHU Rennes, France Rouen - CHU Rouen, France, 76000 Centre Etienne Dolet Saint-Nazaire, France CHU Strasbourg Strasbourg, France Toulon - CHI Toulon, France, 83000 Toulouse - CHU Larrey Toulouse, France CHU Tours - Pneumologie Tours, France Gustave Roussy Villejuif, France, 94800 Less <<
NCT03432598 Locally Advanced or Metastatic... More >> Lung Cancer Less << Phase 2 Recruiting July 2019 China, Beijing ... More >> Chinese Academy of Medical Sciences Tumor Hospital Recruiting Beijing, Beijing, China, 100021 Contact: Lijuan Zhao    861087788495    cancergcp@163.com    Principal Investigator: Jie Wang, MD          Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Jun Huang    861088196023    hj19840804@163.com    Principal Investigator: Jun Zhao, MD          Beijing Chest Hospital Recruiting Beijing, Beijing, China, 133500 Contact: Jing Liu    861089509157    liujingworkbj@126.com    Principal Investigator: Zhe Liu, MD          China, Henan Henan Cancer Hospital Recruiting Zhengzhou, Henan, China, 450008 Contact: Hongxia Li    8637165588007    51lihongxia@sina.com    Principal Investigator: Zhiyong Ma, MD          China, Jiangsu Jaingsu People's Hospital Recruiting Nanjing, Jiangsu, China, 210029 Contact: Mingmin Sun    862568136221    jsphkj@163.com    Principal Investigator: Yongqian Shu, MD          China, Jilin Jilin University First Hospital Recruiting Changchun, Jilin, China, 130021 Contact: Fei Wang    8643188786014    wangfei5780@126.com    Principal Investigator: Ying Cheng, MD          Jilin Cancer Hospital Recruiting Changchun, Jilin, China, 132000 Contact: Yan Xi    8643185879120    417064629@qq.com    Principal Investigator: Ying Cheng, MD Less <<
NCT02951897 Lung Adenocarcinoma, Stage I ... More >> Diagnoses Diseases Circulating Tumor Cells Treatment Less << Not Applicable Recruiting December 2019 China ... More >> Daping hospital Recruiting Chongqing, China Contact: Bo Deng    +86-13637782166    deng.bo@dphospital.tmmu.edu.cn Less <<
NCT03631784 Non-small Cell Lung Cancer Phase 2 Recruiting January 12, 2022 United States, California ... More >> St Joseph Heritage Healthcare ( Site 1403) Recruiting Santa Rosa, California, United States, 95403 Contact: Study Coordinator    707-521-3830       United States, Indiana Parkview Cancer Institute ( Site 1415) Recruiting Fort Wayne, Indiana, United States, 46845 Contact: Study Coordinator    833-724-8356       United States, Massachusetts UMass Memorial Medical Center ( Site 1417) Recruiting Worcester, Massachusetts, United States, 01655 Contact: Study Coordinator    508-334-5539       United States, Michigan Henry Ford Hospital ( Site 1418) Recruiting Detroit, Michigan, United States, 48202 Contact: Study Coordinator    313-916-2635       United States, Nebraska St. Francis Cancer Treatment Center ( Site 1421) Recruiting Grand Island, Nebraska, United States, 68803 Contact: Study Coordinator    308-398-5450       United States, New Jersey Rutgers Cancer Institute of New Jersey ( Site 1422) Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Study Coordinator    732-235-6048       United States, Oklahoma CTCA Southwestern ( Site 1428) Recruiting Tulsa, Oklahoma, United States, 74133 Contact: Study Coordinator    918-286-5448       Australia, New South Wales Blacktown Hospital Western Sydney Local Health District ( Site 0204) Recruiting Blacktown, New South Wales, Australia, 2148 Contact: Study Coordinator    +61403170371       MNCCI Port Macquarie Base Hospital ( Site 0200) Recruiting Port Macquarie, New South Wales, Australia, 2444 Contact: Study Coordinator    +61265801818       Australia, Victoria Ballarat Health Services ( Site 0206) Recruiting Ballarat, Victoria, Australia, 3350 Contact: Study Coordinator    +61353204735       Korea, Republic of Chungbuk National University Hospital ( Site 1003) Recruiting Cheongju si, Chungcheongbuk Do, Korea, Republic of, 28644 Contact: Study Coordinator    +82432696015       Samsung Medical Center ( Site 1001) Recruiting Seoul, Korea, Republic of, 06351 Contact: Study Coordinator    +82234103459       Ulsan University Hospital ( Site 1000) Recruiting Ulsan, Korea, Republic of, 44033 Contact: Study Coordinator    +82522508832       Poland Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 0811) Recruiting Bydgoszcz, Poland, 85-796 Contact: Study Coordinator    +48523743029       Osrodek Badan Klinicznych przy Szpitalu Specjalistycznym ( Site 0802) Recruiting Krakow, Poland, 31-826 Contact: Study Coordinator    +48721295010       Centrum Onkologii Instytut im. Marii Sklodowskiej Curie ( Site 0800) Recruiting Warszawa, Poland, 02-781 Contact: Study Coordinator    +48225463066       Russian Federation Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 0910) Recruiting Kazan, Russian Federation, 420029 Contact: Study Coordinator    +79172662851       N.N. Blokhin National Medical Oncology Research Centre ( Site 0902) Recruiting Moscow, Russian Federation, 115478 Contact: Study Coordinator    +79031990755       National Medical Research Center of Oncology n.a. N. N. Petrov ( Site 0904) Recruiting St. Petersburg, Russian Federation, 197758 Contact: Study Coordinator    +79117500005       Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 0903) Recruiting Ufa, Russian Federation, 450054 Contact: Study Coordinator    +79050058625       Spain Hospital Universitari Vall d Hebron ( Site 1101) Recruiting Barcelona, Spain, 08035 Contact: Study Coordinator    +34934894158       Hospital Clinic de Barcelona ( Site 1100) Recruiting Barcelona, Spain, 08036 Contact: Study Coordinator    +34932275402       Clinica Universitaria de Navarra ( Site 1102) Recruiting Madrid, Spain, 28027 Contact: Study Coordinator    +349135319027502 Less <<
NCT02013453 Cancer of Head and Neck Phase 2 Withdrawn(Lack of funding) - United States, Michigan ... More >> University of Michigan Hospital Ann Arbor, Michigan, United States, 48109 Less <<
NCT03456076 Carcinoma, Non-Small-Cell Lung Phase 3 Recruiting September 30, 2026 -
NCT00324805 Stage IB Non-Small Cell Lung C... More >>arcinoma Stage IIA Non-Small Cell Lung Carcinoma Stage IIB Non-Small Cell Lung Carcinoma Stage IIIA Non-small Cell Lung Cancer Less << Phase 3 Active, not recruiting October 16, 2023 -
NCT02064491 Non-small Cell Lung Cancer Phase 2 Completed - Finland ... More >> Helsinki University Hospital Espoo, Finland Helsinki University Hospital Helsinki, Finland Oulu University Hospital Oulu, Finland Pori Central Hospital Pori, Finland Tampere University Hospital Tampere, Finland Turku University Hopital Turku, Finland Vaasa Central Hospital Vaasa, Finland Less <<
NCT00324805 - Active, not recruiting - -
NCT01383148 Non-Small-Cell Lung Carcinoma Phase 2 Phase 3 Terminated - -
NCT01672229 Graft Versus Host Disease Phase 1 Active, not recruiting December 2019 United States, California ... More >> University of California Comprehensive Cancer Center Sacramento, California, United States, 95817 Less <<
NCT02579564 Malignant Hydrothorax ... More >> Non Small Cell Lung Cancer Less << Phase 3 Unknown December 2018 -
NCT03760575 Mesotheliomas Pleural Phase 1 Not yet recruiting November 2021 United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Evan W Alley    588-216-0098    penncancertrials@emergingmed.com Less <<
NCT01356368 Non-Small Cell Lung Cancer Phase 2 Terminated(slow accrual rate) - Saudi Arabia ... More >> King Abdul Aziz Medical City for National Guard Health Affairs Riyadh, Saudi Arabia Less <<
NCT02142738 - Active, not recruiting - -
NCT02607423 Stage IIIA Non-Small Cell Lung... More >> Cancer Less << Phase 2 Withdrawn(The study failed to ... More >>meet its accrual targets.) Less << - United States, Pennsylvania ... More >> ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT02906150 Non-Small Cell Lung Cancer Phase 2 Not yet recruiting July 2019 Italy ... More >> Azienda Sanitaria Locale Frosinone Not yet recruiting Frosinone, Italy Contact: Dott.ssa Teresa Gamucci          Principal Investigator: Dott.ssa Teresa Gamucci          Istituto Nazionale dei Tumori Not yet recruiting Milan, Italy Contact: Dott.ssa Marina Chiara Garassino          Principal Investigator: Dott.ssa Marina Chiara Garassino          Roma_Campus Bio-Medico Not yet recruiting Rome, Italy Contact: Prof. Daniele Santini          Principal Investigator: Prof. Daniele Santini          Roma_Gemelli Not yet recruiting Rome, Italy Contact: Prof. Carlo Antonio Mario Barone          Principal Investigator: Prof. Carlo Antonio Mario Barone          Roma_Regina Apostolorum Not yet recruiting Rome, Italy Contact: Dott. Francesco Angelini          Principal Investigator: Dott. Francesco Angelini          Roma_Tor Vergata Not yet recruiting Rome, Italy Contact: Prof. Mario Roselli          Principal Investigator: Prof. Mario Roselli          Sant'Andrea Hospital Not yet recruiting Rome, Italy Contact: Prof. Paolo Marchetti          Principal Investigator: Prof. Paolo Marchetti          Presidio Sanitario San Camillo Not yet recruiting Torino, Italy Contact: Dott.ssa Maria Rita Migliorino          Principal Investigator: Dott.ssa Maria Rita Migliorino Less <<
NCT02142738 Non-Small Cell Lung Carcinoma Phase 3 Active, not recruiting May 31, 2019 -
NCT02576574 First Line Non-Small Cell Lung... More >> Cancer Less << Phase 3 Active, not recruiting September 5, 2024 -
NCT02039674 Non-small Cell Lung Carcinoma Phase 1 Phase 2 Active, not recruiting October 18, 2021 United States, California ... More >> Call for Information (Investigational Site 0018) La Jolla, California, United States, 92037 Call for Information (Investigational Site 0010) San Francisco, California, United States, 94115 United States, Indiana Call for Information (Investigational Site 0019) Indianapolis, Indiana, United States, 46202 United States, Massachusetts Call for Information (Investigational Site 0017) Boston, Massachusetts, United States, 02114 Call for Information (Investigational Site 0002) Boston, Massachusetts, United States, 02215 Call for Information (Investigational Site 0016) Boston, Massachusetts, United States, 02215 United States, Nebraska Call for Information (Investigational Site 0023) Omaha, Nebraska, United States, 68130 United States, New Jersey Call for Information (Investigational Site 0055) Hackensack, New Jersey, United States, 07601 United States, New York Call for Information (Investigational Site 0056) Lake Success, New York, United States, 11042 United States, Pennsylvania Call for Information (Investigational Site 0009) Philadelphia, Pennsylvania, United States, 19104 Call for Information (Investigational Site 0015) Philadelphia, Pennsylvania, United States, 19104 Call for Information (Investigational Site 0004) Philadelphia, Pennsylvania, United States, 19111 United States, Texas Call for Information (Investigational Site 0007) Houston, Texas, United States, 77030 Call for Information (Investigational Site 0003) San Antonio, Texas, United States, 78229 Taiwan Merck Sharp & Dohme (I.A.) Corp. Taipei, Taiwan Less <<
NCT02419495 Advanced Cancers Phase 1 Recruiting December 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02862457 Neoplasms Car... More >>cinoma, Non-Small-Cell Lung Less << Phase 1 Recruiting November 30, 2020 Japan ... More >> MSD K.K. Recruiting Chiyoda-Ku, Tokyo, Japan, 102-8667 Contact: Japan Call Center    81-3-6272-1957 Less <<
NCT02039674 - Active, not recruiting - -
NCT02940990 NSCLC SBRT ... More >> GM-CSF Less << Phase 2 Not yet recruiting - China, Shanghai ... More >> Shanghai Chest Hospital Not yet recruiting Shanghai, Shanghai, China Contact: Xiaolong Fu, PhD    +862122200000 ext 3602    xlfu1964@126.com Less <<
NCT03269162 NSCLC Phase 3 Active, not recruiting September 30, 2019 -
NCT02041533 - Active, not recruiting - -
NCT02041533 Stage IV or Recurrent Non-Smal... More >>l Cell Lung Cancer Less << Phase 3 Active, not recruiting October 1, 2018 -
NCT00969098 - Unknown September 2015 Italy ... More >> Istituto Clinico Humanitas Rozzano, Milano, Italy, 20089 Less <<
NCT03088540 Carcinoma,Non-Small-Cell Lung ... More >> Lung Carcinomas, Non-Small-Cell Non-small-cell Lung Carcinoma Nonsmall Cell Lung Cancer Less << Phase 3 Recruiting September 20, 2022 -
NCT01993810 Stage II Non-Small Cell Lung C... More >>ancer AJCC v7 Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 Stage III Non-Small Cell Lung Cancer AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Less << Phase 3 Recruiting December 31, 2025 United States, Florida ... More >> University of Florida Health Science Center - Jacksonville Recruiting Jacksonville, Florida, United States, 32209 Contact: Site Public Contact    412-339-5294    Roster@nrgoncology.org    Principal Investigator: Bradford S. Hoppe          United States, Illinois Northwestern Medicine Cancer Center Warrenville Suspended Warrenville, Illinois, United States, 60555 United States, Maryland Maryland Proton Treatment Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Site Public Contact    410-369-5226    info@mdproton.com    Principal Investigator: Charles B. Simone          University of Maryland/Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Site Public Contact    800-888-8823       Principal Investigator: Charles B. Simone          Upper Chesapeake Medical Center Recruiting Bel Air, Maryland, United States, 21014 Contact: Site Public Contact    443-643-3010       Principal Investigator: Jack J. Hong          Central Maryland Radiation Oncology in Howard County Recruiting Columbia, Maryland, United States, 21044 Contact: Site Public Contact    443-546-1300       Principal Investigator: Charles B. Simone          Tate Cancer Center Recruiting Glen Burnie, Maryland, United States, 21061 Contact: Site Public Contact    410-553-8100       Principal Investigator: Charles B. Simone          United States, Massachusetts Massachusetts General Hospital Cancer Center Suspended Boston, Massachusetts, United States, 02114 Mass General/North Shore Cancer Center Suspended Danvers, Massachusetts, United States, 01923 United States, Missouri Siteman Cancer Center at West County Hospital Recruiting Creve Coeur, Missouri, United States, 63141 Contact: Site Public Contact    800-600-3606    info@siteman.wustl.edu    Principal Investigator: Jeffrey D. Bradley          Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Site Public Contact    800-600-3606    info@siteman.wustl.edu    Principal Investigator: Jeffrey D. Bradley          United States, New Jersey Memorial Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Site Public Contact    212-639-7592       Principal Investigator: Abraham J. Wu          ProCure Proton Therapy Center-Somerset Suspended Somerset, New Jersey, United States, 08873 United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Site Public Contact    212-639-7592       Principal Investigator: Abraham J. Wu          Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Site Public Contact    212-639-7592       Principal Investigator: Abraham J. Wu          Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Site Public Contact    212-639-7592       Principal Investigator: Abraham J. Wu          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Site Public Contact    212-639-7592       Principal Investigator: Abraham J. Wu          Memorial Sloan Kettering Sleepy Hollow Suspended Sleepy Hollow, New York, United States, 10591 United States, Pennsylvania University of Pennsylvania/Abramson Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Site Public Contact    800-474-9892       Principal Investigator: Samuel Swisher-McClure          Thomas Jefferson University Hospital Active, not recruiting Philadelphia, Pennsylvania, United States, 19107 United States, Tennessee Tennessee Cancer Specialists-Dowell Springs Recruiting Knoxville, Tennessee, United States, 37909 Contact: Site Public Contact    865-244-3209       Principal Investigator: J. B. Wilkinson          United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Site Public Contact    877-312-3961       Principal Investigator: Quynh-Nhu Nguyen          MD Anderson Regional Care Center-Katy Suspended Houston, Texas, United States, 77094 MD Anderson Regional Care Center-Bay Area Suspended Nassau Bay, Texas, United States, 77058 MD Anderson Regional Care Center-Sugar Land Suspended Sugar Land, Texas, United States, 77478 MD Anderson Regional Care Center-The Woodlands Suspended The Woodlands, Texas, United States, 77384 United States, Washington ProCure Proton Therapy Center-Seattle Recruiting Seattle, Washington, United States, 98133 Contact: Site Public Contact    412-339-5294    Roster@nrgoncology.org    Principal Investigator: Ramesh Rengan          University of Washington Medical Center Recruiting Seattle, Washington, United States, 98195 Contact: Site Public Contact    800-804-8824       Principal Investigator: Ramesh Rengan Less <<
NCT02486718 Non-Small Cell Lung Cancer Phase 3 Active, not recruiting September 25, 2026 -
NCT02055144 - Recruiting March 2018 Italy ... More >> IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro Recruiting Genoa, Italy, 16132 Contact: Francesco Grossi, MD    +393355255484    fg1965@libero.it Less <<
NCT02662634 Non-small Cell Lung Cancer (NS... More >>CLC) Less << Phase 2 Unknown March 2018 United States, Nebraska ... More >> Cancer Research Network of Nebraska / Oncology Associates Recruiting Omaha, Nebraska, United States, 68118 Contact: Tony Romero, MS, CCRC    402-697-2229    tromero@gucancer.com    Principal Investigator: Stephen Lemon, MD Less <<
NCT02083679 - Terminated(Sponsor the return ... More >>rights of the compound to the collaboration partner for further clinical development) Less << - -
NCT03351361 Advanced Non Small Cell Lung C... More >>ancer Less << Phase 3 Not yet recruiting June 2022 France ... More >> CH du Pays d'Aix Not yet recruiting Aix-en-Provence, France Contact: Jacques Letreut          CHU d'Angers Not yet recruiting Angers, France Contact: Thierry Urban          CH de la Côte Basque Not yet recruiting Bayonne, France Contact: Marielle Sabatini          CH de Beauvais Not yet recruiting Beauvais, France Contact: Jacky Crequit          CHU de Brest Not yet recruiting Brest, France Contact: Gilles Robinet          Centre Francois Baclesse Not yet recruiting Caen, France Contact: Radj Gervais          CH René Dubos Not yet recruiting Cergy-Pontoise, France Contact: Gislaine Fraboulet          CH de Charleville-Mézières Not yet recruiting Charleville-Mézières, France Contact: Stéphane Chouabe          CH Intercommunal Not yet recruiting Créteil, France Contact: Isabelle Monnet          CH Intercommunal des Alpes du Sud Not yet recruiting Gap, France Contact: Pascal Thomas          CH Départemental Vendée Not yet recruiting La Roche-sur-Yon, France Contact: Marie Marcq          CH de Versailles Not yet recruiting Le Chesnay, France Contact: Cécile Dujon          CH Robert Boulin Not yet recruiting Libourne, France Contact: Menouar-Samir Abdiche          CHU de Limoges Not yet recruiting Limoges, France Contact: Alain Vergnenegre          CH Régional Not yet recruiting Longjumeau, France Contact: Gérard Oliviero          CH de Bretagne Sud Not yet recruiting Lorient, France Contact: Régine Lamy          Centre Léon Bérard Not yet recruiting Lyon, France Contact: Maurice Perol          CH François Quesnay Not yet recruiting Mantes-la-Jolie, France Contact: Jean-Bernard Auliac          APHM Hôpital Nord Not yet recruiting Marseille, France Contact: Laurent Greillier          Institut Paoli-Calmette Not yet recruiting Marseille, France Contact: Anne Madroszyk-Flandin          CH de Meaux Not yet recruiting Meaux, France Contact: Chrystèle Locher          CH de la Région d'Annecy Pringy, France CHU de Rennes Not yet recruiting Rennes, France Contact: Hervé Léna          Sub-Investigator: Romain Corre          Principal Investigator: Hervé Léna          CHU de Rouen Not yet recruiting Rouen, France Contact: Luc Thiberville          CH de Saint-Brieuc Not yet recruiting Saint-Brieuc, France Contact: Gwenaëlle Le Garff          CHU de Saint-Etienne Not yet recruiting Saint-Priest-en-Jarez, France Contact: Pierre Fournel          CLCC Paul Strauss Not yet recruiting Strasbourg, France Contact: Roland Schott          CH Intercommunal Toulon-La Seyne-sur-Mer Not yet recruiting Toulon, France Contact: Clarisse Audigier-Valette          HIA Saint-Anne Not yet recruiting Toulon, France Contact: Henri Berard          CH de Villefranche sur Saône Not yet recruiting Villefranche-sur-Saône, France Contact: Lionel Falchero Less <<
NCT03519971 Non-Small Cell Lung Cancer Phase 3 Recruiting August 1, 2022 -
NCT03530397 Selected Advanced Solid Tumors Phase 1 Recruiting March 27, 2023 Australia ... More >> Research Site Recruiting Melbourne, Australia, 3000 Research Site Recruiting Melbourne, Australia, 3004 Research Site Recruiting Randwick, Australia, 2031 Italy Research Site Not yet recruiting Milano, Italy, 20133 Korea, Republic of Research Site Not yet recruiting Incheon, Korea, Republic of, 21565 Research Site Recruiting Seoul, Korea, Republic of, 03080 Research Site Recruiting Seoul, Korea, Republic of, 03722 Research Site Recruiting Seoul, Korea, Republic of, 05505 Research Site Recruiting Seoul, Korea, Republic of, 06351 Taiwan Research Site Not yet recruiting Taichung, Taiwan, 40705 Research Site Not yet recruiting Tainan, Taiwan, 70403 Research Site Not yet recruiting Taipei, Taiwan, 10048 Less <<
NCT02621333 Lung Adenocarcinoma Phase 2 Unknown September 2018 China, Henan ... More >> Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university Recruiting ZhengZhou, Henan, China, 450008 Contact: Quanli Gao, M.D.    +8615038171966    guaoquanli2015@126.com    Contact: Lingdi Zhao, M.D.    +8637165587483    lingdi1010@sohu.com    Principal Investigator: Quanli Gao, M.D. Less <<
NCT02083679 Carcinoma, Non-Small-Cell Lung Phase 1 Terminated(Sponsor the return ... More >>rights of the compound to the collaboration partner for further clinical development) Less << - United States, Massachusetts ... More >> Please Contact U.S. Medical Information Located in Rockland, Massachusetts, United States Germany Please contact the Merck KGaA Communication Center located in Darmstadt, Germany Less <<
NCT02129699 Lung Cancer Non-small Cell Sta... More >>ge IV Less << Phase 3 Active, not recruiting September 2020 -
NCT02777788 Cancer Phase 2 Phase 3 Active, not recruiting December 2019 -
NCT00775385 Carcinoma, Non-Small-Cell Lung Phase 2 Phase 3 Completed - France ... More >> Centre Hospitalier Aix en Provence, France Clinique de L'Europe Amiens, France Angers - CHU Angers, France, 49000 Centre Hospitalier Béziers, France Centre F. Baclesse Caen, France, 14000 CHU - Pneumologie Caen, France, 14000 Centre Hospitalier Chauny, France Chevilly Larue - CH Chevilly Larue, France Hôpital Percy-Armées - Pneumologie Clamart, France, 92140 Clermont Ferrand - CHU Clermont Ferrand, France, 63000 Colmar - CH Colmar, France, 68000 Dax - CH Dax, France, 40107 Ermont - Clinique Claude Bernard Ermont, France CHU Grenoble - pneumologie Grenoble, France, 38000 Le Mans - CHG Le Mans, France Centre Léon Bérard Lyon, France, 69000 Lyon - Hôpital Louis Pradel (Pneumologie) Lyon, France Mantes La Jolie - CH Mantes La Jolie, France, 78200 APHM - Hôpital Sainte Marguerite Marseille, France, 13000 Institut Paoli Calmette Marseille, France Metz - Belle Isle Metz, France Mont de Marsan - CH Mont de Marsan, France, 40000 Montpellier - Clinique Clémentville Montpellier, France, 34070 Mulhouse - CH Mulhouse, France, 68000 Nancy - Polyclinique Gentilly Nancy, France Nevers - CH Nevers, France, 58033 Paris - Saint Louis Paris, France, 75000 APHP - Hopital Tenon - Pneumologie Paris, France, 75020 Pau - CH Pau, France, 64046 HCL - Lyon Sud (Pneumologie) Pierre Bénite, France, 69495 Reims - CHU Reims, France, 51092 Rennes - CHU Rennes, France Centre Hospitalier Saint-Quentin, France Nouvel Hopital Civil Strasbourg, France, 63000 Hôpital Foch Suresnes, France Centre Hospitalier Intercommunal Toulon, France CHU Toulouse - Pneumologie Toulouse, France Clinique Pasteur Toulouse, France Tours - CHU Tours, France, 37000 Nancy - CHU Vandoeuvre lès Nancy, France, 54500 Institut Gustave Roussy Villejuif, France, 94805 Centre Hospitalier Intercommunal Villeneuve-Saint-Georges, France Less <<
NCT02974426 Non-small Cell Lung Cancer Sta... More >>ge IIIA Radiotherapy Less << Phase 3 Recruiting December 2020 China, Shanghai ... More >> Shanghai Chest Hospital Recruiting Shanghai, Shanghai, China Contact: Xiaolong Fu, PhD    +862122200000 ext 3602    xlfu1964@126.com Less <<
NCT02117024 Non Small Cell Lung Cancer Phase 2 Active, not recruiting September 2018 United States, Arkansas ... More >> Highlands Oncology Group Rogers, Arkansas, United States, 72758 United States, California University of California San Diego La Jolla, California, United States, 92093 University of California at Los Angeles Los Angeles, California, United States, 90029 University of California Davis Sacramento, California, United States, 95817 United States, Georgia Georgia Regents University Augusta, Georgia, United States, 30912 United States, Maryland University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Massachusetts University of Massachusetts Worcester, Massachusetts, United States, 01655 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York SUNY Syracuse Syracuse, New York, United States, 13210 United States, Ohio Gabrail Cancer Center Canton, Ohio, United States, 44718 United States, Oregon Providence Portland Medical Center- Providence Lung Cancer Clinic Portland, Oregon, United States, 97213 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas Texas Oncology PA Texas Cancer Center Abilene, Texas, United States, 79606 Mary Crowley Cancer Center Dallas, Texas, United States, 75201 United States, Washington Cancer Care Northwest Spokane, Washington, United States, 99216 United States, Wisconsin Aurora Research Institute Green Bay, Wisconsin, United States, 54311 Less <<
NCT03562871 NSCLC Phase 1 Phase 2 Recruiting February 2022 Spain ... More >> Servicio de Oncología-El médico del Virgen de la Victoria Recruiting Málaga, Andalusia, Spain, 29010 Contact: José M Trigo Pérez, Dr          Insituto Oncologico Dr Rosell. Hospital Universitario Quiron Dexeus Not yet recruiting Barcelona, Catalonia, Spain, 08028 Contact: Santiago Viteri, Prof          Hospital Universitario de Vall d'Hebron Recruiting Barcelona, Catalonia, Spain, 08035 Contact: Enriqueta Felip, Dr          Hospital Universitari de Girona Doctor Josep Trueta Recruiting Girona, Catalonia, Spain, 17007 Contact: Joaquim Bosch, Dr          Hospital Universitario 12 Octubre Recruiting Madrid, Community Of Madrid, Spain, 28041 Contact: Luis Paz-Ares, Dr          Centro Integral Oncologico Clara Campal, Hospital Universitario HM Sanchinarro Not yet recruiting Madrid, Community Of Madrid, Spain, 28050 Hospital Universitario Ramón y Cajal Not yet recruiting Madrid, Community Of Madrid, Spain, 28134 Contact: Pilar Garrido, Dr          Hospital Puerta del Hierro Majadahonda Recruiting Madrid, Community Of Madrid, Spain Contact: Mariano Provencio, Dr          Hospital Clinico Universitario de València Not yet recruiting València, Horta De València, Spain, 46010 Contact: Amelia Insa, Dr          Hospital Universitario La Paz Recruiting Madrid, Spain, 28050 Contact: Javier de Castro Carpeno, DR    +34917277000    javier.decastro@salud.madrid.org Less <<
NCT02367781 Carcinoma, Non-Small-Cell Lung Phase 3 Active, not recruiting December 28, 2019 -
NCT01192230 Carcinoma, Non-Small-Cell Lung Phase 2 Unknown - China, Shanghai ... More >> Cancer hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Jianhua Chang, MD,PhD    13916619284    changjianhua@hotmail.com Less <<
NCT01840579 Solid Tumor N... More >>on-small Cell Lung Cancer Small Cell Lung Cancer Less << Phase 1 Active, not recruiting April 17, 2020 -
NCT02610140 Mesothelioma Phase 2 Active, not recruiting July 29, 2019 -
NCT01969955 Squamous Cell Carcinoma of Lun... More >>g Less << Phase 2 Unknown June 2015 China, Beijing ... More >> Cancer institute and hospital, Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 100021 Contact: Junling Li       drlijunling@vip.163.com    Principal Investigator: Junling Li Less <<
NCT02568033 Non Small Cell Lung Cancer Early Phase 1 Unknown October 2017 United States, New Jersey ... More >> MD Anderson Cancer Center at Cooper Recruiting Camden, New Jersey, United States, 08103 Contact: Kim Krieger    856-735-6237 Less <<
NCT01809210 Locally Advanced or Metastatic... More >> NSCL Cancer Stage IIIB IV Less << Phase 1 Completed - United Kingdom ... More >> Research Site Glasgow, United Kingdom, G12 0YN Research Site London, United Kingdom, W1G 6AD Research Site Manchester, United Kingdom, M20 4BX Research Site Newcastle upon Tyne, United Kingdom, NE7 7DN Less <<
NCT02103257 EGFR Positive Non-small Cell L... More >>ung Cancer Adenocarcinoma Less << Phase 4 Unknown September 2017 China, Gansu ... More >> First Hospital of Lanzhou University Active, not recruiting Lanzhou, Gansu, China, 730000 Lanzhou military region general hospital Active, not recruiting Lanzhou, Gansu, China, 730050 China, Guangdong General Hospital of Guangzhou Military Command Active, not recruiting Guangzhou, Guangdong, China, 510010 Cancer Hospital of Sun Yat-sen Active, not recruiting Guangzhou, Guangdong, China, 510060 First Affiliated Hospital of Guangzhou Medical College Active, not recruiting Guangzhou, Guangdong, China, 510120 Jiangmen central hospital Active, not recruiting Jiangmen, Guangdong, China, 529030 The university of Hong Kong-Shenzhen Hospital Active, not recruiting Shenzhen, Guangdong, China, 518000 Shenzhen People's Hospital Active, not recruiting Shenzhen, Guangdong, China, 518020 Medical Oncology,Shenzhen Second People's Hospital Active, not recruiting Shenzhen, Guangdong, China, 518035 Thoracic Surgery,Shenzhen Second People's Hospital Active, not recruiting Shenzhen, Guangdong, China, 518035 Peking University Shenzhen Hospital Active, not recruiting Shenzhen, Guangdong, China, 518036 Guangdong Agribusiness Center Hospital Active, not recruiting Zhanjiang, Guangdong, China, 524009 China, Guangxi First Affiliated Hospital of Guangxi Medical University Active, not recruiting Nanning, Guangxi, China, 530021 China, Hainan Hainan Provincal Nong Ken Hospital Active, not recruiting Haikou, Hainan, China, 570311 Hainan Provincial People's Hospital Active, not recruiting Haikou, Hainan, China, 570311 China, Henan First Affiliated Hospital of Zhengzhou University Active, not recruiting Zhengzhou, Henan, China, 450052 China, Ningxia Medical Oncology,General Hospital of Ningxia Medical University Active, not recruiting Yinchuan, Ningxia, China, 750004 Radiation Oncology,General Hospital of Ningxia Medical University Active, not recruiting Yinchuan, Ningxia, China, 750004 Respiratory medicine,General Hospital of Ningxia Medical University Active, not recruiting Yinchuan, Ningxia, China, 750004 China, Shanxi Baoji Central Hospital Active, not recruiting Baoji, Shanxi, China, 721008 3201 Hospital, Hanzhong, Shanxi Active, not recruiting Hanzhong, Shanxi, China, 723000 Shaanxi province people's hospital Active, not recruiting Xi'an, Shanxi, China, 710000 Second Affiliated Hospital of Xi'an Jiaotong University Active, not recruiting Xi'an, Shanxi, China, 710004 Xi'an Chang'an Hospital Active, not recruiting Xi'an, Shanxi, China, 710018 Tangdu Hospital,Fourth Military Medical University Recruiting Xi'an, Shanxi, China, 710038 Contact: Helong Zhang, MD    13709202616       Principal Investigator: Helong Zhang, MD          First Affiliated Hospital of Xi'an Jiaotong University Active, not recruiting Xi'an, Shanxi, China, 710061 Shanxi Cancer Hospital Active, not recruiting Xi'an, Shanxi, China, 710061 China, Xinjiang Urumqi General Hospital of Lanzhou Military Region General Hospital Active, not recruiting Urumqi, Xinjiang, China, 830000 Xinjiang medical university affiliated tumor hospital Active, not recruiting Urumqi, Xinjiang, China, 830000 First Affiliated Hospital of Xinjiang Medical University Active, not recruiting Urumqi, Xinjiang, China, 830054 Autonome Region Xinjiang Uygur Chinese medicine hospital Active, not recruiting Urumqi, Xinjiang, China, 830099 Less <<
NCT01655225 Advanced Cancer ... More >> Metastatic Cancer Non-Hodgkin's Lymphoma Metastatic Breast Cancer Malignant Mesothelioma Non-small Cell Lung Cancer Less << Phase 1 Recruiting March 1, 2021 United States, California ... More >> UCLA Medical Center Recruiting Los Angeles, California, United States, 90095 Contact    3103258252       Principal Investigator: Parvin Fatheddin Peddi          United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact    646-888-4226       Principal Investigator: Anna M Varghese          United States, Oklahoma Peggy and Charles Stephenson Oklahoma Cancer Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact    405-271-8777       Principal Investigator: Raid Aljumaily          United States, Pennsylvania Penn Presbyterian Medical Center Completed Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Sarah Cannon Cancer Center Recruiting Nashville, Tennessee, United States, 37203 Contact    615-239-7615       Principal Investigator: SMO Sarah Cannon Research Inst.          Tennessee Oncology PLLC Recruiting Nashville, Tennessee, United States, 37203 Contact    6153297274       Principal Investigator: Johanna Chock Bendell          Italy Azienda Ospedaliero - Universitaria S. Luigi Gonzaga Completed Orbassano, Torino, Italy, 10043 Puerto Rico Fundacion de Investigacion de Diego Recruiting San Juan, Puerto Rico, 00927 Contact    7877221248       Principal Investigator: Mirelis Acosta-Rivera Less <<
NCT02195453 Non-Small Cell Lung Cancer Phase 4 Unknown December 2016 -
NCT01935947 Recurrent Non-Small Cell Lung ... More >>Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer Less << Phase 2 Terminated - United States, California ... More >> USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States, 92663 United States, Maryland Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT01809210 - Completed - -
NCT01935947 - Terminated - -
NCT01633970 Cancer Phase 1 Active, not recruiting December 31, 2018 United States, Colorado ... More >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, Connecticut Yale University New Haven, Connecticut, United States, 06511 United States, District of Columbia Georgetown University Medical Center Lombardi Cancer Center Washington, District of Columbia, United States, 20007 United States, Illinois Uni of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts Massachusetts General Hospital. Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States, 02215 Dana Farber Can Ins Boston, Massachusetts, United States, 02215 United States, New York Laura and ISAAC Perlmutter Cancer Center at NYU Langone. New York, New York, United States, 10016 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 Carolina BioOncology Institute; Can Therapy & Res Ctr Huntersville, North Carolina, United States, 28078 United States, Tennessee Sarah Cannon Research Inst. Nashville, Tennessee, United States, 37203 Less <<
NCT01059552 Locally Advanced Non-small Cel... More >>l Lung Cancer Less << Phase 1 Active, not recruiting December 1, 2018 United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT01063478 Non-Small Cell Lung Cancer Phase 1 Terminated(Poor accrual) - United States, Illinois ... More >> University of Chicago Medical Center Chicago, Illinois, United States, 60637 Less <<
NCT02031601 Non-Small-Cell Lung Cancer Phase 4 Unknown December 2017 China, Shandong ... More >> Yu Li Recruiting Jinan, Shandong, China, 250012 Contact: Yu Li Less <<
NCT03083808 Non-Small-Cell Lung Cancer Phase 2 Recruiting December 2019 United States, Illinois ... More >> University of Illinois Cancer Center Recruiting Chicago, Illinois, United States, 60612 Contact: Margaret Gavor    312-355-4200    mgavor2@uic.edu    Principal Investigator: Lawrence Feldman, MD          United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Greg Durm, MD    317-656-4260    gdurm@iu.edu    Contact: Ashley Hudson    317-278-5638    ashnhuds@iu.edu    United States, Iowa University of Iowa Hospital Clinics Recruiting Iowa City, Iowa, United States, 52242 Contact: Sarah Heady    319-384-4241    sarah-heady@uiowa.edu    Principal Investigator: Muhammad Furgan, MD          United States, Minnesota University of Minnesota Medcical Center Recruiting Minneapolis, Minnesota, United States, 55455 Principal Investigator: Naomi Fujioka, MD          United States, Wisconsin University of Wisconsin Recruiting Madison, Wisconsin, United States, 53705 Contact: Hilary Hernan    608-263-2079    hernan@wisc.edu    Principal Investigator: Ticiana Leal, MD Less <<
NCT02448797 Non-small Cell Lung Cancer Phase 3 Recruiting December 2022 China, Beijing ... More >> 307 Hospital of PLA Recruiting Beijing, Beijing, China, 100071 Principal Investigator: Xiao-qing Liu, M.D.          China, Fujian Fujian Provincal Cancer Hospital Recruiting Fuzhou, Fujian, China, 350014 Contact: Huang Cheng, M.D.    0086-13905010397       Principal Investigator: Huang Cheng, M.D.          China, Guangdong The First Affiliated Hospital Of Guangzhou Medical Collage Recruiting Guangzhou, Guangdong, China, 510120 Contact: He Jianxing    0086-13802777270       Principal Investigator: He Jianxing, M.D.          Shenzhen People's Hospital Recruiting Shenzhen, Guangdong, China, 518020 Contact: Zheng Wang, MD    13502886638       Principal Investigator: Zheng Wang, MD          China, Liaoning The First Hospital of China Medical University Recruiting Shenyang, Liaoning, China, 110001 Contact: Liu Yunpeng, M.D.    0086-13898865122       Principal Investigator: Liu Yunpeng, M.D.          First Affiliated Hospital of China Medical University Active, not recruiting Shenyang, Liaoning, China, 150081 China, Shanghai Shanghai Pulmonary Hospital Recruiting Shanghai, Shanghai, China, 200433 Principal Investigator: Cai-Cun Zhou          China, Zhejiang The First Affiliated Hospital of Medical School of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310000 Contact: Zhou Jianying, M.D.    0086-13750881678    drzjy@163.com    Principal Investigator: Zhou Jianying, M.D. Less <<
NCT00560573 Carcinoma, Non-Small-Cell Lung Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Charleroi, Belgium, 6000 Ireland Pfizer Investigational Site Dublin, Ireland, 8 Spain Pfizer Investigational Site Madrid, Spain, 28041 Pfizer Investigational Site Sevilla, Spain, 41013 Less <<
NCT01828099 Non-Small Cell Lung Cancer Phase 3 Active, not recruiting April 11, 2022 -
NCT00863512 Lung Cancer Phase 3 Terminated - -
NCT00560573 - Completed - -
NCT00863512 - Terminated - -
NCT01828099 - Active, not recruiting - -
NCT01454934 - Completed - -
NCT01454934 Non-Small Cell Lung Cancer (NS... More >>CLC) Less << Phase 3 Completed - -
NCT02937116 Cancer, Solid Tumor Phase 1 Unknown December 2018 -
NCT03425643 Non-small Cell Lung Cancer Phase 3 Recruiting June 29, 2026 -
NCT03402048 Stage IV, NSCLC ... More >> Lung Neoplasms Bronchial Neoplasms Carcinoma, Bronchogenic Lung Diseases Neoplasms Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms Less << Phase 3 Recruiting December 2018 Italy ... More >> IRCSSIstituto Scientifico Romagnolo per lo studio e la cura dei tumori IRST Recruiting Meldola, Forlì, Italy Contact: Marco Angelo Burgio, MD          Istituto Nazionale Tumori Recruiting Aviano, Pordenone, Italy Contact: Alessandra Bearz, MD          Ospedale di Faenza Recruiting Faenza, Ravenna, Italy Contact: Alessandro Gamboni, MD          Ospedale di Lugo Recruiting Lugo, Ravenna, Italy Contact: Gianni Michele Turolla, MD          AUSL Rimini-Oncologia Medica Cattolica Recruiting Cattolica, Rimini, Italy Contact: Maximilian Papi, MD          AOU San Luigi Gonzaga, Department of Oncology, University of Turin Recruiting Orbassano, Turin, Italy, 10043 Contact: Silvia Novello, MD, PhD    +390119026978    silvia.novello@unito.it    Ospedale Giovanni Paolo II Recruiting Bari, Italy Contact: Domenico Galetta, MD          AO Cannizzaro Recruiting Catania, Italy Contact: Giuseppe Banna, MD          AOU Santa Croce e Carle Recruiting Cuneo, Italy Contact: Ida Colantonio, MD          Azienda Ospedaliera Careggi Recruiting Firenze, Italy Contact: Fabiana Cecere, MD          Istituto Nazionale per la Ricerca sul Cancro Recruiting Genova, Italy Contact: Francesco Grossi, MD          Ospedale Galliera Recruiting Genova, Italy Contact: Carlotta Defferrari, MD          Azienda Ospedaliera Fatebenefratelli Recruiting Milano, Italy Contact: Gabriella Farina, MD          Ospedale S. Raffaele Recruiting Milano, Italy Contact: Vanesa Gregorc          AO San Gerardo Recruiting Monza, Italy Contact: Paolo Bidoli, MD          Istituto Oncologico Veneto Recruiting Padova, Italy Contact: Adolfo Favaretto, MD          Ospedale Santa MAria della Misericordia Recruiting Perugia, Italy Contact: Lucio Crinò, MD          Ospedale S MAria delle Croci Recruiting Ravenna, Italy Contact: Claudio Dazzi, MD          Arcispedale Santa Maria Nuova Recruiting Reggio Emilia, Italy Contact: Corrado Boni, MD          AUSL Rimini-Oncologia medica Recruiting Rimini, Italy Contact: Maximilian Papi, MD          Istituto Nazionale Tumori Regina Elena Recruiting Roma, Italy Contact: Francesco Cognetti, MD          Ospedale S. Giovanni Addolorata Recruiting Roma, Italy Contact: oLGA Martelli, MD          Policlinico Umberto I- Università la Sapienza Recruiting Roma, Italy Contact: Enrico Cortesi, MD          AOU Sassari Recruiting Sassari, Italy Contact: Lorenzo Cordero, MD          Azienda Ospedaliera Sondalo Recruiting Sondalo, Italy Contact: Giuseppe Valmadre, MD          Ospedale Santa Chiara Recruiting Trento, Italy Contact: Orazio Caffo, MD          AOU S.M. Misericordia Recruiting Udine, Italy Contact: Alessandro Follador, MD          AOU Verona Recruiting Verona, Italy Contact: Gianpaolo Tortora, MD Less <<
NCT02368990 - Withdrawn(Since the conception... More >> of the study, the competitive environment has developed and as a result this study is no longer able to generate the necessary information.) Less << June 2018 -
NCT02900742 Cancer Phase 3 Unknown December 2016 -
NCT02930954 Non-small-cell Lung Cancer Phase 2 Unknown December 2018 China ... More >> Department of Oncology, Shanghai pulmonary hospital Shanghai, China, 200433 Less <<
NCT02148380 Non-Small-Cell Lung Cancer Not Applicable Completed - China ... More >> Shanghai Chest Hospital Shanghai, China, 200030 Less <<
NCT03737994 ALK Gene Rearrangement ... More >> ALK Positive Non-Squamous Non-Small Cell Lung Carcinoma Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8 Less << Phase 2 Not yet recruiting December 13, 2025 -
NCT00502567 Advanced Solid Tumor Phase 1 Completed - United States, Michigan ... More >> Research Site Ann Arbor, Michigan, United States Research Site Detroit, Michigan, United States United States, Tennessee Research Site Nashville, Tennessee, United States Less <<
NCT01958372 Adenocarcinoma of the Lung ... More >> Adenosquamous Cell Lung Cancer Bronchoalveolar Cell Lung Cancer Large Cell Lung Cancer Recurrent Non-small Cell Lung Cancer Squamous Cell Lung Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Less << Phase 1 Active, not recruiting June 30, 2018 United States, Michigan ... More >> Karmanos Cancer Institute at McLaren Bay Region Bay City, Michigan, United States, 48706 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Karmanos Cancer Institute at McLaren Lapeer Region Lapeer, Michigan, United States, 48446 Karmanos Cancer Institute at McLaren Central Michigan Mount Pleasant, Michigan, United States, 48858 Karmanos Cancer Institute at McLaren Northern Petoskey, Michigan, United States, 49770 Less <<
NCT03062800 Advanced Nsclc Phase 2 Recruiting October 2018 China, Shandong ... More >> Qilu hospital of Shandong University Recruiting Jinan Shi, Shandong, China, 250012 Contact: Shuguang Li, MD.    +86 18560082862    lishuguang96@163.com    Principal Investigator: Xiuwen Wang, MD. Less <<
NCT02899195 Mesothelioma ... More >>Pleural Mesothelioma Less << Phase 2 Active, not recruiting December 2020 -
NCT01674738 Carcinoma, Non-Small-Cell Lung Phase 2 Withdrawn(Decision of the Spon... More >>sor, as the funding of the study was no longer guaranteed.) Less << - -
NCT01218516 Adenocarcinoma of the Lung Phase 2 Completed - -
NCT01828112 Non-Small Cell Lung Cancer Phase 3 Active, not recruiting February 15, 2021 -
NCT03137771 Recurrent Non-Small Cell Lung ... More >>Carcinoma Stage IV Non-Small Cell Lung Cancer Less << Phase 2 Recruiting April 2022 -
NCT01828112 - Active, not recruiting - -
NCT01951586 Non-Small Cell Lung Cancer Phase 2 Completed - -
NCT02322281 Non-small Cell Lung Cancer Phase 3 Terminated(Sponsor discontinue... More >>d development of CO-1686 for NSCLC) Less << - -
NCT03322566 Lung Cancer Phase 2 Active, not recruiting September 2021 -
NCT02864251 Non-Small-Cell Lung Carcinoma Phase 3 Recruiting December 31, 2023 -
NCT02883543 Non-small Cell Lung Cancer Phase 3 Active, not recruiting June 2019 -
NCT02308020 Breast Cancer ... More >> Non-small Cell Lung Cancer Melanoma Brain Metastases Less << Phase 2 Active, not recruiting November 8, 2019 -
NCT03319316 Squamous Non-small Cell Lung C... More >>ancer Non-Squamous Non-small Cell Lung Cancer Less << Phase 2 Not yet recruiting November 2022 -
NCT01703910 Adenocarcinoma of Colon ... More >> Adenocarcinoma of Rectum Metastatic Disease Less << Phase 2 Completed - Spain ... More >> Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain, 28950 Hospital Madrid Norte Sanchinarro Madrid, Spain, 28050 Less <<
NCT02701231 Lung Neoplasms Not Applicable Recruiting December 2020 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Liang-An Chen, MD, phD    8610-55499027    chenla301@263.net    Principal Investigator: Liang-An Chen, MD, phD          China, Shandong Affiliated hospital of Shandong University of traditional Chinese medicine Not yet recruiting Jinan, Shandong, China, 250011 Shandong Provincial Hospital Not yet recruiting Jinan, Shandong, China, 250021 China, Shanxi Xijing Hospital affiliated to the Fourth Military Medical University Not yet recruiting Xi'an, Shanxi, China, 710032 Less <<
NCT02805530 Carcinoma, Non-Small-Cell Lung... More >> Synchronous Neoplasms Less << Not Applicable Recruiting December 2017 Mexico ... More >> Instituto Nacional de Cancerologia Recruiting Mexico City, Mexico, 14080 Contact: Oscar Arrieta    015556280400    ogarrieta@gmail.com Less <<
NCT01241682 Malignant (Pleural) Mesothelio... More >>ma Less << Phase 1 Completed - Netherlands ... More >> Erasmus Medical Center Rotterdam, Zuid-Holland, Netherlands, 3000 CA Less <<
NCT02998528 Non Small Cell Lung Cancer Phase 3 Recruiting November 8, 2028 -
NCT01951586 - Completed - -
NCT01868022 Neoplasms Phase 1 Completed - -
NCT03770299 Non-Small Cell Lung Cancer ... More >> Non-Small-Cell Lung Carcinoma Circulating Tumor DNA Less << Phase 2 Not yet recruiting March 14, 2024 United States, Florida ... More >> Local Institution Not yet recruiting Jacksonville, Florida, United States, 32224 Contact: Site 0015          United States, Kentucky Local Institution Not yet recruiting Lexington, Kentucky, United States, 40503-1489 Contact: Site 0014          United States, South Carolina Local Institution Not yet recruiting Charleston, South Carolina, United States, 29414 Contact: Site 0010          United States, Texas Local Institution Not yet recruiting Tyler, Texas, United States, 75701 Contact: Site 0013          Germany Local Institution Not yet recruiting Gauting, Germany, 82131 Contact: Site 0005          Local Institution Not yet recruiting Grosshansdorf, Germany, 22927 Contact: Site 0006          Local Institution Not yet recruiting Heidelberg, Germany, 69126 Contact: Site 0007          Switzerland Local Institution Not yet recruiting Lausanne, Switzerland, 1011 Contact: Site 0009          Local Institution Not yet recruiting Zuerich, Switzerland, 8091 Contact: Site 0008          United Kingdom Local Institution Not yet recruiting London, United Kingdom, NW1 2BU Contact: Site 0001 Less <<
NCT01209520 Lung Cancer N... More >>on Small Cell Lung Carcinoma Hypermethylation Less << Not Applicable Completed - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 Less <<
NCT01209520 - Completed - -
NCT02477826 Non-Small Cell Lung Cancer Phase 3 Recruiting December 31, 2020 -
NCT03064854 Non-small Cell Lung Cancer Phase 1 Recruiting February 15, 2022 -
NCT03164616 Non Small Cell Lung Cancer NSC... More >>LC Less << Phase 3 Recruiting September 24, 2021 -
NCT03775486 Non-small Cell Lung Cancer NSC... More >>LC Less << Phase 2 Not yet recruiting May 23, 2022 -
NCT01067794 - Completed - -
NCT03353675 NSCLC Phase 2 Recruiting September 2020 United States, North Carolina ... More >> Charlotte Recruiting Charlotte, North Carolina, United States, 28204 United States, Tennessee Nashville Recruiting Nashville, Tennessee, United States, 37203 Belgium Libramont Recruiting Libramont, Belgium Denmark Herlev Recruiting Herlev, Denmark France Créteil Recruiting Créteil, France Mulhouse Recruiting Mulhouse, France Rennes Recruiting Rennes, France Strasbourg Recruiting Strasbourg, France Hungary Budapest Recruiting Budapest, Hungary Szekesfehervar Recruiting Szekesfehervar, Hungary Less <<
NCT02453282 Non-Small-Cell Lung Carcinoma ... More >>NSCLC Less << Phase 3 Active, not recruiting December 31, 2019 -
NCT03509012 Carcinoma, Squamous Cell of He... More >>ad and Neck Carcinoma, Non-Small-Cell Lung Small Cell Lung Carcinoma Less << Phase 1 Recruiting April 4, 2022 United States, Arizona ... More >> Research Site Recruiting Tucson, Arizona, United States, 85719 United States, Colorado Research Site Recruiting Aurora, Colorado, United States, 80045 United States, Missouri Research Site Not yet recruiting Saint Louis, Missouri, United States, 63110 United States, New Jersey Research Site Withdrawn Middletown, New Jersey, United States, 07748 Japan Research Site Recruiting Koto-ku, Japan, 135-8550 Research Site Recruiting Sunto-gun, Japan, 411-8777 Korea, Republic of Research Site Recruiting Seoul, Korea, Republic of, 03080 Research Site Recruiting Seoul, Korea, Republic of, 03722 Research Site Recruiting Seoul, Korea, Republic of, 05505 Research Site Recruiting Seoul, Korea, Republic of, 135-710 Taiwan Research Site Not yet recruiting Kaohsiung, Taiwan, 807 Research Site Not yet recruiting Taipei, Taiwan, 10002 Less <<
NCT01665417 EGFR Positive Non-small Cell L... More >>ung Cancer Adenocarcinoma Less << Phase 4 Recruiting December 2017 China, Beijing ... More >> Chinese People's Liberation Army (PLA) General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Jiao Shunchang, MD    0086-13801380677       Principal Investigator: Jiao Shunchang, MD Less <<
NCT00312728 Non-Small Cell Lung Cancer ... More >> Brain Neoplasms Less << Phase 2 Completed - -
NCT03257267 Recurrent or Metastatic, Plati... More >>num-refractory Cervical Cancer Less << Phase 3 Recruiting June 7, 2023 -
NCT03348904 Lung Cancer Phase 3 Terminated(Study halted premat... More >>urely and will not resume; participants are no longer being examined or receiving intervention.) Less << - United States, California ... More >> Pacific Cancer Medical Center, Inc Anaheim, California, United States, 92801 United States, Kansas Cancer Center of Kansas Wichita, Kansas, United States, 67214 Less <<
NCT01725165 Lung Cancer Phase 2 Active, not recruiting November 2019 United States, Colorado ... More >> University of Colorado Denver, Colorado, United States, 80204 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Ontario London Health Sciences Centre London, Ontario, Canada, N6A 5W9 Less <<
NCT02045446 Stage IV Non-Small Cell Lung C... More >>ancer Less << Phase 2 Active, not recruiting December 2020 United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75235 Less <<
NCT00312728 - Completed - -
NCT02723955 Cancer Phase 1 Recruiting May 18, 2020 United States, California ... More >> GSK Investigational Site Recruiting Duarte, California, United States, 91010 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, New York GSK Investigational Site Recruiting New York, New York, United States, 10016 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting New York, New York, United States, 10032 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Pennsylvania GSK Investigational Site Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Tennessee GSK Investigational Site Recruiting Nashville, Tennessee, United States, 37203 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Nashville, Tennessee, United States, 37232-6307 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Australia, Victoria GSK Investigational Site Recruiting Heidelberg, Victoria, Australia, 3084 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Melbourne, Victoria, Australia, 3000 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Australia, Western Australia GSK Investigational Site Recruiting Nedlands, Western Australia, Australia, 6009 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Canada, Ontario GSK Investigational Site Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    France GSK Investigational Site Not yet recruiting Bordeaux Cedex, France, 33076 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Not yet recruiting Lyon cedex 08, France, 69373 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Paris, France, 75005 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Villejuif cedex, France, 94805 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Italy GSK Investigational Site Recruiting Siena, Toscana, Italy, 53100 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Netherlands GSK Investigational Site Recruiting Amsterdam, Netherlands, 1066 CX Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    Spain GSK Investigational Site Recruiting Barcelona, Spain, 08035 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Barcelona, Spain, 08036 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Madrid, Spain, 28040 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Málaga, Spain, 29010 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    GSK Investigational Site Recruiting Sevilla, Spain, 41009 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT02574078 Non-Small Cell Lung Cancer Phase 1 Phase 2 Active, not recruiting April 15, 2019 -
NCT01510990 Non-small Cell Lung Cancer Phase 2 Unknown November 2015 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Sang-We Kim, M.D.    82-2-3010-3215    swkim@amc.seoul.kr    Principal Investigator: Sang-We Kim, M.D. Less <<
NCT02542293 Non Small Cell Lung Carcinoma ... More >>NSCLC Less << Phase 3 Active, not recruiting March 29, 2019 -
NCT01376310 Cancer Phase 2 Completed - -
NCT02151981 Anticancer Treatment Phase 3 Active, not recruiting December 30, 2020 -
NCT01997775 Non-small Cell Lung Cancer Phase 2 Terminated(Difficult enrollmen... More >>t) Less << - Taiwan ... More >> National Cheng-Kung Uni. Hosp. Tainan, Taiwan, 704 Less <<
NCT02151981 - Active, not recruiting - -
NCT01899989 Non-small Cell Lung Cancer Phase 1 Recruiting July 2019 United States, New Jersey ... More >> Memorial Sloan Kettering Cancer Center at Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Andreas Rimner, MD    212-639-6025       United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Andreas Rimner, MD    212-639-6025       Contact: Jamie Chaft, MD    646-888-4545       Principal Investigator: Andreas Rimner, MD          Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: Andreas Rimner, MD    212-639-6025       Contact: Jamie Chaft, MD    646-888-4545       Principal Investigator: Andreas Rimner, MD Less <<
NCT02455843 Non Small Cell Lung Cancer Phase 3 Recruiting May 2018 China, Shandong ... More >> Binzhou Medical University Hospital Recruiting Binzhou, Shandong, China, +86 256600 Contact: Shao shui Chen, M.D    +86 15169959936    byfychenss@126.com    Dezhou People's Hospital Recruiting Dezhou, Shandong, China, +86 253000 Contact: Yu ting Dong    +86 13969286066    dyt1963@163.com    The Second People's Hospital of Dezhou Recruiting Dezhou, Shandong, China, +86 253000 Contact: Chun tang Wang, M.D    +86 13181378288    dzeyxwct@sina.com    Jinan Military General Hospital Recruiting Jinan, Shandong, China, +83 250001 Contact: Jing wang Bi, M.D    +86 15963119538    jingwangbi@outlook.com    Affliated Hospital of Shandong Academy of Medical Sciences Recruiting Jinan, Shandong, China, +86 250001 Contact: Ya hong Sun, M.D    13606415915    sunyahong0915@163.com    Shandong Provincial Hospital Recruiting Jinan, Shandong, China, +86 250001 Contact: Xin Ye, M.D    +86 0531-68773171    yexintaian2014@163.com    Affliated Hospital of Jining Medical University Recruiting Jining, Shandong, China, +86 272000 Contact: Jun ye Wang, M.D    +86 13563771996    jiningwangjunye@163.com    Liaocheng Cancer Hospital Recruiting Liaocheng, Shandong, China, +86 252000 Contact: Qing liang Feng, M.D    +86 15339949567    fql-123@sohu.com    The People's Hospital of Pingyi Country Recruiting Linyi, Shandong, China, +86 276000 Contact: Xing lu Xu, M.D    +86 18265398816    xlk2082@126.com    Affliated Hospital of Taishan Medical University Recruiting Taian, Shandong, China, +86 271000 Contact: Ben hua Zhang, M.D    +86 15169887577    zhangbenhua1964@163.com    The People's Liberation Army 88 Hospital Recruiting Taian, Shandong, China, +86 271000 Contact: Li cheng Zhang, M.D    +86 13605383651    zhanglc88@aliyun.com    Weifang People's Hospital Recruiting Weifang, Shandong, China, +86 262000 Contact: Guo hua Yu, M.D    +86 13685368817    ghyry@126.com    Yantai Yuhuangding Hospital Recruiting Yantai, Shandong, China, +86 264000 Contact: Liang ming Zhang, M.D    +86 18660079893    zhanglmdr@163.com    Tengzhou center of people's hospital Recruiting Zaozhuang, Shandong, China, +86 277000 Contact: Kai xian Zhang, M.D    +86 18663069829    kaixianzhang@aliyun.com Less <<
NCT03085914 Solid Tumors ... More >>Colorectal Cancer (CRC) Adenocarcinoma (PDAC) Lung Cancer UC (Urothelial Cancer) Head and Neck Cancer Less << Phase 1 Phase 2 Active, not recruiting January 2020 United States, Arizona ... More >> Mayo Clinic Arizona Phoenix, Arizona, United States, 85054 United States, California University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States, 92093 The Angeles Clinic and Research Institute Los Angeles, California, United States, 90025 United States, Florida Mayo Clinic Jacksonville, Florida, United States, 32224 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Carolina Bio-Oncology Institute, PLLC Huntersville, North Carolina, United States, 28078 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Pennsylvania University of Pennsylvania Health System Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15237 United States, Tennessee Tennessee Oncology - Nashville; The Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Vanderbilt University; Henry Joyce Cancer Clinic Nashville, Tennessee, United States, 37232 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT02132143 Lung Adenocarcinoma Patients W... More >>ith Postoperative in pN2 Less << Not Applicable Unknown January 2017 China ... More >> The People's Hospital of Guangxi Zhuang Autonomous Region Recruiting Nanning Shi, China, 530021 Contact: Hui Lin    8613878133266    linhui33266@sina.com Less <<
NCT02489903 Small Cell Carcinoma ... More >> Carcinoma, Non-Small-Cell Lung Neuroendocrine Tumors Ovarian Epithelial Cancer Less << Phase 2 Recruiting July 2020 United States, California ... More >> Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Melanie San Pedro-Salcedo    650-724-1388    msanpedro@stanford.edu    Principal Investigator: Sukhmani Padda, MD          United States, Connecticut VA Connecticut Cancer Center Recruiting West Haven, Connecticut, United States, 06516 Contact: Jessica Jordan    203-932-5711 ext 3287    jessica.jordan@va.gov    Principal Investigator: Michal Rose, MD          United States, Indiana Memorial Hospital of South Bend Recruiting South Bend, Indiana, United States, 46601 Contact: Amie Lake    574-647-6784    ALake@beaconhealthsystem.org    Contact: Mary Jane Danner    574-647-7309    MDanner@beaconhealthsystem.org    Principal Investigator: Thomas J Reid, MD, PhD          United States, Kentucky Baptist Health Recruiting Lexington, Kentucky, United States, 40503 Contact: Stephanie Cason    859-260-3197    stephanie.cason@bhsi.com    Contact: Micheal F Stephens    859-260-6456    micheal.stephens@BHSI.com    Principal Investigator: Arvinda Padmanabhan, MD          United States, Maryland Walter Reed National Military Medical Center Recruiting Bethesda, Maryland, United States, 20889 Contact: Sonja Skeete    301-319-4599    sonja.t.skeete.ctr@mail.mil    Principal Investigator: Karen Zeman, MD          United States, Michigan Henry Ford Allegiance Health Recruiting Jackson, Michigan, United States, 49201 Contact: Kris Strzalkowski, RN    517-205-1522    KSTRZAL1@hfhs.org    Contact: Natalie Peterson, RN OCN    (517) 205-1549    npeters8@hfhs.org    Principal Investigator: Malcolm Trimble, MD          United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Dan Blume    314-362-0872    dan.blume@wustl.edu    Principal Investigator: Daniel Morgensztern, MD          United States, Ohio University of Cincinnati Cancer Institute Recruiting Cincinnati, Ohio, United States, 45267 Contact: Lauren Hendricks    513-584-5725    hendrilu@ucmail.uc.edu    Principal Investigator: John C Morris, MD          United States, Tennessee University of Tennessee Medical Center Withdrawn Knoxville, Tennessee, United States, 37920 United States, Virginia Virginia Cancer Specialists Recruiting Fairfax, Virginia, United States, 22031 Contact: Karin Choquette, MSN, RN    703-208-9268    Karin.Choquette@USONCOLOGY.COM    Principal Investigator: Alexander Spira, MD          United States, West Virginia West Virginia University Recruiting Morgantown, West Virginia, United States, 26506 Contact: Carla Ross, RN    304-581-1158    cjross@hsc.wvu.edu    Principal Investigator: Patrick Ma, MD Less <<
NCT00989690 Lung Cancer Phase 3 Unknown - Italy ... More >> Istituto Scientifico H. San Raffaele Recruiting Milan, Italy, 20132 Contact: Vanesa Gregor, MD    39-02-2643-7623 Less <<
NCT02284308 NSCLC Not Applicable Recruiting July 2023 Belgium ... More >> University Hospital Gent Not yet recruiting Gent, Belgium, 9000 Contact: Veerle Surmont          Netherlands Radiotherepiegroep Recruiting Arnhem, Gelderland, Netherlands, 6815 AD Principal Investigator: Marcel Stam          Caniusius-Wilhelmina Hospital Recruiting Nijmegen, Gelderland, Netherlands, 6532 SZ Principal Investigator: Yvonne Berk          Ziekenhuisgroep Twente Recruiting Almelo, Overijssel, Netherlands, 7609 PP Principal Investigator: Jeske Staal          Deventer Hospital Recruiting Deventer, Overijssel, Netherlands, 7416 SE Principal Investigator: Suzy Samii          Radiotherapiegroep Recruiting Deventer, Overijssel, Netherlands, 7416 SE Principal Investigator: Ernest Vonk          Gelre ziekenhuis Recruiting Apeldoorn, Netherlands Contact: N Pronk, Dr.          Principal Investigator: N Pronk          Rijnstate Ziekenhuis Recruiting Arnhem, Netherlands, 6815 AD Contact: Niels Claessens          Amphia Ziekenhuis Not yet recruiting Breda, Netherlands, 4818 CK Contact: Joachim Aerts          Medical Centre Haaglanden Recruiting Den Haag, Netherlands, 2512 VA Contact: Klaar Maas          Catharina Hospital Eindhoven Recruiting Eindhoven, Netherlands, 5623 EJ Contact: Ben van den Borne          Zuyderland Recruiting Heerlen, Netherlands, 6419 PC Principal Investigator: Gerben Bootsma          Leiden University Medical Centre Not yet recruiting Leiden, Netherlands, 2333 ZC Contact: Rajen Ramai          MAASTRO clinic Recruiting Maastricht, Netherlands, 6229 ET Contact: Judith van Loon, MD, PhD    +31 88 44 55 666    judith.vanloon@maastro.nl    Contact: Nadja Drummen    +31 88 44 55 817    nadja.drummen@maastro.nl    Principal Investigator: Judith van Loon          Maastricht University Medical Center Recruiting Maastricht, Netherlands, 6229 HX Contact: Anne-Marie Dingemans, MD, PhD    +31 43 387 65 43    a.dingemans@maastro.nl    Principal Investigator: Anne-Marie Dingemans          University Medical Centre Nijmegen Recruiting Nijmegen, Netherlands, 6525 GA Principal Investigator: Olga Schuurbiers          Laurentius Hospital Recruiting Roermond, Netherlands, 6043 VC Contact: Cordula Pitz          VieCuri Medical Centre Recruiting Venlo, Netherlands, 5912 BL Contact: Marcel Westenend Less <<
NCT02383212 Advanced Cancer ... More >> Advanced Malignancies Less << Phase 1 Active, not recruiting December 20, 2019 -
NCT01770418 Lung Neoplasms Phase 1 Phase 2 Recruiting - United States, Florida ... More >> University of Florida Proton Therapy Institute Recruiting Jacksonville, Florida, United States, 32206 Contact: Samantha Sago    904-588-1529    SSago@floridaproton.org    Principal Investigator: Brad Hoppe, MD          United States, Illinois Northwestern Medicine Chicago Proton Center Recruiting Warrenville, Illinois, United States, 60555 Contact: Megan Boroczk    630-315-1797    Megan.Boroczk@nm.org    Principal Investigator: John Chang, MD          United States, Maryland Maryland Proton Treatment Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Carl Brown    410-364-5353    CarlBrown@umm.edu    Principal Investigator: Pranshu Mohindra, MD          United States, New Jersey Princeton ProCure Management LLC Recruiting Somerset, New Jersey, United States, 08873 Contact: Heba Darwish    732-357-2676    heba.darwish@nj.procure.com    Principal Investigator: Brian Chon, MD          United States, Oklahoma ProCure Proton Therapy Center Recruiting Oklahoma City, Oklahoma, United States, 73142 Contact: Kayla Tarrant    405-773-6775    research@okc.procure.com    Principal Investigator: Gary Larson, MD          United States, Virginia Hampton University Proton Therapy Institute Recruiting Hampton, Virginia, United States, 23666 Contact: Donna Sternberg, RN, BSN, OCN    757-251-6839    Donna.Sternberg@hamptonproton.org    Principal Investigator: Christopher Sinesi, MD Less <<
NCT01119664 Mesothelioma Phase 1 Phase 2 Unknown - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03003962 Non Small Cell Lung Carcinoma ... More >>NSCLC Less << Phase 3 Recruiting December 31, 2020 -
NCT01850147 Cancer Lung C... More >>ancer Less << Phase 2 Unknown December 2014 China ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, China, 100021 Less <<
NCT01564329 Advanced Primary Lung Adenocar... More >>cinoma Less << Phase 2 Unknown July 2013 China, Sichuan ... More >> The Department of Thoracic Oncology in West China Hospital of Sichuan University Recruiting Chengdu, Sichuan, China, 610041 Contact: Meijuan Huang, MD          Contact: You Lu, MD Less <<
NCT01533727 Non-small Cell Lung Cancer Phase 2 Withdrawn(Few patients would l... More >>ike to participate ,since CIK cell transfusion was a new treatment and its efficacy was doubted.) Less << December 2020 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT00705549 Non-Small-Cell Lung Cancer Phase 2 Terminated(Due to poor accrual... More >>) Less << - Greece ... More >> University General Hospital of Alexandroupolis, Dept. of Medical Oncology Alexandroupolis, Greece "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece 401 Military Hospital, Medical Oncology Unit Athens, Greece Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece Sismanogleio General Hospital, 1st, 2nd Dep of Pulmonary Diseases Athens, Greece Sotiria" General Hospital, 1st, 3rd, 8th Dep of Pulmonary Diseases Athens, Greece "Metaxa's" Anticancer Hospital of Piraeus,1st Dep of Medical Oncology Piraeus, Greece "Theagenion" Anticancer Hospital of Thessaloniki Thessaloniki, Greece Less <<
NCT01358968 Cancer Phase 1 Completed - United States, Tennessee ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States, 38120 Less <<
NCT00003706 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Texas ... More >> San Antonio Cancer Institute San Antonio, Texas, United States, 78229-3264 Less <<
NCT00034489 Breast Neoplasms Phase 2 Completed - United States, Minnesota ... More >> Rochester, Minnesota, United States Less <<
NCT01358968 - Completed - -
NCT03656094 Non-small Cell Lung Cancer Met... More >>astatic Less << Phase 2 Not yet recruiting November 1, 2021 Korea, Republic of ... More >> Jong-Mu Sun Not yet recruiting Seoul, Korea, Republic of, 06351 Contact: Jong-Mu Sun    82234103459 ext 82234103459    jongmu.sun@skku.edu Less <<
NCT00577707 - Completed - -
NCT01257139 Non Small-cell Lung Cancer Phase 3 Completed - France ... More >> CH du Pays d'Aix Aix en Provence, France CHU Amien Picardie Amiens, France Centre Hospitalier Universitaire d'Angers Angers, France Centre Hospitalier d'Annecy Annecy, France Centre Hospitalier Général de la Fontonne Antibes Antibes, France CH de Bastia Bastia, France Centre Hospitalier de Beauvais Beauvais, France CHU Bordeaux Hôpital Haut Lévêque Bordeaux Pessac, France Centre Hospitalier Universaitaire de Brest Brest, France HIA Tonnerre Brest, France Centre François Baclesse Caen, France CH René Dubos - Pontoise Cergy Pontoise, France Centre Hospitalier Charleville mézières Charleville Mézières, France CHI Créteil Créteil, France Centre hospitalier de Draguignan Draguignan, France Centre Hospitalier de Elbeuf Elbeuf, France CH Gap Gap, France CH La Roche sur Yon La Roche sur Yon, France Hôpital A Mignot Le Chesnay Le Chesnay, France Centre Omar Lambret Lille, France Hôpital du Cluzeau Limoges, France CHR Longjumeau Longjumeau, France Centre Hospitalier de Bretagne Sud Lorient, France Hôpital de la Croix Rousse Lyon, France Centre Hospitalier Mantes La Jolie, France Hôpital Sainte Marguerite Marseille, France Institut Paoli-Calmette Marseille, France Centre Hospitalier Martigues, France Hôpital Saint Farron Meaux, France Centre Hospitalier de Mulhouse Mulhouse, France CHR Orléans Orléans, France Paris Hôpital saint Antoine Paris, France Centre Catalan Perpignan, France Centre Hospitalier de Périgueux Périgueux, France Rennes Hospital University Rennes, France, 35033 CHU Rouen Hôpital Boisguillaume Rouen, France Hôpital Charles Nicolle Rouen, France Hôpital Yves Le Foll saint Brieuc, France CHU Saint Etienne - Hôpital Nord Saint Etienne, France Centre Hospitalier Général Salon de Provence Salon de Provence, France Institut de Cancérologie de la Loire St Priest en Jarez, France Hôpital d'Instruction des Armées Toulon Naval, France Hôpital Font-Pre Toulon, France CHU Touloues Toulouse, France Centre Hospitalier De Villefranche sur Saone Villefranche sur Saone, France Less <<
NCT00859495 Pleural Mesothelioma Phase 2 Unknown December 2014 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Less <<
NCT01343264 - Unknown - Germany ... More >> Dr. Horst Schmidt Klinik, Department of Thoracic Surgery Recruiting Wiesbaden, Germany Contact: Joachim Schirren, MD, PhD    +49 611 433132    joachim.schirren@hsk-wiesbaden.de    Principal Investigator: Joachim Schirren, MD, PhD          Sub-Investigator: Servet Bölükbas, MD, PhD Less <<
NCT02264990 Non-squamous Non-small Cell Lu... More >>ng Cancer Less << Phase 3 Active, not recruiting July 26, 2019 -
NCT02507518 Non-small Cell Lung Cancer Phase 2 Recruiting March 2019 France ... More >> CHU Rouen-Hôpital Bois-Guillaume Recruiting Bois-Guillaume, France, 76230 Contact: Dominique Paillotin, MD    +33232889083    dominique.paillotin@chu-rouen.fr    CH Dieppe Recruiting Dieppe, France, 76200 Contact: Julie Tillon, MD    +33232888031    julie.tillon@chu-rouen.fr    Centre hospitalier intercommunal Elbeuf Louviers Recruiting Elbeuf, France, 76500 Contact: Pierre-Alexandre Hauss, MD    02 32 82 21 45    pierre-alexandre.hauss@chi-elbeuf-louviers.fr    Centre Henri Becquerel Recruiting Rouen, France, 76000 Contact: Stephanie Becker, MD    +33232082258    stephanie.becker@chb.unicancer.fr    CHU Rouen Recruiting Rouen, France, 76000 Contact: Suzanna Bota, MD    +33232888287    suzanna.bota@chu-rouen.fr Less <<
NCT00577707 Non Small Cell Lung Cancer ... More >> Lung Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT03762018 Pleural Mesothelioma Malignant... More >> Advanced Less << Phase 3 Not yet recruiting December 31, 2024 -
NCT02859077 Non-Small-Cell Lung Cancer Phase 3 Unknown July 2018 -
NCT03758677 Non Small Cell Lung Cancer Phase 2 Not yet recruiting November 20, 2021 China, Jilin ... More >> The First Hospital of Jilin University Not yet recruiting Changchun, Jilin, China, 130021 Contact: Kewei Ma    008613756060506    makw@jlu.edu.cn    Contact: Yinghui Xu    008613944826247    305682733@qq.com Less <<
NCT02921984 Salivary Gland Tumors ... More >> Head and Neck Cancer Less << Phase 1 Completed - China, Shanghai ... More >> Shanghai ninth people's hospital Shanghai, Shanghai, China, 200011 Less <<
NCT02220894 Non-small Cell Lung Cancer Phase 3 Active, not recruiting January 31, 2020 -
NCT02761863 - Not yet recruiting July 30, 2021 -
NCT00095225 Non-Small-Cell Lung Carcinoma ... More >> Neoplasm Recurrence, Local Less << Phase 2 Completed - -
NCT01447225 Solid Tumors Phase 1 Completed - United States, Indiana ... More >> Lafayette, Indiana, United States, 47905 United States, New York Buffalo, New York, United States, 14263 United States, Ohio Cincinnati, Ohio, United States, 45267 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19111 France Villejuif, France Less <<
NCT01447225 - Completed - -
NCT00003711 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Texas ... More >> Brooke Army Medical Center Fort Sam Houston, Texas, United States, 78234 San Antonio Cancer Institute San Antonio, Texas, United States, 78229 Less <<
NCT01395758 - Completed - -
NCT01098266 Malignant Pleural Mesothelioma Phase 3 Completed - -
NCT00766246 Non-small Cell Lung Cancer Sta... More >>ge IIIB Non-small Cell Lung Cancer Stage IV Less << Phase 2 Terminated(Withdrawal of fundi... More >>ng support) Less << - -
NCT02795884 NSCLC Phase 3 Withdrawn(Because of reconside... More >>ration of using erlotinib(EGFR Tyrosine kinase inhibitor) as adjuvant aim) Less << November 2020 -
NCT01395758 Metastatic Non-Small Cell Lung... More >> Cancer Less << Phase 2 Completed - United States, California ... More >> Stanford, California, United States, 94305 United States, District of Columbia Washington, District of Columbia, United States, 20057 United States, Florida Weston, Florida, United States, 33331 United States, Georgia Atlanta, Georgia, United States, 30341 United States, Illinois Chicago, Illinois, United States, 60611 United States, Kansas Kansas City, Kansas, United States, 66160 United States, Maryland Baltimore, Maryland, United States, 21205 United States, Massachusetts Boston, Massachusetts, United States, 02114 Burlington, Massachusetts, United States, 01805 United States, New York New York, New York, United States, 10016 United States, Pennsylvania Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Dallas, Texas, United States, 75390 Less <<
NCT02784171 Mesothelioma Phase 2 Recruiting December 2019 Canada, Alberta ... More >> Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Desiree Hao    403 521-3706       Cross Cancer Institute Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Quincy Chu    780 432-8248       Canada, British Columbia BCCA - Cancer Centre for the Southern Interior Recruiting Kelowna, British Columbia, Canada, V1Y 5L3 Contact: Delia Sauciuc    250 712-3900 ext 683930       BCCA - Fraser Valley Cancer Centre Recruiting Surrey, British Columbia, Canada, V3V 1Z2 Contact: Christopher Lee    604 930-4017       Canada, Manitoba CancerCare Manitoba Recruiting Winnipeg, Manitoba, Canada, R3E 0V9 Contact: David Dawe    204 787-8644       Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Recruiting Hamilton, Ontario, Canada, L8V 5C2 Contact: John Goffin    905 387-9495       London Regional Cancer Program Recruiting London, Ontario, Canada, N6A 5W9 Contact: Mark D. Vincent    519 685-8640       Ottawa Hospital Research Institute Recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: Paul Wheatley-Price    613 737-7700 ext 79859       University Health Network Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Penelope A. Bradbury    416 946-4501 ext 3544       Canada, Quebec CHUM-Centre Hospitalier de l'Universite de Montreal Recruiting Montreal, Quebec, Canada, H2X 3E4 Contact: Marie Florescu    514 890-8444       The Research Institute of the McGill University Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Scott Owen    514 398-8307       University Institute of Cardiology and Recruiting Quebec City, Quebec, Canada, G1V 4G5 Contact: Catherine Labbe    418 656-8711 ext 5504       Canada, Saskatchewan Allan Blair Cancer Centre Recruiting Regina, Saskatchewan, Canada, S4T 7T1 Contact: Mussawar Iqbal    306 766-2691       Italy Oncologia SS Antonio e Biagio Alessandria Recruiting Alessandria, AL, Italy, 15121 Contact: Federica Grosso          Azienda Ospedaliera San Giuseppe Moscati Recruiting Avellino, AV, Italy, 83100 Contact: Gridelli Cesare          Oncologia Medica Humanitas Gavazzeni Bergamo Not yet recruiting Bergamo, BG, Italy, 24125 Contact: Giovanni Luca Ceresoli          Azienda Ospedaliera Garibaldi Nesima Recruiting Catania, CT, Italy, 95123 Contact: Roberto Bordonaro          Oncologia Medica IRCCS Arcispedale Maria Recruiting Reggio Emilia, RE, Italy, 42123 Contact: Maria Pagano          Istituti Fisioterapici Ospitalieri IFO Istituto Recruiting Rome, RM, Italy, 00144 Contact: Fabiana Letizia Cecere          PO A Perrino ASL Brindisi - UOC Oncologia Medica Recruiting Brindisi, Italy, 72100 Contact: Saverio Cinieri          AOU Policlinico Vittorio Emanuele UOC di Oncologia Recruiting Catania, Italy, 95125 Contact: Hector Jose Soto Parra    2 8224-4459       U.O. di Oncologia Ospedale Villa Scassi Recruiting Genova, Italy, 16149 Contact: Manlio Mencoboni    010 410-2639       Intstituto Scientifico Romangnolo Recruiting Meldola, Italy, 47014 Contact: Marco Angelo Burgio    054 373-9100       Instituto Nazionale Tumori Recruiting Milan, Italy Contact: Maria Chiara Garassino          U.O.C. di Oncologia U.L.S.S. 13 Recruiting Mirano, Italy, 30035 Contact: Francesco Rosetti    3904 1579-4002       Azienda Ospedaliera di Rilievo Nazionale Not yet recruiting Napoli, Italy, 80131 Contact: Giacomo Carteni          Dott. Fortunato Ciardiello,Cattedra Oncologia Medica Recruiting Napoli, Italy, 80131 Contact: Fortunato Ciardiello    081 566-6745       Unita Sperimentazioni Cliniche Istituto per lo Recruiting Napoli, Italy, 80131 Contact: Alessandro Morabito    081 590-3571       Azienda USL di Piacenza, Ospedale Gugliemimo Salieto Recruiting Piacenza, Italy, 29100 Contact: Luigi Cavanna    052 330-2697 Less <<
NCT03307785 Metastatic Cancer ... More >> Advanced Cancer Solid Tumor Non Small Cell Lung Cancer Metastatic Non Small Cell Lung Cancer Stage IIIB Non Small Cell Lung Cancer Less << Phase 1 Recruiting March 2020 United States, Arizona ... More >> Honor Health Recruiting Scottsdale, Arizona, United States, 85258 Principal Investigator: Jasgit Sachdev, MD          United States, California California Cancer Associates for Research and Excellence (cCare) Recruiting Encinitas, California, United States, 92024 Principal Investigator: Alberto Bessudo, MD          United States, Florida Florida Cancer Specialist Recruiting Sarasota, Florida, United States, 34232 Principal Investigator: Manish Patel, MD          United States, Ohio Gabrail Cancer Center Research Recruiting Canton, Ohio, United States, 44718 Principal Investigator: Nashat Gabrail, MD          United States, Tennessee Tennessee Oncology Recruiting Nashville, Tennessee, United States, 37203 Principal Investigator: Erika Hamilton, MD          United States, Texas MD Anderson Recruiting Houston, Texas, United States, 77030 Principal Investigator: Timothy Yap, MD Less <<
NCT02037997 Non Small Cell Lung Cancer Phase 2 Unknown December 2017 China, Shanghai ... More >> Cancer hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Chang J hua, PD    13916619284    changjianhua@163.com Less <<
NCT01443078 Lung Cancer Phase 2 Completed - United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT01443078 - Completed - -
NCT02603003 Non-small Cell Lung Cancer(NSC... More >>LC) Less << Phase 1 Active, not recruiting December 2019 -
NCT01707329 Non-small Cell Lung Cancer Phase 2 Unknown December 2016 China, Hunan ... More >> Hunan Province Tumor Hospital Active, not recruiting Changsha, Hunan, China, 410205 China, Zhejiang Sir Run Run Shaw Hospital Active, not recruiting Hangzhou, Zhejiang, China, 310000 The First Affiliated Hospital of Medical School of Zhejiang University Active, not recruiting Hangzhou, Zhejiang, China, 310000 The Second Affiliated Hospital of Zhejiang University School of Medicine Active, not recruiting Hangzhou, Zhejiang, China, 310000 Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310000 Contact: Zhang Yi Ping, M.D.    0086-13750881678    zyp@medmail.com.cn    Principal Investigator: Zhang Yi Ping, M.D.          The First Affiliated Hospital of Wenzhou Medical College Active, not recruiting Wenzhou, Zhejiang, China, 325000 Less <<
NCT01746277 Non Small Cell Lung Cancer Phase 2 Unknown June 2016 China ... More >> Department of Respiratory Medicne, Peking Union Medical Hospital Recruiting Beijing, China, 100730 Contact: Mengzhao Wang, MD    010-69155039    mengzhaowang@sina.com    Contact: Jing Zhao, MD    010-69158206    zhaojing0@163.com    Sub-Investigator: Wei Zhong, MD Less <<
NCT02296671 Esophagogastric Cancer Phase 2 Withdrawn(Was unable to accrue... More >> any patients) Less << February 2022 -
NCT02276560 - Terminated(This study was term... More >>inated due to lack of funding.) Less << - -
NCT02276560 Stage IIIA Non-Small Cell Lung... More >> Cancer Less << Phase 2 Terminated(This study was term... More >>inated due to lack of funding.) Less << - United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Emory - Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Kansas University of Kansas Cancer Center Kansas City, Kansas, United States, 66160 United States, Louisiana Ochsner Cancer Institute New Orleans, Louisiana, United States, 70121 United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Rex Cancer Center and Rex of Wakefield Raleigh, North Carolina, United States, 27607 United States, Ohio Case Western Reserve University - Seidman Cancer Center Cleveland, Ohio, United States, 44106 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 United States, Washington Swedish Cancer Institute Seattle, Washington, United States, 98104 Less <<
NCT01982955 Non-small Cell Lung Cancer Phase 1 Phase 2 Active, not recruiting October 16, 2018 Germany ... More >> Please contact the Merck KGaA Communication Center located in Darmstadt, Germany Less <<
NCT02001168 Non-small Cell Lung Cancer Phase 3 Active, not recruiting October 2022 China, Xinjiang ... More >> Cancer Hospital of Xinjiang Medical University Urumqi, Xinjiang, China, 830011 Less <<
NCT02117167 Non-small Cell Lung Cancer Met... More >>astatic Less << Phase 2 Recruiting February 2022 France ... More >> Centre Hospitalier Henri Duffau Recruiting Avignon, France Contact: Nicolas CLOAREC, MD       nicolas.cloarec@ch-avignon.fr    Principal Investigator: Nicolas CLOAREC, MD          Centre Hospitalier Universitaire de Besancon - Hopital Jean Minjoz Recruiting Besancon, France Contact: Virginie WESTEEL, MD       virginie.westeel@univ.fcomte.fr    Principal Investigator: Virginie WESTEEL, MD          Hôpital Avicenne Recruiting Bobigny, France Contact: Boris DUCHEMANN, MD       boris.duchemann@aphp.fr    Principal Investigator: Boris DUCHEMANN, MD          Institut Bergonié Recruiting Bordeaux, France Contact: François Chomy, MD       f.chomy@bordeaux.unicancer.fr    Principal Investigator: François Chomy, MD          Hôpital Ambroise Paré Recruiting Boulogne Billancourt, France Contact: Etienne GIROUX LEPRIEUR, MD       etienne.giroux-leprieur@aphp.fr    Principal Investigator: Etienne GIROUX LEPRIEUR, MD          Hospices Civils de Lyon- Hôpital Louis Pradel Recruiting Bron, France Contact: Nicolas Girard, MD       nicolas.girard@chu-lyon.fr    Principal Investigator: Nicolas Girard, MD          Centre François Baclesse Recruiting Caen, France Contact: Radj Gervais, MD       r.gervais@baclesse.unicancer.fr    Principal Investigator: Radj Gervais, MD          CHU Caen Recruiting Caen, France Contact: Gérard Zalcman, MD       zalcman-g@chu-caen.fr    Principal Investigator: Gérard Zalcman, MD          Chu de Caen - Hopital Cote de Nacre Recruiting Caen, France Contact: Jeannick MADELAINE, MD       madelaine-j@chu-caen.fr    Principal Investigator: Jeannick MADELAINE, MD          Hôpital Louis Pasteur Recruiting Chartres, France Contact: Claire Lethrosne, MD       clethrosne@ch-chartres.fr    Principal Investigator: Claire Lethrosne, MD          centre Jean Perrin Recruiting Clermont-Ferrand, France Contact: Xavier Durando, MD       xavier.durando@cjp.fr    Principal Investigator: Xavier Durando, MD          CHU Clermont Ferrand - Hôpital Gabriel Montpied Recruiting Clermont-Ferrand, France Contact: Henri Janicot, MD       hjanicot@chu-clermontferrand.fr    Principal Investigator: Henri Janicot, MD          Hopitaux Civils de Colmar Recruiting Colmar, France Contact: Lionel MOREAU, MD       lionel.moreau@ch-colmar.fr    Principal Investigator: Lionel MOREAU, MD          Centre Hopsitalier Intercommunal de Créteil Recruiting Créteil, France Contact: Isabelle Monnet, MD       isabelle.monnet@chicreteil.fr    Principal Investigator: Isabelle Monnet, MD          Centre Georges François Leclerc Recruiting Dijon, France Contact: Bruno Coudert, MD       bcoudert@cgfl.fr    Principal Investigator: Bruno Coudert, MD          CHU Grenoble Recruiting Grenoble, France Contact: Denis Moro-Sibilot, MD       Dmoro-Sibilot@chu-grenoble.fr    Principal Investigator: Denis Moro-Sibilot, MD          Chd Vendee Recruiting La Roche Sur Yon, France Contact: Tifenn L'HARIDON, MD          Principal Investigator: Tifenn L'HARIDON, MD          CH du Mans Recruiting Le Mans, France Contact: Olivier Molinier, MD       omolinier@ch-lemans.fr    Principal Investigator: Olivier Molinier, MD          Centre Oscar Lambret Recruiting Lille, France Contact: Eric Dansin, MD       e-dansin@o-lambret.fr    Principal Investigator: Eric Dansin, MD          CHRU de Lille Recruiting Lille, France Contact: Alexis Cortot, MD       Alexis.CORTOT@CHRU-LILLE.FR    Principal Investigator: Alexis Cortot, MD          Centre Léon Bérard Recruiting Lyon, France Contact: Maurice Pérol, MD       maurice.perol@lyon.unicancer.fr    Principal Investigator: Maurice Pérol, MD          Hôpital Nord Recruiting Marseille, France Contact: Fabrice Barlesi, MD       fabrice.barlesi@ap-hm.fr    Principal Investigator: Fabrice Barlési, MD          Institut Paoli Calmettes Recruiting Marseille, France Contact: Anne MADROSZYK, MD       madroszyka@ipc.unicancer.fr    Principal Investigator: Anne MADROSZYK, MD          Institut de cancérologie de l'Ouest Recruiting Nantes, France Contact: Jaafar Bennouna, MD       jaafar.bennouna@ico.unicancer.fr    Principal Investigator: Jaafar Bennouna, MD          Centre Antoine Lacassagne Recruiting Nice, France Contact: Josiane OTTO, MD       josiane.otto@nice.unicancer.fr    Principal Investigator: Josiane OTTO, MD          Chr Orleans Recruiting Orleans, France Contact: Hugues MOREL, MD       hugues.morel@chr-orleans.fr    Contact: , MD          Principal Investigator: Hugues MOREL          AH-HP Hôpital Saint Louis Recruiting Paris, France Contact: Damien Pouessel, MD       damien.pouessel@sls.aphp.fr    Principal Investigator: Damien Pouessel, MD          AP-HP Hôpital Cochin Recruiting Paris, France Contact: Jeanne Chapron, MD       jeanne.chapron@cch.aphp.fr    Principal Investigator: Jeanne Chapron, MD          AP-HP Hôpital Européen Georges Pompidou Withdrawn Paris, France AP-HP Hôpital Tenon Recruiting Paris, France Contact: Marie Wislez, MD       marie.wislez@tnn.aphp.fr    Principal Investigator: Marie Wislez, MD          Institut Curie Recruiting Paris, France Contact: Catherine Daniel, MD       catherine.daniel@curie.fr    Principal Investigator: Catherine Daniel, MD          Centre Hospitalier de Pau Recruiting PAU, France Contact: Aldo RENAULT, MD       aldo.renault@ch-pau.fr    Principal Investigator: Aldo RENAULT, MD          Centre Hospitalier Lyon Sud Recruiting Pierre Bénite, France Contact: Jean-Pierre Souquet, MD       pierre-jean.souquet@chu-lyon.fr    Principal Investigator: Jean-Pierre Souquet, MD          CHR Pontchailloux Withdrawn Rennes, France Chru Strasbourg - Nouvel Hopital Civil Recruiting Strasbourg, France Contact: Philippe BARTHELEMY, MD          Principal Investigator: Philippe BARTHELEMY, MD          CHI de Toulon - Hôpital Sainte-Musse Recruiting Toulon, France Contact: Xavier TCHIKNAVORIAN, MD          Principal Investigator: Xavier TCHIKNAVORIAN, MD          CHU Toulouse -Hôpital Larrey Recruiting Toulouse, France Contact: Julien Mazières, MD       mazieres.j@chu-toulouse.fr    Principal Investigator: Julien Mazières, MD          Hôpital Bretonneau Recruiting Tours, France Contact: Eric Pichon, MD       e.pichon@chu-tours.fr    Principal Investigator: Eric Pichon, MD          Gustave Roussy Recruiting Villejuif, France Contact: Benjamin Besse, MD       Benjamin.BESSE@gustaveroussy.fr    Principal Investigator: Benjamin Besse, MD          Sub-Investigator: Jean-Charles Soria, MD Less <<
NCT01336543 Stage III Non-small Cell Lung ... More >>Cancer Less << Phase 2 Withdrawn(Low accrual, small p... More >>atient population at center.) Less << - United States, Louisiana ... More >> LSU Health Sciences Center, 1501 Kings Highway Shreveport, Louisiana, United States, 71103 Less <<
NCT00034593 Urologic Neoplasms Phase 2 Completed - Finland ... More >> "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Helsinki, Finland "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Pikonlinna, Finland "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Turku, Finland France "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Bordeaux Cedex, France For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Lille Cedex, France "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Marseille Cedex 09, France "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Montpellier, France "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Paris Cedex 14, France Germany For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Homburg/Saar, Germany Less <<
NCT02439450 Non-small Cell Lung Cancer Phase 1 Phase 2 Recruiting December 2021 -
NCT01263782 Lung Cancer Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00454649 Neoplasms Phase 1 Completed - United States, Georgia ... More >> Pfizer Investigational Site Augusta, Georgia, United States, 30909 Pfizer Investigational Site Augusta, Georgia, United States, 30912 United States, Illinois Pfizer Investigational Site Harvey, Illinois, United States, 60426-4265 Pfizer Investigational Site Harvey, Illinois, United States, 60426 Pfizer Investigational Site Tinley Park, Illinois, United States, 60477 United States, Indiana Pfizer Investigational Site Hobart, Indiana, United States, 46342 Pfizer Investigational Site Munster, Indiana, United States, 46321 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111 United States, Texas Pfizer Investigational Site Houston, Texas, United States, 77030-4009 United States, Washington Pfizer Investigational Site Kennewick, Washington, United States, 99336 Poland Pfizer Investigational Site Warszawa, Poland, 02-781 Spain Pfizer Investigational Site Barcelona, Spain, 08003 Pfizer Investigational Site Madrid, Spain, 28046 Less <<
NCT01781988 Lung Cancer C... More >>arboplatin Adverse Reaction Less << Phase 2 Completed - China, Guangdong ... More >> The first affiliated hospital of Guangzhou MC Guangzhou, Guangdong, China, 510120 Less <<
NCT02964013 Neoplasms Phase 1 Recruiting December 1, 2020 United States, Arizona ... More >> Call for Information (Investigational Site 0013) Recruiting Gilbert, Arizona, United States, 85234 United States, California Call for Information (Investigational Site 0012) Recruiting Duarte, California, United States, 91010 United States, Colorado Call for Information (Investigational Site 0006) Recruiting Aurora, Colorado, United States, 80045 United States, Connecticut Call for Information (Investigational Site 0003) Recruiting New Haven, Connecticut, United States, 06511 United States, Michigan Call for Information (Investigational Site 0009) Recruiting Detroit, Michigan, United States, 48201 United States, New Jersey Call for Information (Investigational Site 0005) Recruiting Hackensack, New Jersey, United States, 07601 United States, North Carolina Call for Information (Investigational Site 0011) Recruiting Charlotte, North Carolina, United States, 28204 United States, Pennsylvania Call for Information (Investigational Site 0010) Recruiting Pittsburgh, Pennsylvania, United States, 15232 United States, Tennessee Call for Information (Investigational Site 0004) Recruiting Nashville, Tennessee, United States, 37203 United States, Texas Call for Information (Investigational Site 0001) Recruiting San Antonio, Texas, United States, 78229 Australia Merck Sharp & Dohme Recruiting North Ryde, Australia Contact: Australian Medical Information Centre    61 2 8988 8428       Israel Merck Sharp & Dohme Co. Ltd. Recruiting Hod Hasharon, Israel Contact: Dan Goldstaub    972-9-9533326       Korea, Republic of MSD Korea LTD Recruiting Seoul, Korea, Republic of, 4130 Contact: TaeYoun Jo    8223312313 Less <<
NCT00454649 - Completed - -
NCT02947113 Non-Small Cell Lung Cancer Phase 2 Withdrawn(New studies availabl... More >>e with immunotherapy so recruitment is no longer acceptable.) Less << November 2017 -
NCT01784549 Non Small Cell Lung Cancer Phase 2 Unknown December 2015 Italy ... More >> IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro Recruiting Genoa, Italy, 16132 Contact: Francesco Grossi, MD    +393355255484    fg1965@libero.it Less <<
NCT02124148 Neoplasm Metastasis ... More >> Colorectal Neoplasms Breast Cancer Less << Phase 1 Recruiting February 27, 2020 United States, Florida ... More >> Florida Cancer Specialists Recruiting Sarasota, Florida, United States, 34232 Contact    9413779993       Principal Investigator: Manish Rajni Patel          United States, Oklahoma University of Oklahoma Health Sciences Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact    405-271-4022       Principal Investigator: Kathleen Moore          United States, Tennessee Sarah Cannon Research Institute SCRI Recruiting Nashville, Tennessee, United States, 37203 Contact    615-329-7615       Principal Investigator: SMO Sarah Cannon Research Inst.          Tennessee Oncology PLLC Recruiting Nashville, Tennessee, United States, 37203 Contact    6153297274       Principal Investigator: Johanna Chock Bendell          United States, Texas University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact    713-563-5844       Principal Investigator: David S Hong Less <<
NCT02591615 Non-Small Cell Lung Cancer Phase 2 Recruiting December 2019 United States, California ... More >> UCSD Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Contact: Lyudmila Bazhenova, MD          Principal Investigator: Lyudmila Bazhenova          United States, Illinois The University of Chicago Medical Center Recruiting Chicago, Illinois, United States, 60637 Contact: Jyoti Patel, MD          Principal Investigator: Jyoti Patel          NorthShore University HealthSystem Recruiting Evanston, Illinois, United States, 60201 Contact: Thomas Hensing, MD          Principal Investigator: Thomas Hensing          United States, Iowa Medical Oncology & Hematology Associates Recruiting Des Moines, Iowa, United States, 50309 Contact: Robert Behrens, MD          Principal Investigator: Robert Behrens          United States, Maine EMMC Cancer Care Recruiting Brewer, Maine, United States, 04412 Contact: Antoine Harb, MD          Principal Investigator: Antoine Harb          United States, Maryland University of Maryland, Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Katherine Scilla, MD          Principal Investigator: Katherine Scilla          United States, Minnesota Metro MN Community Oncology Research Consortium Recruiting Minneapolis, Minnesota, United States, 55416 Contact: Arkadiusz Dudek, MD          Principal Investigator: Arkadiusz Dudek          United States, Missouri University of Missouri - Ellis Fischel Cancer Center Recruiting Columbia, Missouri, United States, 65212 Contact: Puja Nistala, MD          Principal Investigator: Puja Nistala          Missouri Baptist Medical Center Recruiting Saint Louis, Missouri, United States, 63131 Contact: Bryan Faller, MD          Principal Investigator: Bryan Faller          United States, Nebraska Nebraska Methodist Hospital Recruiting Omaha, Nebraska, United States, 68114 Contact: Robert Langdon, MD          Principal Investigator: Robert Langdon          United States, New Hampshire NH Oncology (Concord) Recruiting Concord, New Hampshire, United States, 03301 Contact: Douglas Weckstein, MD          Principal Investigator: Douglas Weckstein          NH Oncology Recruiting Hooksett, New Hampshire, United States, 03106 Contact: Douglas Weckstein, MD          Principal Investigator: Douglas Weckstein          Dartmouth Hitchcock Medical Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Konstantin Dragnev, MD          Principal Investigator: Konstantin Dragnev          United States, New York Hematology Oncology Associates of Central New York, PC Recruiting East Syracuse, New York, United States, 13057 Contact: Jeffrey Kirshner, MD          Principal Investigator: Jeffrey Kirshner          SUNY Upstate Medical University Recruiting Syracuse, New York, United States, 13210 Contact: Stephen Graziano, MD          Principal Investigator: Stephen Graziano          United States, North Carolina Wake Forest Baptist Health Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: William Petty, MD          Principal Investigator: William Petty          United States, Ohio The Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: Gregory Otterson, MD          Principal Investigator: Gregory Otterson          United States, Oklahoma University of Oklahoma Health Sciences Center Stephenson Cancer Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Raid Aljumaily, MD          Principal Investigator: Raid Aljumaily          United States, South Carolina Lexington Oncology/ Lexington Medical Center Recruiting West Columbia, South Carolina, United States, 29169 Contact: James Wells, MD          Principal Investigator: James Wells Less <<
NCT02944396 Non-Small Cell Lung Cancer Phase 1 Phase 2 Active, not recruiting January 2, 2019 United States, Alabama ... More >> University of Alabama /ID# 155135 Birmingham, Alabama, United States, 35233 United States, California Icri /Id# 155593 Whittier, California, United States, 90603 United States, Colorado Univ of Colorado Cancer Center /ID# 153820 Aurora, Colorado, United States, 80045 United States, Illinois University of Chicago /ID# 153824 Chicago, Illinois, United States, 60637-1443 United States, Indiana Goshen Center for Cancer Care /ID# 153822 Goshen, Indiana, United States, 46526 United States, North Carolina Duke Univ Med Ctr /ID# 153821 Durham, North Carolina, United States, 27710 Less <<
NCT01544179 Non-Small Cell Lung Cancer Phase 3 Active, not recruiting December 31, 2018 -
NCT03664024 Non-Small Cell Lung Cancer Phase 2 Recruiting March 4, 2022 United States, Maryland ... More >> Harry & Jeanette Weinberg Cancer Institute ( Site 0901) Recruiting Baltimore, Maryland, United States, 21237 Contact: Study Coordinator    443-777-7364       Canada, Quebec CISSS de la Monteregie-Centre ( Site 0801) Recruiting Greenfield Park, Quebec, Canada, J4V 2H1 Contact: Study Coordinator    45046650003226       Hungary Orszagos Koranyi TBC es Pulmonologiai Intezet ( Site 0400) Recruiting Budapest, Hungary, 1121 Contact: Study Coordinator    +36302005233       Petz Aladar Megyei Oktato Korhaz ( Site 0402) Recruiting Gyor, Hungary, 9024 Contact: Study Coordinator    +3696418244       Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet ( Site 0401) Recruiting Szolnok, Hungary, 5900 Contact: Study Coordinator    +36209323256       Israel Meir Medical Center ( Site 0501) Recruiting Kfar-Saba, Israel, 4428132 Contact: Study Coordinator    +97297472414       Chaim Sheba Medical Center ( Site 0500) Recruiting Ramat Gan, Israel, 5262000 Contact: Study Coordinator    +97235307096       Spain Hospital Universitario Insular de Gran Canaria ( Site 0700) Recruiting Las Palmas de Gran Canaria, Gran Canaria, Spain, 35001 Contact: Study Coordinator    +34928441738       H.U. Vall de Hebron ( Site 0701) Recruiting Barcelona, Spain, 08035 Contact: Study Coordinator    +34932746085       Hospital General Universitario 12 de Octubre ( Site 0703) Recruiting Madrid, Spain, 28041 Contact: Study Coordinator    +34914692313       Hospital Universitario Central de Asturias ( Site 0704) Recruiting Oviedo, Spain, 33011 Contact: Study Coordinator    +34609804227 Less <<
NCT01003964 Non Small Cell Lung Cancer Phase 2 Unknown December 2014 Korea, Republic of ... More >> National Cancer Center, Korea Goyang-si, Gyeonggi-do, Korea, Republic of Less <<
NCT00006007 Breast Cancer Phase 2 Completed - -
NCT01860040 Non-squamous Cell Non-Metastat... More >>ic Non-Small Cell Lung Cancer Squamous Cell Non-Metastatic Non-Small Cell Lung Cancer Less << Phase 2 Terminated(Poor accrual, no da... More >>ta to analyze) Less << - United States, Arizona ... More >> Western Regional Medical Center Goodyear, Arizona, United States, 85338 Less <<
NCT01544179 - Active, not recruiting - -
NCT01860040 - Terminated(Poor accrual, no da... More >>ta to analyze) Less << - -
NCT03589950 Lung Neoplasms ... More >> Docetaxel Pemetrexed S-1 Anlotinib Less << Phase 2 Not yet recruiting August 1, 2021 China, Jiangsu ... More >> The Affiliated Lianyungang Hospital of Xuzhou Medical University Not yet recruiting Lianyungang, Jiangsu, China, 222002 Contact: xiaodong jiang, MD    18961326201    jxdysy1970@163.com    Sub-Investigator: lijun liang, MM          Sub-Investigator: yixuan wen, MM Less <<
NCT01708993 Non Small Cell Lung Cancer Phase 2 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Canada, British Columbia BCCA - Abbotsford Centre Abbotsford, British Columbia, Canada, V2S 0C2 BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada, V3V 1Z2 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada, K7L 5P9 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Lakeridge Health Oshawa Oshawa, Ontario, Canada, L1G 2B9 Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Less <<
NCT00227539 Lung Cancer Phase 2 Completed - United States, Washington ... More >> Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 University of Washington School of Medicine Seattle, Washington, United States, 98195 Less <<
NCT02662504 Malignant Pleural Mesothelioma Phase 2 Completed - France ... More >> CHRU de Lille Hôpital Calmette Lille, France Less <<
NCT00051506 Lung Neoplasms Phase 2 Completed - United States, Arkansas ... More >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Springdale, Arkansas, United States United States, California For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Los Angeles, California, United States United States, Florida For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Fort Myers, Florida, United States For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Miami, Florida, United States United States, New York For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Latham, New York, United States United States, North Carolina For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Burlington, North Carolina, United States For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Chapel Hill, North Carolina, United States United States, South Carolina For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Charleston, South Carolina, United States Less <<
NCT00227539 - Completed - -
NCT01590160 Lung Cancer - Malignant Pleura... More >>l Mesothelioma Less << Phase 1 Phase 2 Active, not recruiting November 2018 United Kingdom ... More >> UCL Cancer Trials Centre London, United Kingdom, W1T 4TJ Less <<
NCT03472053 Non Small Cell Lung Cancer Sta... More >>ge IIIB Less << Phase 2 Active, not recruiting June 30, 2019 India ... More >> Vardhman Mahavir Medical College & Hospital New Delhi, Delhi, India, 110029 Unique Hospital and Research Institute Surat, Gujarat, India, 395002 Aadhar Health Institute Hisar, Hariyana, India, 125005 HCG Manavata Cancer Center Nashik, Maharashtra, India, 422004 Deenanath Mangeshkar Hospital & Research Center Pune, Maharashtra, India, 411004 Tata Memorial Hospital Mumbai, Maharastra, India, 400012 Navsanjeevani Hospital Nashik, Maharastra, India, 422002 Chirayu Cancer Hospital Bhopal, MP, India, 462030 Sparsh Hospitals and Critical Care Bhubaneswar, Odisa, India, 751007 SMS Medical College & Hospital Jaipur, Rajasthan, India, 302016 Nehru Hospital & Post Graduate Institute of Medical Education Chandigarh, India, 160012 Less <<
NCT00227630 Malignant Mesothelioma Phase 2 Completed - Belgium ... More >> Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 Italy Istituto Nazionale per la Ricerca sul Cancro Genoa, Italy, 16132 Azienda Ospedaliera Di Parma Parma, Italy, 43100 Universita Degli Studi di Udine Udine, Italy, 33100 Netherlands Sint Antonius Ziekenhuis Nieuwegein, Netherlands, 3435 CM Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands, 3008 AE United Kingdom Princess Royal Hospital at Hull and East Yorkshire NHS Trust Hull, England, United Kingdom, HU8 9HE Edinburgh Cancer Centre at Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Less <<
NCT00402883 Lung Cancer Phase 2 Terminated(Terminated due to b... More >>evacizumab and chemoradiotherapy toxicity) Less << - United States, Florida ... More >> Gainsville Hematology Oncology Associates Gainesville, Florida, United States, 32605 Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States, 33805 United States, Georgia Wellstar Cancer Research Marietta, Georgia, United States, 30060 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Associates in Hematology Oncology Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00402883 - Terminated(Terminated due to b... More >>evacizumab and chemoradiotherapy toxicity) Less << - -
NCT03351842 Chemotherapy, Adjuvant ... More >> Lung Adenocarcinoma, Stage I Treatment Histological Type of Neoplasm Less << Phase 2 Recruiting September 1, 2024 China ... More >> Thoracic Surgery Department of Shanghai Pulmonary Hospital Recruiting Shanghai, China, 200000 Contact: Yingran Shen    86-18117166317    elaineshen91@gmail.com Less <<
NCT01185847 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 2 Completed - Belgium ... More >> Charleroi, Belgium, B6000 Leuven, Belgium, 3000 Liège, Belgium, 4000 France Caen, France, 14033 Marseille, France, 13915 Saint Herblain, France, 44805 Toulouse, France, 31400 Germany Bad Berka, Germany, 99437 Gauting, Germany, 82131 Grosshansdorf, Germany, 22927 Heidelberg, Germany, 69126 Köln, Germany, 51109 Mainz, Germany, 55131 Mannheim, Germany, 68167 Italy Milano, Lombardia, Italy, 20162 Milan, Lombardia, Italy, 20132 Ancona, Marche, Italy Lido Di Camaiore, Toscana, Italy, 55043 Livorno, Toscana, Italy, 57100 Perugia, Umbria, Italy, 06156 Poland Lodz, Poland, 93-509 Otwock, Poland, 05-400 Warszawa, Poland, 02-781 Spain Barcelona, Spain, 08003 Barcelona, Spain, 08035 Madrid, Spain, 28040 Madrid, Spain, 28041 Madrid, Spain, 28046 Madrid, Spain, 28050 Malaga, Spain, 29010 Sevilla, Spain, 41013 United Kingdom London, United Kingdom, SE1 9RT Less <<
NCT01102231 Stage III Non-small Cell Lung ... More >>Cancer Less << Phase 2 Completed - France ... More >> Clinique de l'Europe Amiens, France Centre Hospitalier Annemasse, France CHU Besancon - Pneumologie Besancon, France, 25000 Bordeaux - Polyclinique Nord Bordeaux, France, 33300 Caen - Centre François Baclesse Caen, France, 14000 Caen - CHU Côte de Nacre Caen, France, 14000 CH Chartres, France CH Cholet, France CHU Clermont-Ferrand, France CH Colmar, France Clinique des Cèdres Cornebarrieu, France Dijon - CAC Dijon, France, 21000 CHU Grenoble Grenoble, France, 38000 Institut d'Oncologie Hartmann Levallois, France CHU (Hôpital Calmette) - Pneumologie Lille, France, 59000 CH Longjumeau, France Clinique des 4 Pavillons Lormont, France Hôpital Louis Pradel Lyon, France Hôpital Nord Marseille, France Centre Hospitalier Montélimar, France CHU Nancy, France CH Nevers, France Centre Hospitalier Niort, France APHP - Hopital Tenon - Pneumologie Paris, France, 75020 Hôpital du Val de Grâce Paris, France Hôpital Saint-Joseph Paris, France Perpignan - Centre Catalan d'Oncologie Perpignan, France, 66000 HCL - Lyon Sud Pierre Bénite, France, 69495 CHU Poitiers, France Centre Hospitalier Rambouillet, France Reims - CHU Reims, France, 51092 Institut Jean Godinot Reims, France Centre Frederic Joliot Rouen, France Centre Etienne Dolet Saint-Nazaire, France Hôpitaux Universitaires - Nouvel Hôpital Civil Strasbourg, France, 63000 Suresnes - Hopital Foch Suresnes, France, 92151 Tours - CHU Tours, France, 37000 Institut Gustave Roussy Villejuif, France, 94800 Less <<
NCT01211275 Malignant Pleural Mesothelioma Phase 1 Phase 2 Completed - Netherlands ... More >> Antoni van Leeuwenhoekziekenhuis (NKI-AVL) Amsterdam, Noord-Holland, Netherlands, 1066 CX Less <<
NCT03041181 Non-Squamous Non-Small Cell Lu... More >>ng Cancer (NSCLC) Adenocarcinoma of the Lung Lung Cancer Squamous Cell Lung Cancer Less << Phase 2 Recruiting September 2020 United States, Indiana ... More >> St. Vincent Anderson Regional Hospital Recruiting Anderson, Indiana, United States, 46016 Contact: Kellie Ballman    765-648-4106    kellie.ballman@ascension.org    Principal Investigator: Praveen Ranaganath, MD          Indiana University Melvin and Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Nasser Hanna, M.D.       nhanna@iu.edu    Contact: Maggie Uhrich    317-274-4505    muhrich@iu.edu    IU Health Central Indiana Cancer Center Recruiting Indianapolis, Indiana, United States, 46219 Contact: Melody Sands    317-678-2700    MSands1@iuhealth.org    Principal Investigator: Andrew Greenspan, MD          Community Regional Cancer Care Recruiting Indianapolis, Indiana, United States, 46256 Contact: Kelly Verel    317-497-2836    KVerel@ecommunity.com    Principal Investigator: Radhika Walling, MD          IU Health Ball Memorial Hospital Cancer Center Recruiting Muncie, Indiana, United States, 47303 Contact: Stacey Cadogan    765-281-2030    scadogan@iuhealth.org    Principal Investigator: William Fisher, MD          Community Healthcare System Recruiting Munster, Indiana, United States, 46321 Contact: Mary Shields    219-836-6879    mshields@comhs.org    Principal Investigator: Mohamad Kassar, MD          United States, Minnesota HealthPartners Institute Recruiting Minneapolis, Minnesota, United States, 55440 Contact: Jennifer Collier    651-254-3391    Jennifer.Collier@parknicollet.com    Principal Investigator: Arkadiusz Dudek, MD, PhD          United States, Texas University of Texas Medical Branch at Galveston Recruiting Galveston, Texas, United States, 77555 Contact: Renee Brown    409-772-9583    renbrown@utmb.edu    Principal Investigator: Maurice Willis, MD          United States, Virginia University of Virginia Health System Recruiting Charlottesville, Virginia, United States, 22908 Contact: Marian Abdelmalek    434-924-5834    MKA6S@hscmail.mcc.virginia.edu    Principal Investigator: Richard Hall, MD Less <<
NCT00482014 - Completed - -
NCT02162537 Non-small Cell Lung Cancer Met... More >>astatic Non-small Cell Lung Cancer Adenocarcinoma of Lung Metastatic to Brain Cerebral Metastases Less << Phase 3 Recruiting January 2019 France ... More >> Centre Hospitalier du Pays d'Aix Recruiting Aix En Provence, France, 13613 Contact: Jacques LE TREUT       jletreut@ch-aix.fr    Principal Investigator: Jacques LE TREUT          Centre Hospitalier Victor Dupouy Recruiting Argenteuil, France, 95100 Contact: Christine RAYNAUD       christine.raynaud@ch-argenteuil.fr    Principal Investigator: Christine RAYNAUD          Centre d'Oncologie et de Radiothérapie du Pays Basque Recruiting Bayonne, France, 64100 Contact: Aurélien BLOUET       aurelien.blouet@oncologie-pays-basque.org    Principal Investigator: Aurélien BLOUET          Centre Hospitalier Recruiting Beauvais, France, 60021 Contact: Jacky CREQUIT       Jacky.crequit@orange.fr    Principal Investigator: Jacky CREQUIT          Hôpital Avicenne Not yet recruiting Bobigny, France, 93000 Contact: Antoine CARPENTIER       antoine.carpentier@avc.aphp.fr    Principal Investigator: Antoine CARPENTIER          HIA de Clermont-Tonnerre Not yet recruiting Brest, France, 22240 Contact: Nicolas PALEIRON       nicolas.paleiron@free.fr    Principal Investigator: Nicolas PALEIRON          CHU Recruiting Brest, France, 29200 Contact: Gilles ROBINET       gilles.robinet@chu-brest.fr    Principal Investigator: Gilles ROBINET          Centre François Baclesse Recruiting Caen, France, 14000 Contact: Radj GERVAIS       r.gervais@baclesse.fr    Principal Investigator: Radj GERVAIS          Centre Hospitalier Recruiting Charleville Meziere, France, 08000 Contact: Stéphane CHOUABE       Schouabe@ch-charleville-mezieres.fr    Principal Investigator: Stéphane CHOUABE          Centre Hospitalier Laennec Recruiting Creil, France, 60109 Contact: Sandrine LOUTSKI-VETTESE       sandrine.loutski@ch-creil.fr.fr    Principal Investigator: Sandrine LOUTSKI-VETTESE          Centre Hospitalier Intercommunal Recruiting Creteil, France, 94010 Contact: Isabelle MONNET       isabelle.monnet@chicreteil.fr    Principal Investigator: Isabelle MONNET          Centre Hospitalier Recruiting Draguignan, France, 83300 Contact: Hervé LE CAER       herve.lecaer@ch-draguignan.fr    Principal Investigator: Hervé LE CAER          Centre Hospitalier Recruiting GAP, France, 05000 Contact: Pascal THOMAS       pascal.thomas@chicas-gap.fr    Principal Investigator: Pascal THOMAS          Centre Hospitalier Robert Boulin Recruiting Libourne, France, 33500 Contact: Samir ABDICHE       samir.abdiche@ch-libourne.fr    Principal Investigator: Samir ABDICHE          Hôpital Le Cluzeau Recruiting Limoges, France, 87042 Contact: Alain VERGNENEGRE       avergne@unilim.fr    Principal Investigator: Alain VERGNENEGRE          Centre Hospitalier Régional Recruiting Longjumeau, France, 91161 Contact: Gérard OLIVIERO       gerard.oliviero@ch-longjumeau.fr    Principal Investigator: Gérard OLIVIERO          Centre Hospitalier de Bretagne Sud Recruiting Lorient, France, 56322 Contact: Régine LAMY       r.lamy@ch-bretagne-sud.fr    Principal Investigator: Régine LAMY          Centre Léon Bérard Recruiting Lyon, France, 69373 Contact: Maurice PEROL       maurice.perol@lyon.unicancer.fr    Principal Investigator: Maurice PEROL          Centre Hospitalier Les Chanaux Recruiting Macon, France, 71000 Contact: Dominique ARPIN       doarpin@ch-macon.fr    Principal Investigator: Dominique ARPIN          Centre Hospitalier F. QUESNAY Recruiting Mantes La Jolie, France, 78200 Contact: Jean-Bernard AULIAC       j-b.auliac@ch-mantes-la-jolie.rss.fr    Principal Investigator: Jean-Bernard AULIAC          Institut Paoli Calmette Recruiting Marseille, France, 13000 Contact: Anne MADROSZYC       madroszyca@marseille.fnclcc.fr    Principal Investigator: Anne MADROSZYC          Hôpital Nord APHM Recruiting Marseille, France, 13915 Contact: Laurent GREILLIER       laurent.greillier@mail.ap-hm.fr    Principal Investigator: Laurent GREILLIER          Centre Hospitalier Recruiting Meaux, France, 77108 Contact: Chrystèle LOCHER       ch-locher@ch-meaux.fr    Principal Investigator: Chrystèle LOCHER          Centre Hospitalier Intercommunal Recruiting Meulan, France, 78250 Contact: Etienne LEROY-TERQUEM       etiennelt@hotmail.fr    Principal Investigator: Etienne LEROY-TERQUEM          Clinique du Pont de Chaume Recruiting Montauban, France, 82000 Contact: Franck THOUVENY       fthouveny@clinique-pontdechaume.fr    Principal Investigator: Franck THOUVENY          Centre Hospitalier Recruiting Perigueux, France, 24019 Contact: Jean-Yves DELHOUME       jy.delhoume@ch-perigeux.fr    Principal Investigator: Jean-Yves DELHOUME          Centre Catalan d'Oncologie Recruiting Perpignan, France, 66000 Contact: Sabine VIEILLOT       sabinevieillot@gmail.com    Principal Investigator: Sabine VIEILLOT          Centre Hospitalier René Dubos Recruiting Pontoise, France, 95303 Contact: Gislaine FRABOULET       gislaine.fraboulet@ch-pontoise.fr    Principal Investigator: Gislaine FRABOULET          Centre Hospitalier de la Région d'Annecy (CHRA) Recruiting Pringy, France, 74374 Contact: Chantal DECROISETTE       cdecroisette@ch-annecy.fr    Principal Investigator: Chantal DECROISETTE          Centre Hospitalier Intercommunal de Cornouaille Recruiting Quimper, France, 29107 Contact: Anne-Marie CHIAPPA       am.chiappa@ch-cornouaille.fr    Principal Investigator: CHIAPPA Anne-Marie          Hôpital Pontchailloux Recruiting Rennes, France, 35033 Contact: Hervé LENA       herve.lena@chu-rennes.fr    Principal Investigator: Hervé LENA          Hôpital Charles Nicolle Recruiting Rouen, France, 79031 Contact: Suzanna BOTA       Suzanna.bota@chu-rouen.fr    Principal Investigator: Suzanna BOTA          Clinique Mutualiste de l'Estuaire Recruiting Saint Nazaire, France, 44600 Contact: Philippe DEGUIRAL       philippe.deguiral@mla.fr    Principal Investigator: Philippe DEGUIRAL          Institut de Cancérologie de la Loire (I.C.L) Recruiting Saint Priest En Jarez, France, 42271 Contact: Pierre FOURNEL       pierre.fournel@icloire.fr    Principal Investigator: Pierre FOURNEL          Centre Hospitalier de Salon de Provence Recruiting Salon de Provence, France, 13658 Contact: Jacques LE TREUT       jletreut@ch-aix.fr    Principal Investigator: Jacques LE TREUT          Centre Hospitalier Recruiting Sens, France, 89108 Contact: GONZALEZ Gilles       ggonzalez@ch-sens.fr    Principal Investigator: GONZALEZ Gilles          Centre Paul Strauss Recruiting Strasbourg, France, 67000 Contact: Roland SCHOTT       rschott@strasbourg.unicancer.fr    Principal Investigator: Roland SCHOTT          Hopital d'Instruction des Armées Sainte Anne Recruiting Toulon, France, 83800 Contact: Henri BERARD       hberard@libertysurf.fr    Principal Investigator: Henri BERARD          Hôpital Larrey Recruiting Toulouse, France, 31059 Contact: Laurence BIGAY-GAME       bigaygame.l@chu-toulouse.fr    Principal Investigator: Laurence BIGAY-GAME          Clinique Pasteur Recruiting Toulouse, France, 31076 Contact: Olivier GALLOCHER       o.gallocher@clinique-pasteur.com    Principal Investigator: Olivier GALLOCHER          Centre Hospitalier Recruiting Villefranche Sur Saone, France, 69655 Contact: Lionel FALCHERO       lfalchero@ch-villefranche.fr    Principal Investigator: Lionel FALCHERO Less <<
NCT00482014 Non-Small-Cell Lung Cancer Phase 1 Phase 2 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States, 90095 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wichita, Kansas, United States, 67214 United States, Missouri For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St Louis, Missouri, United States, 63110 United States, Nevada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Las Vegas, Nevada, United States, 89135 United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Burlington, North Carolina, United States, 27216 United States, Tennessee For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States, 38120 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Corpus Christi, Texas, United States, 78405 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75390 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Temple, Texas, United States, 76508 India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Delhi, India, 110085 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trivandrum, India, 695 011 Less <<
NCT02804646 Adenocarcinoma of Lung Phase 4 Unknown December 2018 China, Anhui ... More >> Anhui provincial hospital Recruiting Hefei, Anhui, China, 230000 Contact: Lejie Cao, prefessor       sycaolejie@163.com    Contact: Nana Hu       493305821@qq.com Less <<
NCT00269152 Non-Small Cell Lung Cancer Phase 2 Completed - France ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bordeaux, France, 33076 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris, France, 75571 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rennes, France, 35033 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St Priest En Jarez, France, 42270 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toulouse, France, 31059 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bad Berka, Germany, 99437 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bielefeld, Germany, D-33604 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Großhansdorf, Germany, D-22927 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Halle, Germany, D-06120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, D-30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kassel, Germany, 34125 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Köln, Germany, D-51109 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Loewenstein, Germany, 74245 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, D-55131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mannheim, Germany, 68167 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28046 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santiago De Compostela, Spain, 15706 Less <<
NCT03709147 Advanced LKB1-inactive Lung Ad... More >>enocarcinoma Less << Phase 2 Not yet recruiting September 10, 2023 Italy ... More >> Marina Chiara Garassino Not yet recruiting Milan, Italy, 20133 Contact: MARINA CHIARA GARASSINO, MD    0223903813 ext +39    marina.garassino@istitutotumori.mi.it Less <<
NCT00447057 - Completed - -
NCT00269152 - Completed - -
NCT00065533 Breast Cancer Phase 2 Completed - Argentina ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Buenos Aires, Argentina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Capitol Federal, Argentina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. S.M. De Tucuman, Argentina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Tucuman, Argentina Belgium For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Brussels, Belgium For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Leuven, Belgium For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Namur, Belgium Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Munich, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Wiesbaden, Germany Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Bucuresti, Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Cluj, Romania Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Badalona, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Barcelona, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Madrid, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Malaga, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Santander, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Valencia, Spain United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Newcastle Upon Tyne, Tyne and Wear, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician. Birmingham, West Midlands, United Kingdom Less <<
NCT00320515 Neoplasm, Gastric Phase 1 Phase 2 Completed - Argentina ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Buenos Aires, Argentina, 1264 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tucumain, Argentina, 4000 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 136-705 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ciudad Obregon, Mexico, 85100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guadalajara, Mexico, 44280 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tainan, Taiwan, 704 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 112 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 Less <<
NCT00320515 - Completed - -
NCT00227565 Lung Cancer Phase 2 Completed - -
NCT00447057 Histological or Cytological Di... More >>agnosis of Locally Advanced or Metastatic NSCLC of Nonsquamous Histology and Not Amenable to Curative Therapy. Less << Phase 2 Completed - Austria ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salzburg, Austria, 5020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vienna, Austria, A-1140 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bochum, Germany, 44791 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Freiburg, Germany, 79106 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gauting, Germany, 82131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gerlingen, Germany, 70839 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, D 21075 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Immenhausen, Germany, 34376 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trier, Germany, 54219 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tübingen, Germany, 72076 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ulm, Germany, 89075 Hungary For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Deszk, Hungary, 6772 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Matrahaza, Hungary, 3233 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nyiregyhaza, Hungary, H-4400 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Szekesfehervar, Hungary, 8000 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alicante, Spain, 03010 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28050 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46010 Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Linkoping, Sweden, 58185 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lund, Sweden, 221 85 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Solna, Sweden, 17176 Less <<
NCT00923273 Carcinoma, Non-Small-Cell Lung Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00079872 Colorectal Cancer PHASE2 COMPLETED 2025-05-06 For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, NSW, QLD, South Australia, Victoria, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Woodville, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Frankfurt/Main, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Krete, Greece|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Amsterdam, Netherlands|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Sevilla, Spain Less <<
NCT01215916 Solid Tumors Phase 1 Completed - United States, New Jersey ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New Brunswick, New Jersey, United States, 08901 Less <<
NCT00475657 Small Cell Lung Cancer Phase 2 Terminated(Terminated due to l... More >>ack of efficacy) Less << - Spain ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ferrol, Spain, 15405 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Coruña, Spain, 15002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lugo, Spain, 27004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ourense, Spain, 15009 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santiago de Compostela, Spain, 15706 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vigo, Spain, 36211 Less <<
NCT00475657 - Terminated(Terminated due to l... More >>ack of efficacy) Less << - -
NCT00351039 Non-Small Cell Lung Cancer Phase 1 Phase 2 Terminated(slow accrual) - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00351039 - Terminated(slow accrual) - -
NCT00061477 Mesothelioma Phase 2 Completed - United States, Colorado ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tampa, Florida, United States United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States United States, Massachusetts For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Boston, Massachusetts, United States United States, Michigan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Detroit, Michigan, United States United States, New Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Albuquerque, New Mexico, United States United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New York, New York, United States United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cleveland, Ohio, United States United States, Pennsylvania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Philadelphia, Pennsylvania, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559 or 317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pittsburgh, Pennsylvania, United States Less <<
NCT01020786 Non Small Cell Lung Cancer Phase 4 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 460-0001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 277 8577 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ehime, Japan, 790-0007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 812-8582 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 062-0931 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 673-8558 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 236-0051 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kumamoto, Japan, 860-8556 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miyagi, Japan, 980-8574 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Niigata, Japan, 951-8520 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okayama, Japan, 700-8558 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 589-8511 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shizuoka, Japan, 411-8777 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tochigi, Japan, 320-0834 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 113-8677 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yamaguchi, Japan, 755-0241 Less <<
NCT00102804 Non-Small Cell Lung Cancer Phase 3 Completed - -
NCT00691301 Cervical Cancer Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange, California, United States, 92868 United States, Mississippi University of Mississippi Cancer Clinic Jackson, Mississippi, United States, 39216 United States, Nevada Women's Cancer Center - La Canada Las Vegas, Nevada, United States, 89169 United States, Ohio MetroHealth Cancer Care Center at MetroHealth Medical Center Cleveland, Ohio, United States, 44109 United States, Oklahoma Oklahoma University Cancer Institute Oklahoma City, Oklahoma, United States, 73104 Cancer Care Associates - Saint Francis Campus Tulsa, Oklahoma, United States, 74136-1929 United States, Texas Parkland Memorial Hospital Dallas, Texas, United States, 75235 Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Lyndon B. Johnson General Hospital Houston, Texas, United States, 77026-1967 M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 United States, Virginia Carilion Gynecologic Oncology Associates Roanoke, Virginia, United States, 24016 Less <<
NCT00410904 Recurrent Non-small Cell Lung ... More >>Cancer Less << Phase 2 Completed - United States, Maryland ... More >> University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Michigan Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT00691301 - Completed - -
NCT01020786 - Completed - -
NCT00191984 Metastatic Colorectal Cancer Phase 2 Completed - France ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Angers, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Lille, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Montfermeil, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Paris, France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Suresnes, France Less <<
NCT00191984 - Completed - -
NCT00320073 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT00102804 - Completed - -
NCT00410904 - Completed - -
NCT00923273 - Completed - -
NCT00402051 Non-Small-Cell Lung Cancer Phase 2 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Coswig, Germany, D-01640 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, 65929 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Großhansdorf, Germany, D-22927 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Halle, Germany, D-06120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, D-21075 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hofheim, Germany, D-65719 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Homburg/Saar, Germany, 66421 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Immenhausen, Germany, D-34376 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leipzig, Germany, 04207 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Luebeck, Germany, 23538 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, 55131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Muenchen, Germany, 81664 Less <<
NCT00886678 Non-Small Cell Lung Cancer Phase 2 Unknown July 2010 China, Zhejiang ... More >> Zhejiang Cancer Hospital Hangzhou, Zhejiang, China, 310022 Less <<
NCT00268437 Esophageal Cancer Phase 2 Terminated(Trial closed early ... More >>because, during an interim analysis, the primary endpoint fell short.) Less << - -
NCT00402051 - Completed - -
NCT00192088 Advanced Gastric Carcinoma Phase 2 Completed - Italy ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ancona, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bari, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bergamo, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brescia, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Firenze, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gorgonzola, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mantova, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Padova, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Parma, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Roma, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Varese, Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-371-615-4559) Mon - Fri from 9 AM - 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Verona, Italy Less <<
NCT00786552 Thyroid Cancer Phase 2 Unknown November 2013 Germany ... More >> Medical Center II, University of Kiel Recruiting Kiel, Germany, 24105 Contact: Joerg T Hartmann, MD    +49 431 597 2484    joerg.hartmann@uk-sh.de Less <<
NCT00798603 Lung Cancer Phase 2 Completed - -
NCT00702299 Fallopian Tube Cancer ... More >> Ovarian Cancer Peritoneal Cavity Cancer Less << Phase 1 Completed - United States, Arizona ... More >> Arizona Oncology - Scottsdale Scottsdale, Arizona, United States, 85258 Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724-5024 Less <<
NCT00702299 - Completed - -
NCT00798603 - Completed - -
NCT01105390 Advanced Malignant Mesotheliom... More >>a Epithelial Mesothelioma Recurrent Malignant Mesothelioma Sarcomatous Mesothelioma Less << Phase 2 Withdrawn(withdrawn) - -
NCT00799240 Non Small Cell Lung Cancer Phase 2 Completed - United States, Kansas ... More >> Hutchinson Clinic, PA Hutchinson, Kansas, United States, 67502 Kansas University Cancer Center Kansas City, Kansas, United States, 66160 Stormont Vail Healthcare Topeka, Kansas, United States, 66606 United States, Missouri VA Medical Center Kansas City, Missouri, United States, 64128 Less <<
NCT00407459 Mesothelioma Phase 2 Completed - Italy ... More >> Istituto Clinico Humanitas Rozzano, Milan, Italy, 20089 Less <<
NCT00268437 - Terminated(Trial closed early ... More >>because, during an interim analysis, the primary endpoint fell short.) Less << - -
NCT00191191 Non-small Cell Lung Cancer Phase 2 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Chiba, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Ehime, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Fukuoka, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Gifu, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Gunma, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Hokkaido, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Hyogo, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Kanagawa, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Kumamoto, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Miyagi, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Niigata, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Okayama, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Osaka, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Saitama, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Shizuoka, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Tokyo, Japan Less <<
NCT00191191 - Completed - -
NCT00234052 Lung Cancer Phase 2 Active, not recruiting May 2020 United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 Rush Cancer Institute at Rush University Medical Center Chicago, Illinois, United States, 60612 Evanston Northwestern Healthcare - Evanston Hospital Evanston, Illinois, United States, 60201-1781 Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Advocate Lutheran General Cancer Care Center Park Ridge, Illinois, United States, 60068-1174 Less <<
NCT00508144 Lung Cancer Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00281125 Non-Small Cell Lung Cancer and... More >> Pleural Mesothelioma Less << Phase 1 Phase 2 Terminated(Suspended due to da... More >>ta issues revealed at DSMB meeting. Planned amendment but was never submitted. Study was then closed.) Less << - United States, Nevada ... More >> Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 Less <<
NCT00053209 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer Less << Phase 2 Completed - -
NCT01837329 Non-Small Cell Lung Cancer Phase 1 Recruiting October 2018 United States, New York ... More >> University of Rochester Recruiting Rochester, New York, United States, 14642 Contact: Amy Jasek    585-273-1912    Amy_Jasek@urmc.rochester.edu    Principal Investigator: David Dougherty, MD Less <<
NCT00193414 Lung Cancer Phase 2 Completed - United States, Tennessee ... More >> Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT03050437 Carcinoma, Non-Small-Cell Lung Phase 2 Recruiting March 2017 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Myung-Ju Ahn, Ph.D.    822-3410-1795    silkahn@skku.edu Less <<
NCT00193414 - Completed - -
NCT00508144 - Completed - -
NCT00438204 Lung Cancer Phase 2 Terminated(All data collection... More >> has completed.) Less << - United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0942 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT00280748 - Terminated(Slow accrual) - -
NCT01578668 Lung Adenocarcinoma ... More >> Brain Metastases Less << Phase 2 Completed - China, Guangdong ... More >> The first affiliated hospital of Guangzhou MC Guangzhou, Guangdong, China, 510120 Less <<
NCT00179699 Non-Small Cell Lung Cancer Phase 1 Terminated - United States, Florida ... More >> MD Anderson - Orlando Orlando, Florida, United States, 32806 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Kentucky Norton Healthcare Louisville, Kentucky, United States, 40202 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, New York North Shore Hem/Onc Associates East Setauket, New York, United States, 11733-3456 Less <<
NCT02879669 To Determine Safety, Tolerabil... More >>ity and Efficacy of ONCOS-102 in Combination With Chemotherapy Less << Phase 1 Phase 2 Recruiting - France ... More >> Centre Georges-François Leclerc Recruiting Dijon, France Contact: Nicolas Isambert, MD          CHU de Rennes - Pontchaillou Recruiting Rennes, France Contact: Hervé Lena, MD          Spain Hospital Universitario Quirón Recruiting Barcelona, Spain Contact: Santiago Viteri          Vall d'Hebron Univerity Hospital Recruiting Barcelona, Spain Contact: Susanna Cedres, MD          Hospital Universitari de Girona Doctor Josep Trueta - Institut Català d'Oncologia Recruiting Girona, Spain Contact: Joaquim Bosch          Hospital 12 de octubre Recruiting Madrid, Spain Contact: Luis Paz-Ares, MD          Hospital Universitario HM Sanchinarro Recruiting Madrid, Spain Contact: Javier de Castro, MD Less <<
NCT00619424 Lung Cancer, Non-Small Cell Phase 1 Completed - United States, Colorado ... More >> GSK Investigational Site Aurora, Colorado, United States, 80045 United States, New York GSK Investigational Site Buffalo, New York, United States, 14263 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 Italy GSK Investigational Site Orbassano (TO), Piemonte, Italy, 10043 Less <<
NCT00280748 Lung Cancer M... More >>etastatic Cancer Less << Phase 2 Terminated(Slow accrual) - United States, North Carolina ... More >> Alamance Oncology/Hematology Associates, LLP Burlington, North Carolina, United States, 27216 Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT00530621 Non-small Cell Lung Cancer Phase 2 Completed - -
NCT03366766 Non-Squamous Non-Small Cell Lu... More >>ng Carcinoma Stage I Non-Small Cell Lung Cancer Stage IA Non-Small Cell Lung Carcinoma Stage IB Non-Small Cell Lung Carcinoma Stage II Non-Small Cell Lung Cancer Stage IIA Non-Small Cell Lung Carcinoma Stage IIB Non-Small Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer Less << Phase 2 Recruiting July 2022 United States, Pennsylvania ... More >> Abington Hospital - Jefferson Health Not yet recruiting Abington, Pennsylvania, United States, 19001 Contact: Mark Sundemeyer, MD    215-481-2400       Principal Investigator: Mark Sundemeyer, MD          Sidney Kimmel Cancer Center at Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Ralph Zinner, MD    215-503-5098    ralph.zinner@jefferson.edu    Lankenau Institute for Medical Research Not yet recruiting Wynnewood, Pennsylvania, United States, 19096 Contact: Paul Gilman, MD    484-476-4837       Principal Investigator: Paul Gilman, MD Less <<
NCT00438204 - Terminated(All data collection... More >> has completed.) Less << - -
NCT00374868 Urologic Neoplasms Phase 1 Phase 2 Completed - Spain ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pamplona, Spain, 31008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sabadell, Spain, 08208 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santander, Spain, 39008 Less <<
NCT00749346 Non-small Cell Lung Cancer ... More >> NSCLC Less << Phase 1 Phase 2 Completed - Switzerland ... More >> CCRC Basel, Switzerland Kantonspital Graubunden Chur, Switzerland Kantonspital Fribourg Fribourg, Switzerland Kantonspital Winterthur Winterthur, Switzerland Less <<
NCT03498222 Carcinoma, Non-Small-Cell Lung Phase 1 Not yet recruiting December 31, 2021 -
NCT00998166 Non-Small Cell Lung Cancer Phase 2 Terminated(Poor enrollment) - United States, New York ... More >> North Shore University Hospital Lake Success, New York, United States, 11042 Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00374868 - Completed - -
NCT00698815 - Completed - -
NCT00101283 Mesothelioma Phase 2 Completed - -
NCT00101283 - Completed - -
NCT00268489 Lung Cancer Phase 2 Completed - -
NCT00698815 Recurrent Non-Small Cell Lung ... More >>Carcinoma Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Stage IV Non-Small Cell Lung Cancer AJCC v7 Less << Phase 2 Completed - -
NCT01490437 Urothelial Carcinoma Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00190671 - Completed - -
NCT00190671 Breast Cancer Phase 1 Phase 2 Completed - Austria ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Salzburg, Austria, 5020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Wels, Austria, 4600 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Wien, Austria, A-1100 Czech Republic For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Brno, Czech Republic, 625 00 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Nova Ves Pod Plesi, Czech Republic, 26204 Hungary For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Budapest, Hungary, 1122 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Szeged, Hungary, 6720 Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Gdansk, Poland, 80-210 Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Bucharest, Romania, 022328 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Cluj-Napoca, Romania, 3400 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Iasi, Romania, 6600 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Moscow, Russian Federation, 129128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Saint Petersburg, Russian Federation, 197022 Less <<
NCT06296745 Leptomeningeal Metastasis PHASE2 NOT_YET_RECRUITING 2026-03-20 -
NCT05805631 Carcinoma, Non-Small-Cell Lung... More >>|Epidermal Growth Factor Receptor|Leptomeningeal Metastasis Less << PHASE2 NOT_YET_RECRUITING 2027-06-01 -
NCT00190762 Mesothelioma PHASE3 COMPLETED 2025-11-05 For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9:00 AM - 5:00 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician, Ottawa, Ontario, K1H8L6, Canada Less <<
NCT00523419 Osteosarcoma PHASE2 COMPLETED 2025-06-10 For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bordeaux, 33076, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lyon, 69437, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Marseille, 13385, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Villejuif, 94805, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Heidelberg, 69120, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Munich, 81377, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bologna, 40136, Italy|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Milano, 20133, Italy|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Torino, 1053, Italy|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Barcelona, 08025, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madrid, 28050, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Pamplona, 31008, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Newcastle-Upon-Tyne, Tyneside, NE4 6BE, United Kingdom Less <<
NCT00109096 Ovarian Neoplasms|Primary Peri... More >>toneal Cancer Less << PHASE2 COMPLETED 2025-03-07 For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bruxelles, Belgium|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Leuven, Belgium|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Berlin, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Erlangen, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Hamburg, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Homburg/Saar, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Jena, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Magdeburg, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mainz, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Munchen, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Wolfsburg, Germany|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Barcelona, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Jaen, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Malaga, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Palma De Mallorca, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Sabadell, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Valencia, Spain|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Birmingham, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Leeds, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Newcastle-Upon-Tyne, United Kingdom|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Sutton, United Kingdom Less <<
NCT06346977 Diagnosis NOT_YET_RECRUITING 2024-12-31 Union hospital, Wuhan, Hubei, ... More >>430000, China Less <<
NCT00191750 Carcinoma, Small Cell PHASE2 COMPLETED 2025-09-06 For additional information reg... More >>arding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Aurora, Colorado, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Chapel Hill, North Carolina, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician, Dallas, Texas, United States Less <<
NCT03955042 Chordoma PHASE1 COMPLETED 2023-01-18 John Wayne Cancer Institute, S... More >>anta Monica, California, 90404, United States Less <<
NCT04843007 Non Small Cell Lung Cancer|Mal... More >>ignant Pleural Mesothelioma Less << COMPLETED 2020-01-22 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.34mL

0.47mL

0.23mL

11.70mL

2.34mL

1.17mL

23.40mL

4.68mL

2.34mL

References

 

Historical Records

Categories